<SEC-DOCUMENT>0001104659-22-115148.txt : 20221107
<SEC-HEADER>0001104659-22-115148.hdr.sgml : 20221107
<ACCEPTANCE-DATETIME>20221107080053
ACCESSION NUMBER:		0001104659-22-115148
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20221103
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221107
DATE AS OF CHANGE:		20221107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Certara, Inc.
		CENTRAL INDEX KEY:			0001827090
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39799
		FILM NUMBER:		221363781

	BUSINESS ADDRESS:	
		STREET 1:		100 OVERLOOK CENTER, SUITE 101
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		(609) 716-7900

	MAIL ADDRESS:	
		STREET 1:		100 OVERLOOK CENTER, SUITE 101
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2229794d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:CERT="http://certara.com/20221103">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_CERT_certara.com_20221103 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20221103_20221103 -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0001827090 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:EntityCentralIndexKey">0001827090</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cert-20221103.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-11-03to2022-11-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001827090</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-03</xbrli:startDate>
        <xbrli:endDate>2022-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 9pt Sans-Serif; color: Red"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 9pt Sans-Serif; color: Red"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 14pt Times New Roman, Times, Serif"><b>UNITED
STATES</b></span>&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_908_edei--DocumentType_c20221103__20221103_zaU4NgM2TNe3"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of</b>&#160; <b>the Securities Exchange
Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_904_edei--DocumentPeriodEndDate_c20221103__20221103_zU5hJj7sywrg"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">November 3, 2022</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90A_edei--EntityRegistrantName_c20221103__20221103_zjjugdogyXz4"><b><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:EntityRegistrantName">Certara,
Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20221103__20221103_zFb8FZhmytPd"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityFileNumber_c20221103__20221103_z93g8BWH9lm2"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:EntityFileNumber">001-39799</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20221103__20221103_zG5exoTmx0W9"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:EntityTaxIdentificationNumber">82-2180925</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">of incorporation)</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">File Number)</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Identification No.)</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: middle; text-align: center">&#160;</td>
    <td style="vertical-align: middle; text-align: center">&#160;</td>
    <td style="vertical-align: middle; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: middle; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityAddressAddressLine1_c20221103__20221103_zsEq4zHNjkz2"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:EntityAddressAddressLine1">100 Overlook Center</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; vertical-align: middle">&#160;</td>
    <td style="text-align: center; vertical-align: middle">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: middle; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--EntityAddressAddressLine2_c20221103__20221103_ziVRHok72Od"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:EntityAddressAddressLine2">Suite 101</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; vertical-align: middle">&#160;</td>
    <td style="text-align: center; vertical-align: middle">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: middle; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20221103__20221103_zLy8qR2IpTvl"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:EntityAddressCityOrTown">Princeton</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20221103__20221103_z9zoVFhyPc0e"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New Jersey</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; vertical-align: middle">&#160;</td>
    <td style="vertical-align: middle; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--EntityAddressPostalZipCode_c20221103__20221103_zyLDB377nEAi"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:EntityAddressPostalZipCode">08540</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</span></td>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center"><b>(<span id="xdx_900_edei--CityAreaCode_c20221103__20221103_z5KFCVLyRM72"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:CityAreaCode">609</ix:nonNumeric></span>) <span id="xdx_907_edei--LocalPhoneNumber_c20221103__20221103_zsSe5aixBiDc"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:LocalPhoneNumber">716-7900</ix:nonNumeric></span></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center">(Registrant's telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 16.5pt"><span style="font-family: Wingdings"><span id="xdx_902_edei--WrittenCommunications_c20221103__20221103_z4kpSPzWOzRh"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td><td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 16.5pt"><span style="font-family: Wingdings"><span id="xdx_904_edei--SolicitingMaterial_c20221103__20221103_znCeFoMyruR2"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td><td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 16.5pt"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20221103__20221103_zaIKLcUDofIg"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td><td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 16.5pt"><span style="font-family: Wingdings"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20221103__20221103_zM6KA79AtPxl"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title of each class</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading <br />
Symbol</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name of  exchange<br />
 on which registered</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_edei--Security12bTitle_c20221103__20221103_zLhGQhKSeY9l"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:Security12bTitle">Common stock, par value $0.01 per share</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_edei--TradingSymbol_c20221103__20221103_zNVewaDL9ul5"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" name="dei:TradingSymbol">CERT</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--SecurityExchangeName_c20221103__20221103_zqjCPQ5R8f69"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Global Select Market</ix:nonNumeric></span></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 337pt; text-align: right">Emerging growth company <span style="font-family: Wingdings"><span id="xdx_902_edei--EntityEmergingGrowthCompany_c20221103__20221103_zWu0gD66Rfgl"><ix:nonNumeric contextRef="From2022-11-03to2022-11-03" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><b>&#160;</b></p>

<p style="margin: 0"><b>Item 1.01 Entry into a Material Definitive Agreement.&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">On November 3, 2022, an
institutional shareholder of Certara, Inc. (the &#8220;Company&#8221;) affiliated with EQT AB entered into an agreement to sell an aggregate
of 29,954,521 shares of the Company&#8217;s common stock, par value $0.01 per share (&#8220;Common Stock&#8221;), at a price of $15.00
per share to an affiliate of Arsenal Capital Partners (together with certain of its affiliated investment funds, &#8220;Arsenal&#8221;).
The closing of the transaction (the &#8220;closing&#8221;) is subject to the satisfaction or waiver of customary closing conditions, including
the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In connection with the
transaction, the Company entered into the following agreements:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Letter Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The Company entered into
a letter agreement, dated as of November 3, 2022 (the &#8220;Letter Agreement&#8221;), with Arsenal providing that, until the two-year
anniversary of the closing, Arsenal will, subject to certain exceptions, be prohibited from transferring the shares of Common Stock that
it will acquire in connection with the closing. Except in the case of certain provisions specified therein, the Letter Agreement will
be effective upon the closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Stockholders Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The Company entered into
a Stockholders Agreement, dated as of November 3, 2022 (the &#8220;Stockholders Agreement&#8221;), with Arsenal. Pursuant to the Stockholders
Agreement, Arsenal will have the right, but not the obligation, to nominate to the Board two directors until the latest of: (i) from the
closing date of the transaction until the two-year anniversary thereof, for so long as Arsenal continues to own 100% of the shares Arsenal
purchases in connection with the transaction, (ii) after the two-year anniversary of the closing date of the transaction, for so long
as Arsenal beneficially owns at least 12% of the total number of Adjusted Shares Outstanding (as defined in and calculated by the Stockholders
Agreement) and (iii) from the closing date of the transaction until the five-year anniversary thereof, for so long as Arsenal continues
to own 100% of the shares Arsenal purchases in connection with the transaction. Arsenal will have the right, but not the obligation, to
nominate to the Board one director for so long as Arsenal beneficially owns at least 6%, but less than 12%, of the total number of Adjusted
Shares Outstanding (as defined in and calculated by the Stockholders Agreement). Any individual designated by Arsenal (any individual
so designated, an &#8220;Arsenal Director Nominee&#8221;) must be (i) a full-time senior employee of Arsenal Capital Management LP or
its affiliates, such as an investment partner, a senior partner or an operating partner, or (ii) another individual that Arsenal reasonably
believes is appropriately qualified to serve as a director on the board of a public company, provided that the designation of any individual
pursuant to clause (ii) is subject to the consent of the Board (excluding any Arsenal Director Nominees), acting in its sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">If, at any time, there
are two Arsenal Director Nominees serving on the Board and Arsenal ceases to have the right to designate two Arsenal Director Nominees
but continues to have the right to designate one Arsenal Director Nominee, Arsenal shall cause the Arsenal Director Nominee who is closest
in time to being subject to re-election to irrevocably offer to tender his or her resignation from the Board, which resignation may be
accepted or rejected by the Board (excluding any Arsenal Director Nominees) in its sole discretion. Arsenal&#8217;s right to designate
any Arsenal Director Nominees pursuant to the Stockholders Agreement will terminate at such time that Arsenal beneficially owns less than
6% of the total number of Adjusted Shares Outstanding (as defined in and calculated by the Stockholders Agreement), and any Arsenal Director
Nominee(s) serving on the Board at such time must, and Arsenal must cause any such Arsenal Director Nominee(s) to, irrevocably offer to
tender his or her resignation to the Board, which resignation may be accepted or rejected by the Board (excluding any Arsenal Director
Nominees) in its sole discretion. As long as the Board is classified, the Arsenal Director Nominees will be Class I and Class III directors,
as designated by Arsenal. Upon the closing, the Board will be comprised of eleven members. The initial Arsenal Director Nominees will
be Steve McLean as a Class III director and Dave Spaight as a Class I director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">For so long as Arsenal
has the right to designate two Arsenal Director Nominees for nomination to serve on the Board, the Board (excluding the Arsenal Director
Nominees) shall appoint one Arsenal Director Nominee to the Nominating and Corporate Governance Committee and one Arsenal Director Nominee
to the Compensation Committee. At such time that Arsenal ceases to have the right to designate two Arsenal Director Nominees but continues
to have the right to designate one Arsenal Director Nominee for nomination to serve on the Board, the Board (excluding any Arsenal Director
Nominees) shall appoint one Arsenal Director Nominee (who is specified by Arsenal) to either the Nominating and Corporate Governance Committee
or the Compensation Committee (or allow such Arsenal Director Nominee to continue to serve on such committee, as applicable), and immediately
remove the other Arsenal Director Nominee from any and all committees of the Board. At such time that Arsenal ceases to have the right
to designate any Arsenal Director Nominees for nomination to serve on the Board pursuant to the Stockholders Agreement, the Board (excluding
any Arsenal Director Nominees) shall immediately remove any and all Arsenal Director Nominees from any and all committees of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The Company shall include
the Arsenal Director Nominees on the slate that is included in its proxy statement relating to the election of directors of the class
to which such persons belong and must provide at least the same level of support for the election of each such person as it provides to
any other individual standing for election as a director. In addition, Arsenal agrees with the Company to vote in favor of the Company
slate that is included in its proxy statement for so long as Arsenal is entitled to designate any Arsenal Director Nominees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In the event that an Arsenal
Director Nominee ceases to serve as a director for any reason (other than (i) the failure of the Company&#8217;s stockholders to elect
such individual as a director or (ii) due to Arsenal no longer having the right to designate such an Arsenal Director Nominee), Arsenal
will be entitled to designate a replacement Arsenal Director Nominee and the Company will take all reasonable actions necessary to cause
the appointment of any such replacement Arsenal Director Nominee to fill the resulting vacancy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The Stockholders Agreement
will be effective upon the closing. In connection with the closing, that certain Stockholders Agreement, dated as of December 10, 2020,
by and among Certara, Inc. and the other parties named therein, will be terminated in accordance with its terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Registration Rights Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The Company entered into
a Registration Rights Agreement, dated as of November 3, 2022 (the &#8220;Registration Rights Agreement&#8221;), with Arsenal. The Registration
Rights Agreement contains provisions that entitle Arsenal to certain rights to have their securities registered by the Company under the
Securities Act. While the Registration Rights Agreement is in effect, Arsenal is entitled to (i) four &#8220;demand&#8221; registrations,
(ii) one underwritten offering in any consecutive 90-day period and (iii) two underwritten offerings in any consecutive 360-day period,
subject in each case to certain limitations. In addition, the Registration Rights Agreement provides that the Company will share certain
expenses of Arsenal relating to such registrations and indemnify Arsenal against certain liabilities which may arise under the Securities
Act. The Registration Rights Agreement will be effective upon the closing. In connection with the closing, that certain Amended and Restated
Registration Rights Agreement, dated as of December 10, 2020, by and among Certara, Inc. and the other parties named therein, will be
terminated in accordance with its terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The foregoing descriptions
of the Letter Agreement, the Stockholders Agreement and the Registration Rights Agreement are qualified in their entirety by reference
to the full text of the Letter Agreement, the Stockholders Agreement and the Registration Rights Agreement, copies of which are filed
as Exhibits 10.1, 10.2 and 10.3 to this Current Report on Form 8-K and are incorporated in this Item 1.01 by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 10%; text-align: left"><b>Item 5.02</b></td><td style="text-align: justify; width: 90%"><b>Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In connection with the transaction, Eric Liu and Ethan Waxman are each expected to resign from the Board following the closing. Mssrs.
Liu and Waxman intend to remain on the Board until after the closing. In accordance with the Stockholders Agreement, Arsenal intends to
nominate David Spaight to the Board following the closing and the departure of Mssrs. Liu and Waxman from the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 10%; font-size: 10pt"><span style="color: black"><b>Item 7.01</b></span></td>
    <td style="width: 90%; font-size: 10pt"><span style="color: black"><b>Regulation FD Disclosure.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On November 7, 2022, the Company issued a press
release announcing the transaction. A copy of that press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information included in this Current Report
on Form 8-K under this Item 7.01 (including Exhibit 99.1 hereto) is being &#8220;furnished&#8221; and shall not be deemed &#8220;filed&#8221;
for purposes of the Exchange Act, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as
amended, except as expressly set forth by specific reference in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 10%; font-size: 10pt"><b>Item 9.01</b></td>
    <td style="width: 90%; font-size: 10pt"><b>Financial Statements and Exhibits. </b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits. The following exhibits are filed herewith:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">Exhibit<br />
No.</td>
    <td style="width: 93%; text-align: center">Description</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><a href="tm2229794d1_ex10-1.htm" style="-sec-extract: exhibit">10.1</a></td>
    <td><a href="tm2229794d1_ex10-1.htm" style="-sec-extract: exhibit">Letter Agreement, dated as of November 3, 2022, by and among Certara, Inc. and Arsenal Saturn Holdings LP</a></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><a href="tm2229794d1_ex10-2.htm" style="-sec-extract: exhibit">10.2</a></td>
    <td><a href="tm2229794d1_ex10-2.htm" style="-sec-extract: exhibit">Stockholders Agreement, dated as of November 3, 2022, by and among Certara, Inc. and the other parties thereto</a></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><a href="tm2229794d1_ex10-3.htm" style="-sec-extract: exhibit">10.3</a></td>
    <td><a href="tm2229794d1_ex10-3.htm" style="-sec-extract: exhibit">Registration Rights Agreement, dated as of November 3, 2022, by and among Certara, Inc. and the other parties thereto</a></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><a href="tm2229794d1_ex99-1.htm" style="-sec-extract: exhibit">99.1</a></td>
    <td><a href="tm2229794d1_ex99-1.htm" style="-sec-extract: exhibit">Press Release, dated November 7, 2022</a></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">104</td>
    <td>Cover Page Interactive Data File (formatted as Inline XBRL).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="width: 50%">&#160;</td>
    <td style="width: 50%">CERTARA, INC.</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>(Registrant)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="width: 50%">Date: November 7, 2022</td>
    <td style="width: 3%">By:</td>
    <td style="border-bottom: black 1pt solid; width: 47%">/s/ Richard M. Traynor</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Name: Richard M. Traynor</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Title: Senior Vice President and General Counsel</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LdoVhro7HTrEKTJEvC0uSnFrRlr/Hsm3tG6IIRCSc74cIQYip6WpkeE4LwvYY9PW2iOUeEZGe8LgyFbrFMIs8WKcZ219t/7AjAKDgUmGEx3unfNuHFYpyGSk5EjFIKepGsNsI6KvnpE9mwqtN7oGbSvYMbVs0Gt+9R/2+kmWmleXdEB2hmwK8VD28huUjBVs6a4fxFcHRZGJaNBVJHKmW/uNuTlPDSxqbEKW69F/Rx/Zi0kR -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2229794d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Execution Version</I>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certara,
Inc.</B></FONT><BR>
100 Overlook Center, Suite 101<BR>
Princeton, NJ 08540</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">November 3, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies &amp; Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of Certara, Inc., a Delaware corporation (together with its successors and permitted assigned, the &ldquo;<B>Company</B>&rdquo; or &ldquo;<B>Certara</B>&rdquo;),
and Arsenal Saturn Holdings LP (the &ldquo;<B>Arsenal Party</B>&rdquo;), make reference to: (i) that certain Stockholders Agreement (as
amended, modified or supplemented from time to time in accordance with its terms, the &ldquo;<B>Stockholders Agreement</B>&rdquo;) of
the Company, entered into as of the date hereof, by and among </FONT>the Company, the Arsenal Party, Arsenal Capital Partners III LP and
Arsenal Capital Partners III-B LP; (ii) that certain Purchase Agreement, dated as of the date hereof (as it may be amended, amended and
restated, supplemented or otherwise modified from time to time, the &ldquo;<B>Purchase Agreement</B>&rdquo;), by and among the Arsenal
Party and EQT Avatar Parent L.P. (&ldquo;<B>EQT</B>&rdquo; or the &ldquo;<B>Seller</B>&rdquo;), which provides for, subject to the satisfaction
of the terms and conditions set forth in the Purchase Agreement, the sale of certain shares of common stock, par value $0.01 per share,
of the Company (&ldquo;<B>Sale Shares</B>&rdquo;) from the Seller to the Arsenal Party (and such transaction, the &ldquo;<B>Sale Transaction</B>&rdquo;);
and (iii) that certain Registration Rights Agreement (as amended, modified or supplemented from time to time in accordance with its terms,
the &ldquo;<B>Registration Rights Agreement</B>&rdquo;), entered into as of the date hereof, by and among the Company, the Arsenal Party,
Arsenal Capital Partners III LP and Arsenal Capital Partners III-B LP. For the avoidance of doubt, without limiting the foregoing, each
of Arsenal Capital Partners III LP and Arsenal Capital Partners III-B LP (collectively, &ldquo;<B>Fund III</B>&rdquo;) shall not be deemed
to be an &ldquo;Arsenal Party&rdquo; under the terms of this letter agreement and the terms of this letter agreement, including the restrictions
on transfer in Sections 1 and 4 hereof, shall not apply to Fund III. Capitalized terms used in this letter agreement that are not defined
shall have the meaning given to them in the Stockholders Agreement. The parties agree that Section 1, Section 2 and Section 4 of this
letter agreement are subject to the closing of the Sale Transaction under the Purchase Agreement (the &ldquo;<U>Closing</U>&rdquo;), and
shall become effective upon the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In consideration of the premises and of the representations, warranties,
covenants and agreements set forth herein, each of the Company and the Arsenal Party agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1.</FONT></TD><TD><B><U>Restrictions on Transfers</U></B>. Subject to, and on and from, Closing occurring under the Purchase Agreement:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT></TD><TD>the Arsenal Party agrees with the Company that, until the two (2) year anniversary of the consummation of the Sale Transaction (the
 &ldquo;<B>Lock-Up Period</B>&rdquo;), the Arsenal Party shall not Transfer all or any of the Shares owned by it (including, for the avoidance
of doubt, the Sale Shares, (collectively, the &ldquo;<B>Lock-Up Shares</B>&rdquo;)) to any Person other than as permitted by Section 2
hereof. Any attempted Transfer of Lock-Up Shares by the Arsenal Party not permitted by this letter agreement shall be null and void, and
the Company shall not in any way give effect to such impermissible Transfer. After the expiry of the Lock-Up Period, there shall be no
restrictions on a Transfer of Lock-Up Shares by the Arsenal Party pursuant to this letter agreement; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT></TD><TD>any Lock-Up Shares Transferred by the Arsenal Party pursuant to this letter agreement prior to the expiry of the Lock-Up Period shall
remain subject to the Transfer restrictions set forth in this letter agreement and each intended transferee pursuant to this letter agreement
shall execute and deliver to the Company a letter agreement in the same form as this letter agreement (with such changes as may be agreed
by the Company in its sole discretion), which shall evidence such transferee&rsquo;s agreement to be subject to the same terms and conditions
as contained in this letter agreement as to such Lock-Up Shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.</FONT></TD><TD><B><U>Permitted Transfers</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT></TD><TD>Subject to the conditions below, the Arsenal Party may Transfer the Lock-Up Shares during the Lock-Up Period:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD>as a distribution or other Transfer by a partnership to its partners or former partners or by a limited liability company to its members
or retired members or by a corporation to its stockholders or former stockholders;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD>to any investment fund or other entity directly or indirectly, affiliated with, or managed, controlled or sponsored by the Arsenal
Party or any affiliates of the Arsenal Party;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD>in connection with the financing of the Arsenal Party&rsquo;s obligations under the Purchase Agreement, or in connection with the
settlement of any such financing; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD>to the Company;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>provided</U></FONT>
that, as a condition of the consummation of any of the Transfers provided for in clauses (i), (ii) or (iii) above, the intended transferee
must comply with Section 1(b) of this Letter Agreement, including first executing and delivering to the Company a letter agreement in
the same form as this letter agreement (with such changes as may be agreed by the Company in its sole discretion), which shall evidence
such transferee&rsquo;s agreement to be subject to the same terms and conditions as contained in this letter agreement as to such Lock-Up
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT></TD><TD>Furthermore, no provision in this letter agreement shall be deemed to restrict or prohibit the Transfer of Lock-Up Shares at the completion
of a bona fide third-party tender offer, merger, consolidation or other similar transaction made to all holders of the Company&rsquo;s
securities involving a change of control of the Company; <U>provided</U>, <U>however</U>, that in the event that such tender offer, merger,
consolidation or other such transaction is not completed, such securities held by the Arsenal Party shall remain subject to the restrictions
on transfer set forth in this letter agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.</FONT></TD><TD><B><U>Permitted Assignment</U></B>. To the extent the Arsenal Party wishes to assign all or any portion of its rights, interests and
obligations under the Purchase Agreement to an Arsenal Managed Vehicle (as that term is defined in the Purchase Agreement) or a Co-Investor
(as that term is defined in the Purchase Agreement), as provided for in Section 5.3 of the Purchase Agreement, as a condition to any such
assignment, the Arsenal Party shall cause the intended transferee of such assignment to first execute and deliver to the Company a letter
agreement in the same form as this letter agreement (with such changes as may be agreed by the Company in its sole discretion), which
shall evidence such transferee&rsquo;s agreement to be subject to the same terms and conditions as contained in this letter agreement
as to such Lock-Up Shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">4.</FONT></TD><TD><B><U>Legends; Stop Transfer Instructions</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT></TD><TD>The Arsenal Party understands that the Lock-Up Shares owned by it and recorded on the books and records of the Company or its transfer
agent and register shall bear restrictive legends in substantially the following forms until such time as the Company determines that
such legend has ceased to be applicable:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE HELD BY
A PERSON WHO MAY BE DEEMED TO BE AN AFFILIATE OF THE ISSUER FOR PURPOSES OF RULE 144 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">THE SECURITIES REPRESENTED BY THIS CERTIFICATE WERE ISSUED
IN A TRANSACTION THAT WAS NOT REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE SECURITIES LAWS OF ANY STATE AND MAY
NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAWS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT
TO THE TERMS AND CONDITIONS SET FORTH IN A LETTER AGREEMENT, DATED AS OF NOVEMBER 3, 2022, AS AMENDED, RESTATED OR SUPPLEMENTED FROM TIME
TO TIME. NO TRANSFER OF SUCH SECURITIES WILL BE MADE ON THE BOOKS OF THE ISSUER UNLESS ACCOMPANIED BY EVIDENCE OF COMPLIANCE WITH THE
TERMS OF SUCH AGREEMENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT></TD><TD>The Arsenal Party agrees and consents to the entry of stop transfer instructions with the Company&rsquo;s transfer agent and registrar
against the Transfer of Shares held by the Arsenal Party, except in compliance with the foregoing restrictions.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5.</FONT></TD><TD STYLE="text-align: left"><B><U>Remedies</U></B>. Each of the parties to this letter agreement
acknowledges and agrees that the other parties to this Agreement would be irreparably damaged in the event that any of the terms or provisions
of this letter agreement are not performed in accordance with their specific terms or otherwise are breached. Therefore, notwithstanding
anything to the contrary contained in this letter agreement, in the event of any breach or threatened breach by of any covenant, agreement,
undertaking or commitment provided for herein, any party entitled to the benefit of such covenant, agreement, undertaking or commitment
shall be entitled to enforce specific performance of this letter agreement or obtain an injunction or injunctions to prevent breaches
of any of the terms or provisions of this Agreement, and specifically the performance by each party hereto under this letter agreement.
The right to specific performance is an integral part of the transactions contemplated by this letter agreement and without that right,
the parties would not have entered into this letter agreement. Each party to this letter agreement hereby agrees to waive the defense
in any such suit that the other parties to this letter agreement have an adequate remedy at law and hereby agrees to waive any requirement
to post any bond or similar indemnity in connection with obtaining such relief. The equitable remedies described in this Section 5 shall
be in addition to, and not in lieu of, any other remedies at law or in equity that the parties to this letter agreement may elect to
pursue.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">6.</FONT></TD><TD><B><U>Entire Agreement; Amendment; Waiver</U></B>. This letter agreement together with the Stockholders Agreement sets forth the entire
understanding of the Company and the Arsenal Party, and as of the date hereof supersedes all prior agreements and all other arrangements
and communications, whether oral or written, with respect to the subject matter hereof and thereof. This letter agreement may only be
amended, modified, supplemented, restated, waived or terminated by mutual agreement of the Company and the Arsenal Party as evidenced
in writing. Notwithstanding any provisions to the contrary contained herein, any party may waive any rights with respect to which such
party is entitled to benefits under this letter agreement. No waiver of or consent to any departure from any provision of this letter
agreement shall be effective unless signed in writing by the party entitled to the benefit thereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.</FONT></TD><TD><B><U>Severability</U></B>. It is the desire and intent of the Company and the Arsenal Party that the provisions of this letter agreement
be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is
sought. Accordingly, the invalidity or unenforceability of any particular provision of this letter agreement shall not affect the other
provisions hereof, and this letter agreement shall be construed in all respects as if the invalid or unenforceable provision were omitted.
Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid or unenforceable in such jurisdiction,
it shall, as to such jurisdiction, be so more narrowly drawn, without invalidating the remaining provisions of this letter agreement or
affecting the validity or enforceability of such provision in any other jurisdiction.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">8.</FONT></TD><TD><B><U>Notices</U></B>. Unless otherwise specified herein, all notices, consents, approvals, reports, designations, requests, waivers,
elections and other communications authorized or required to be given pursuant to this letter agreement shall be in writing and shall
be deemed to have been given (a) when personally delivered, (b) when transmitted via facsimile to the number set out below, as applicable,
if the sender receives confirmation of delivery or if the sender on the same or following business day sends a confirming copy of such
notice by a recognized delivery service (charges prepaid), (c) the day following the day (except if not a business day then the next business
day) on which the same has been delivered prepaid to a reputable national overnight air courier service, (d) when transmitted via email
(including via attached pdf document) to the email address set out below or (e) the third business day following the day on which the
same is sent by certified or registered mail, postage prepaid, in each case, to the respective parties, as applicable, at the address,
facsimile number or email address set forth below, as applicable (or such other address, facsimile number or email address as either party
may specify by notice to the other in accordance with this Section 8. By notices complying with the forgoing provisions of this Section
8, each party to this letter agreement shall have the right to change the mailing address or facsimile number for future notices and communications
to such party.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT></TD><TD>For notices and communications to the Company, to:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certara,
Inc.<BR>
100 Overlook Center, Suite 101<BR>
Princeton, NJ 08550<BR>
Attention: Richard M. Traynor<BR>
Email: [</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy to (which shall not constitute actual or constructive notice):<BR>
<BR>
Simpson Thacher &amp; Bartlett LLP<BR>
425 Lexington Avenue<BR>
New York, New York 10017<BR>
Attention: Michael T. Holick<BR>
Email: [</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simpson
Thacher &amp; Bartlett LLP<BR>
2475 Hanover Street<BR>
Palo Alto, CA 94304<BR>
Attention: William Brentani and Frederick W.P. de Albuquerque<BR>
Email: [</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT></TD><TD>For notices and communications to the Arsenal Party, to:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c/o
Arsenal Capital Management LP<BR>
100 Park Avenue, 31<SUP>st</SUP> Floor<BR>
New York, NY 10017<BR>
Attention: Chief Financial Officer, Frank Scrudato<BR>
Email: [</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy to:<BR>
<BR>
Kirkland &amp; Ellis LLP<BR>
300 North LaSalle<BR>
Chicago, Illinois 60654<BR>
Attention: Ted M. Frankel, P.C. and Robert E. Goedert, P.C.<BR>
Email: [</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.</FONT></TD><TD><B><U>Governing
                                            Law</U></B>. All matters relating to the interpretation, construction, validity and enforcement
                                            of this letter agreement, including all claims (whether in contract or tort) that may be
                                            based upon, arise out of or relate to this letter agreement or the negotiation, execution
                                            or performance of this letter agreement, shall be governed by and construed in accordance
                                            with the domestic laws of the State of Delaware without giving effect to any choice or conflict
                                            of law provision or rule (whether of the State of Delaware or any other jurisdiction) that
                                            would cause the application of laws of any jurisdiction other than the State of Delaware.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">10.</FONT></TD><TD><B><U>No Waiver</U></B>. No course of dealing and no delay on the part of any party hereto in exercising any right, power or remedy
conferred by this letter agreement shall operate as waiver thereof or otherwise prejudice such party&rsquo;s rights, powers and remedies.
No single or partial exercise of any rights, powers or remedies conferred by this letter agreement shall preclude any other or further
exercise thereof or the exercise of any other right, power or remedy.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">11.</FONT></TD><TD><B><U>Costs and Expenses</U></B>. Each party shall be responsible for and shall pay its own costs and expenses incurred in connection
with this letter agreement and the performance of such party&rsquo;s duties and obligations hereunder.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">12.</FONT></TD><TD><B><U>Counterpart</U></B>. This letter agreement may be executed in two or more counterparts each of which shall be deemed an original
but all of which together shall constitute one and the same instrument, and all signatures need not appear on any one counterpart. Furthermore,
in the event that any signature or counterpart is delivered by facsimile transmission, electronic mail or otherwise by electronic transmission
evidencing an intent to sign this letter agreement, such facsimile transmission, electronic mail or other electronic transmission shall
create a valid and binding obligation of the undersigned with the same force and effect as if such signature were an original. Execution
and delivery of this letter agreement by facsimile transmission, electronic mail or other electronic transmission is legal, valid and
binding for all purposes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">13.</FONT></TD><TD><B><U>Consent to Jurisdiction</U></B>. The Company and the Arsenal Party (i) hereby irrevocably submit to the exclusive jurisdiction
of the state and federal courts in the State of Delaware for the purposes of any claim or action arising out of or based upon this letter
agreement or relating to the subject matter hereof, (ii) hereby waive, to the extent not prohibited by applicable law, and agree not to
assert by way of motion, as a defense or otherwise, in any such claim or action, any claim that it or he is not subject personally to
the jurisdiction of the above-named courts, that its, his or her property is exempt or immune from attachment or execution, that any such
proceeding brought in the above-named court is improper or that this letter agreement or the subject matter hereof may not be enforced
in or by such court and (iii) hereby agree not to commence any claim or action arising out of or based upon this letter agreement or relating
to the subject matter hereof other than before the above-named courts nor to make any motion or take any other action seeking or intending
to cause the transfer or removal of any such claim or action to any court other than the above-named courts whether on the grounds of
inconvenient forum or otherwise. The Company and the Arsenal Party hereby consent, to the fullest extent permitted by law, to service
of process in any such proceeding, and agree that service of process by registered or certified mail, return receipt requested, at its
address specified pursuant to Section 8 is reasonably calculated to give actual notice.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">14.</FONT></TD><TD><B><U>WAIVER OF JURY TRIAL</U></B>. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH PARTY HERETO HEREBY
WAIVES AND COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN
RESPECT OF ANY ISSUE OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE), INQUIRY, PROCEEDING OR INVESTIGATION
ARISING OUT OF OR BASED UPON THIS LETTER AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL
TO THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING. EACH PARTY HERETO ACKNOWLEDGES THAT IT
HAS BEEN INFORMED BY THE OTHER PARTIES HERETO THAT THIS SECTION 14 CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH THEY ARE RELYING AND WILL
RELY IN ENTERING INTO THIS LETTER AGREEMENT. ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 14 WITH ANY COURT
AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">15.</FONT></TD><TD><B><U>Representations and Warranties</U></B>. The Company hereby represents and warrants to the Arsenal Party that it has full power,
capacity, legal right and authority to execute, deliver and perform this letter agreement, and the Arsenal Party hereby represents and
warrants to the Company that the Arsenal Party has full power, capacity, legal right and authority to execute, deliver and perform this
letter agreement. Further, the Arsenal Party represents and warrants to the Company on the date hereof as follows:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(a)</FONT></TD><TD>the Arsenal Party is duly organized or incorporated, validly existing and in good standing under the laws of the jurisdiction of its
organization or incorporation and has all requisite power and authority to conduct its business as it is now being conducted and is proposed
to be conducted. The execution, delivery and performance of this letter agreement have been duly authorized by all necessary action, corporate
or otherwise, of the Arsenal Party. This letter agreement has been duly executed and delivered by the Arsenal Party and constitutes its
legal, valid and binding obligation, enforceable against it in accordance with its terms, subject to applicable bankruptcy, insolvency
and similar laws affecting creditors&rsquo; rights generally;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(b)</FONT></TD><TD>The execution and delivery by the Arsenal Party of this letter agreement, and the performance by the Arsenal Party of its obligations
hereunder, does not and will not violate (i) any provision of the Arsenal Party&rsquo;s organizational or constituent documents, as applicable,
(ii) any provision of any material agreement to which the Arsenal Party is a party or by which it is bound or (iii) any law, rule, regulation,
judgment, order or decree to which the Arsenal Party is subject. No notice, consent, waiver, approval, authorization, exemption, registration,
license or declaration is required to be made or obtained by such Arsenal Party in connection with the execution, delivery or enforceability
of this letter agreement (other than as set out expressly in the Purchase Agreement); and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">(c)</FONT></TD><TD>the Arsenal Party is not currently in violation of any law, rule, regulation, judgment, order or decree, which violation could reasonably
be expected at any time to have a material adverse effect upon the Arsenal Party&rsquo;s ability to enter into this letter agreement or
to perform its obligations hereunder. There is no pending legal action, suit or proceeding that would materially and adversely affect
the ability of the Arsenal Party to enter into this letter agreement or to perform its obligations hereunder.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16.</FONT></TD><TD><B><U>Inconsistency with Stockholders Agreement</U></B>. To the extent there is any inconsistency between the terms and conditions
of this letter agreement and the Stockholders Agreement, the terms and conditions of this letter agreement shall prevail and apply.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">17.</FONT></TD><TD><B><U>Termination</U></B>. This letter agreement shall terminate automatically and be of no further force or effect upon the earliest
to occur of: (i) the termination of the Purchase Agreement without the Sale Transaction having occurred and (ii) the expiration of the
Lock-Up Period.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS HEREOF, each of the parties hereto has duly executed this
letter agreement (or caused this letter agreement to be executed on its behalf by its officer or representative thereunto duly authorized)
as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">CERTARA, INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-size: 10pt">/s/
    William Feehery</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: William Feehery</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: CEO</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ARSENAL SATURN HOLDINGS LP</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By: Arsenal Capital Investment VI
    LP, its general partner</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By: Arsenal Group LLC, its general
    partner</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Frank Scrudato</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Frank Scrudato</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: CFO</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tm2229794d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Execution Version</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTARA,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STOCKHOLDERS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Dated as of November&nbsp;3, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>TABLE OF CONTENTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Page</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">ARTICLE&nbsp;I
    DEFINITIONS</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">1.1</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Certain
    Matters of Construction</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">1.2</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Definitions</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right">2</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">ARTICLE&nbsp;II
    COVENANTS AND CONDITIONS</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">5</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">2.1</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Corporate
    Governance</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">5</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">2.2</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Confidentiality</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">8</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">ARTICLE&nbsp;III
    MISCELLANEOUS</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">9</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.1</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Remedies</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">9</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.2</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Entire
    Agreement; Amendment</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">9</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.3</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Severability</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">9</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.4</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Notices</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right">10</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.5</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Binding
    Effect; Assignment</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right">1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.6</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Governing
    Law</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">11</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.7</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Termination</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">11</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.8</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Recapitalizations,
    Exchanges, Etc.</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">11</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.9</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Action
    Necessary to Effectuate the Agreement</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">11</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.10</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Other Business
    Opportunities</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">12</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.11</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">No Waiver</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">13</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.12</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Costs and
    Expenses</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">13</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.13</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Counterpart</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">13</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.14</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Headings</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">13</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.15</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Consent
    to Jurisdiction</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">13</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.16</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">WAIVER
    OF JURY TRIAL</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">14</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.17</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Representations
    and Warranties</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">14</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.18</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Consents,
    Approvals and Actions</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">15</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.19</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">No Third
    Party Liabilities</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">15</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.20</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Mutual
    Drafting</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">15</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.21</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Enforcement</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">15</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.22</FONT></TD>
    <TD STYLE="padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Effectiveness</FONT></TD>
    <TD STYLE="padding-bottom: 5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">15</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STOCKHOLDERS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">This Stockholders Agreement (as amended, modified
or supplemented from time to time in accordance with its terms, this &ldquo;<U>Agreement</U>&rdquo;) of Certara,&nbsp;Inc. (together
with its successors and permitted assigns, the &ldquo;<U>Company</U>&rdquo;), a Delaware corporation, is entered into as of November&nbsp;3,
2022, by and among (i)&nbsp;the Company and (ii)&nbsp;the Arsenal Stockholders (defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, in connection with the 2020 Initial Public
Offering (defined below), the Company and certain stockholders entered into that certain Stockholders Agreement, dated as of December&nbsp;10,
2020 (the &ldquo;<U>Prior Agreement</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, on December&nbsp;11, 2020, the Company
consummated an initial public offering of shares of Common Stock (defined below) (&ldquo;<U>2020 Initial Public Offering</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, on the date hereof, the Company and Arsenal
entered into a letter agreement (&ldquo;<U>Letter Agreement</U>&rdquo;) in connection with the Sale Transaction (as that term is defined
in the Letter Agreement, the &ldquo;<U>Sale Transaction</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, the Prior Agreement will terminate in accordance
with its terms in connection with the consummation of the Sale Transaction and the Company and the Arsenal Stockholders wish to enter
into this Agreement in connection with the Sale Transaction with this Agreement taking effect upon the consummation of the Sale Transaction;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, in connection with such events, the parties
hereto desire to provide for certain governance rights and other matters upon the effectiveness of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">NOW, THEREFORE, in consideration of the mutual promises,
representations, warranties, covenants and conditions set forth in this Agreement, and other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the parties hereby agree, subject to <U>Section&nbsp;3.22</U>, that in connection with
the consummation of the Sale Transaction that the Prior Agreement be terminated and this Agreement shall become effective as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #010000"><FONT STYLE="text-transform: uppercase">ARTICLE&nbsp;I</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Certain
Matters of Construction</U>. In addition to the definitions referred to or set forth below in this <U>ARTICLE&nbsp;I</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
words &ldquo;<U>hereof</U>,&rdquo; &ldquo;<U>herein</U>,&rdquo; &ldquo;<U>hereunder</U>&rdquo; and words of similar import shall, unless
the context requires otherwise, refer to this Agreement as a whole and not to any particular Section&nbsp;or provision of this Agreement,
and reference to a particular Section&nbsp;of this Agreement shall include all subsections thereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>References
to Sections and Articles refer to Sections and Articles of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Definitions
shall be equally applicable to both nouns and verbs and the singular and plural forms of the terms defined; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
masculine, feminine and neuter genders shall each include the others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Definitions</U>.
For the purposes of this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>2020 Initial Public Offering</U>&rdquo;
shall have the meaning set forth in the recitals of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Adjusted Shares Outstanding</U>&rdquo;
shall mean, (i)&nbsp;as of any measurement date between the Effective Date until the five (5)&nbsp;year anniversary of the Effective
Date, the total number of issued and outstanding Shares, as adjusted to exclude the impact of any Shares that are issued, or that the
Company has agreed to issue, at any time after the date hereof and on or prior to the five (5)&nbsp;year anniversary of the Effective
Date, in connection with any merger transaction involving the Company or any of its Subsidiaries or the purchase by the Company or any
of its Subsidiaries of any assets or stock of another Person, including Shares issued as consideration to target company stockholders
and Shares issued in exchange for a primary investment in the Company to fund such transaction, and (ii)&nbsp;as of any measurement date
from and after the five (5)&nbsp;year anniversary of the Effective Date, the total number of issued and outstanding Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Affiliate</U>&rdquo; shall mean, with
respect to any specified Person, any other Person which, directly or indirectly, through one or more intermediaries controls, or is controlled
by, or is under common control with, such specified Person (for the purposes of this definition, &ldquo;<U>control</U>&rdquo; (including,
with correlative meanings, the terms &ldquo;<U>controlling</U>,&rdquo; &ldquo;<U>controlled by</U>&rdquo; and &ldquo;<U>under common
control with</U>&rdquo;), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or
cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or
otherwise); <U>provided</U>, <U>however</U>, that, for purposes of this Agreement, (i)&nbsp;the Company and its Subsidiaries shall not
be an Affiliate of any Arsenal Stockholder or Co-Investor or any of their respective Affiliates, (ii)&nbsp;none of the Arsenal Stockholders
shall be considered Affiliates of any portfolio company in which (a)&nbsp;the Arsenal Stockholders or (b)&nbsp;any investment funds,
vehicles and accounts affiliated with, or advised, managed or sponsored by the Arsenal Stockholders or their Affiliates have made a debt
or equity investment (and vice versa), and (iii)&nbsp;no Co-Investor shall be considered an Affiliate of any portfolio company in which
(x)&nbsp;such Co-Investor or (y)&nbsp;any investment funds, vehicles and accounts affiliated with, or advised, managed or sponsored by
such Co-Investor or any of its Affiliates have made a debt or equity investment (and vice versa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Agreement</U>&rdquo; shall have the meaning
set forth in the preamble of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Arsenal</U>&rdquo; shall mean Arsenal
Saturn Holdings LP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Arsenal Amount</U>&rdquo; shall mean the
aggregate number of Shares Beneficially Owned by (i)&nbsp;the Arsenal Stockholders, and (ii)&nbsp;any Co-Investor or any of its Affiliates
to which such Co-Investor has transferred Shares, <U>provided</U>, that Shares Beneficially Owned by such Co-Investor or any of its Affiliates,
as applicable, shall only be included if (a)&nbsp;such Co-Investor or any of its Affiliates to which such Co-Investor has transferred
Shares, as applicable, has signed a Joinder Agreement, evidencing that such Co-Investor or such Affiliate, as applicable, agrees to be
bound by <U>Section&nbsp;2.1(b)</U>&nbsp;and <U>Section&nbsp;2.2</U> hereof; (b)&nbsp;such Co-Investor or any of its Affiliates to which
such Co-Investor has transferred Shares, as applicable, has executed an irrevocable proxy agreement reasonably acceptable to the Company
providing an Arsenal Stockholder with a full proxy with respect to voting such Person&rsquo;s Shares, including the full and exclusive
right to direct the voting with respect to any matters on which the Shares are entitled to vote, as of any measurement date; provided,
however, that such irrevocable proxy agreement shall not apply to Shares held by any such Co-Investor prior to the Effective Date; and
(c)&nbsp;in the case of an Affiliate of such Co-Investor to which such Co-Investor has transferred Shares, such Affiliate of such Co-Investor
has executed a letter agreement the same form as the Letter Agreement if such transfer has occurred prior to the two (2)&nbsp;year anniversary
of the Effective Date; <U>provided</U>, <U>further</U>, that any Shares Beneficially Owned by any such Co-Investor or any of its Affiliates
prior to the Effective Date shall not be included in the Arsenal Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Arsenal Consent</U>&rdquo; shall mean
the prior written consent of the Arsenal Stockholders holding a majority of shares of Common Stock held by the Arsenal Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Arsenal Director Nominee</U>&rdquo; shall
have the meaning as set forth in <U>Section&nbsp;2.1(a)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Arsenal
Stockholders</U>&rdquo; shall mean, in each case only for so long as such Person is a holder of Shares, Arsenal, Arsenal Capital Partners
III LP, Arsenal Capital Partners III-B LP and their respective Affiliates who have signed </FONT>a Joinder agreeing to be bound by this
Agreement, including <U>Section&nbsp;2.1(b)</U>&nbsp;and <U>Section&nbsp;2.2</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Beneficially Own</U>&rdquo; shall mean
that a specified person has or shares the right, directly or indirectly, through any contract, arrangement, understanding, relationship
or otherwise, to vote shares of capital stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Board</U>&rdquo; or &ldquo;<U>Board of
Directors</U>&rdquo; shall mean the Board of Directors of the Company as the same shall be constituted from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Co-Investor</U>&rdquo; shall mean any
Person who has executed and delivered to the Company (i)&nbsp;a letter agreement in the same form as the Letter Agreement and (ii)&nbsp;a
joinder to the Purchase Agreement as a &ldquo;Co-Investor&rdquo;, in each case, pursuant to and in accordance with the terms of the Purchase
Agreement. Upon the consummation of the Sale Transaction, each Co-Investor shall deliver to the Company a Joinder Agreement, evidencing
that it agrees to be bound by the terms of <U>Section&nbsp;2.1(b)</U>&nbsp;and <U>Section&nbsp;2.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Common Stock</U>&rdquo; shall mean the
Company&rsquo;s common stock, par value $0.01 per share, and shall also include any common stock of the Company hereafter authorized
and any capital stock of the Company of any other class hereafter authorized which does not have a preference as to dividends or distribution
of assets in liquidation over any other class of capital stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company</U>&rdquo; shall have the meaning
set forth in the preamble of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Director Election Proxy Statement</U>&rdquo;
has the meaning set forth in Section&nbsp;<U>2.1(a)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Effective Date</U>&rdquo; shall mean the
date upon which the closing of the Sale Transaction occurs under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Joinder Agreement</U>&rdquo; means a joinder
agreement substantially in the form of <U>Annex I</U> attached hereto or such other form as may be agreed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Law</U>&rdquo; shall have the meaning
as set forth in <U>Section&nbsp;2.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Letter Agreement</U>&rdquo; shall have
the meaning set forth in the recitals of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Permitted Transfer</U>&rdquo; shall mean
a Transfer of Shares by any Arsenal Stockholder to (a)&nbsp;any Affiliate of such Arsenal Stockholder or (b)&nbsp;any investment fund
or alternative investment vehicle, directly or indirectly, affiliated with, or managed or sponsored by, such Arsenal Stockholder; <U>provided</U>,
however, that no Permitted Transfer shall be effective unless and until the transferee of the Shares so transferred executes and delivers
to the Company a Joinder Agreement. If at any time after a Permitted Transfer, a transferee ceases to be a Permitted Transferee of the
Arsenal Stockholder who transferred the Shares to such transferee, then such transferee shall no longer be a Permitted Transferee and
shall have no further rights under this Agreement. No Permitted Transfer shall conflict with or result in any violation of a judgment,
order, decree, statute, law, ordinance, rule&nbsp;or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Permitted Transferee</U>&rdquo; shall
mean any Person who shall have acquired and who shall hold Shares pursuant to a Permitted Transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Person</U>&rdquo; shall mean any individual,
partnership, corporation, association, limited liability company, trust, joint venture, unincorporated organization or entity, or any
government, governmental department or agency or political subdivision thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Prior Agreement</U>&rdquo; shall have
the meaning set forth in the recitals of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Proprietary Information</U>&rdquo; shall
have the meaning as set forth in <U>Section&nbsp;2.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Purchase Agreement</U>&rdquo; shall mean
that certain Purchase Agreement, dated as of the date hereof (as it may be amended, amended and restated, supplemented or otherwise modified
from time to time), by and among Arsenal and the seller party thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Sale Transaction</U>&rdquo; shall have
the meaning set forth in the recitals of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>SEC</U>&rdquo; shall mean the United States
Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Shares</U>&rdquo; shall mean (i)&nbsp;shares
of Common Stock, (ii)&nbsp;other shares of capital stock of the Company or its Subsidiaries convertible into shares of Common Stock (as
calculated on an as-converted basis), or (iii)&nbsp;securities of the Company or its Subsidiaries issued in exchange for, upon reclassification
of, or as a dividend or distribution in respect of, the foregoing (as applicable, as calculated on an as-converted basis).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Subsidiary</U>&rdquo; with respect to
any entity (the &ldquo;<U>parent</U>&rdquo;) shall mean any corporation, limited liability company, company, firm, association or trust
of which such parent, at the time in respect of which such term is used, (i)&nbsp;owns directly or indirectly more than fifty percent
(50%) of the equity, membership interest or beneficial interest, on a consolidated basis, or (ii)&nbsp;owns directly or controls with
power to vote, directly or indirectly through one or more Subsidiaries, shares of the equity, membership interest or beneficial interest
having the power to elect more than fifty percent (50%) of the directors, trustees, managers or other officials having powers analogous
to that of directors of a corporation. Unless otherwise specifically indicated, when used herein the term Subsidiary shall refer to a
direct or indirect Subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Transfer</U>&rdquo; and &ldquo;<U>Transferred</U>&rdquo;
shall mean to transfer, sell, assign, pledge, hypothecate, give, create a security interest in or lien on, place in trust (voting or
otherwise), assign or in any other way encumber or dispose of, directly or indirectly, and whether or not by operation of law or for
value, any Shares or any legal, economic or beneficial interest therein; <U>provided</U>, <U>however</U>, that (i)&nbsp;as long as the
Person who has control over such Arsenal Stockholder retains control over such Arsenal Stockholder after such transfer, a transfer of
limited partnership interests, limited liability company interests or similar interests in any of the Arsenal Stockholders, any other
private equity fund or any parent entity or investment holding vehicle that owns such Arsenal Stockholder and (ii)&nbsp;a transfer pursuant
to a pledge, lien or other security interest securing any current, former or future indebtedness incurred by the Company or any of its
Subsidiaries in favor of any lender or other holder of such indebtedness, in each case, shall not constitute a Transfer for purposes
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #010000"><FONT STYLE="text-transform: uppercase">ARTICLE&nbsp;II</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">COVENANTS
AND CONDITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Subject to the provisions of <U>Section&nbsp;3.7
</U>hereof relating to the termination of certain provisions of this Agreement, the following covenants and conditions shall apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Corporate
Governance</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Board
of Directors</U>. The Company hereby agrees that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Arsenal Stockholders shall have the right, but not the obligation, to nominate to the Board: two (2)&nbsp;directors until the latest
of: (A)&nbsp;from the Effective Date until the two (2)&nbsp;year anniversary of the Effective Date for so long as the Arsenal Stockholders
continue to own 100% of the Shares Arsenal purchased in connection with the Sale Transaction, as identified on Exhibit&nbsp;B of the
Purchase Agreement, (B)&nbsp;after the two (2)&nbsp;year anniversary of the Effective Date, for so long as the Arsenal Amount represents
at least 12% of the total number of Adjusted Shares Outstanding and (C)&nbsp;from the Effective Date until the five (5)&nbsp;year anniversary
of the Effective Date, for so long as the Arsenal Stockholders continue to own 100% of the Shares Arsenal purchased in connection with
the Sale Transaction, as identified on Exhibit&nbsp;B of the Purchase Agreement, as such number may be adjusted from time to time for
any reorganization, recapitalization, stock dividend, stock split, reverse stock split or other similar changes in the Company&rsquo;s
capitalization. The Arsenal Stockholders shall have the right, but not the obligation, to nominate to the Board one (1)&nbsp;director,
for so long as the Arsenal Amount represents at least 6%, but less than 12%, of the total number of Adjusted Shares Outstanding. The
designees of the Arsenal Stockholders pursuant to this <U>Section&nbsp;2.1(a)(i)&nbsp;</U>shall be referred to herein as the &ldquo;<U>Arsenal
Director Nominees</U>.&rdquo; Notwithstanding the foregoing, (i)&nbsp;any such individual designated by the Arsenal Stockholders shall
be (A)&nbsp;a full-time senior employee of Arsenal Capital Management LP or its Affiliates, such as an investment partner, a senior partner
or an operating partner, or (B)&nbsp;another individual that the Arsenal Stockholders reasonably believe is appropriately qualified to
serve as a director on the board of a public company, provided that the designation of any such other individual pursuant to this clause
(B)&nbsp;shall be subject to the consent of the Board (excluding any Arsenal Director Nominees), acting in its sole discretion; (ii)&nbsp;if,
at any time, there are two (2)&nbsp;Arsenal Director Nominees appointed to the Board and the Arsenal Stockholders cease to have the right
to designate two (2)&nbsp;Arsenal Director Nominees but continue to have the right to designate one (1)&nbsp;Arsenal Director Nominee
under this <U>Section&nbsp;2.1(a)(i)</U>, the Arsenal Director Nominee who is closest in time to being subject to re-election shall irrevocably
offer to tender his or her resignation to the Board within five (5)&nbsp;business days after (A)&nbsp;the Arsenal Stockholders determine
that, or (B)&nbsp;the Company provides notice to the Arsenal Stockholders that, the Arsenal Amount represents less than the applicable
threshold set forth in this <U>Section&nbsp;2.1(a)(i)</U>, which resignation may be accepted or rejected by the Board (excluding any
Arsenal Director Nominees) in its sole discretion (it being understood that, if the Board (excluding any Arsenal Director Nominees) accepts
such offer, then such Arsenal Director Nominee shall promptly and irrevocably tender his or her resignation to the Board); and (iii)&nbsp;the
right of the Arsenal Stockholders to designate any Arsenal Director Nominees pursuant to this <U>Section&nbsp;2.1(a)(i)</U>&nbsp;shall
automatically terminate at such time that the Arsenal Amount represents less than 6% of the total number of Adjusted Shares Outstanding,
and any Arsenal Director Nominee(s)&nbsp;serving on the Board at such time shall, and the Arsenal Stockholders shall cause any such Arsenal
Director Nominee(s)&nbsp;to, irrevocably offer to tender his or her resignation to the Board within five (5)&nbsp;business days after
(A)&nbsp;the Arsenal Stockholders determine that, or (B)&nbsp;the Company provides notice to the Arsenal Stockholders that, the Arsenal
Amount represents less than the applicable threshold set forth in this <U>Section&nbsp;2.1(a)(i)</U>, which resignation may be accepted
or rejected by the Board (excluding any Arsenal Director Nominees) in its sole discretion (it being understood that if the Board (excluding
any Arsenal Director Nominees) accepts such offer, then such Arsenal Director Nominee shall promptly and irrevocably tender his or her
resignation to the Board). As long as the Board of Directors is classified, the Arsenal Director Nominees shall be Class&nbsp;I and Class&nbsp;III
directors, as designated by the Arsenal Stockholders. In the event that the Arsenal Stockholders have nominated less than the total number
of designees that they are entitled to nominate pursuant to this <U>Section&nbsp;2.1(a)(i)</U>, the Arsenal Stockholders shall have the
right to nominate such additional designees to which they are entitled, in which case, the Company and the Board shall take all necessary
corporation action (including increasing the size of the Board to create a vacancy), to the fullest extent permitted by applicable law
(including with respect to fiduciary duties under Delaware law), to (x)&nbsp;enable the Arsenal Stockholders to nominate such additional
individuals at the next annual meeting of the Company in which the class of director the Arsenal Stockholders did not nominate as a designee
is subject to election, in each case, in accordance with this <U>Section&nbsp;2.1(a)(i)</U>. The Arsenal Stockholders hereby agree that
any Arsenal Director Nominees nominated pursuant to this <U>Section&nbsp;2.1(a)(i)</U>&nbsp;or that serve on the Board must comply with
and will be subject to any rules, procedures, requirements and other obligations which apply to the other directors of the Board from
time-to-time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company shall include as part of the slate that is included in the proxy statement (or consent solicitation or similar document) of the
Company relating to the election of directors to the Board of Directors (a &ldquo;<U>Director Election Proxy Statement</U>&rdquo;) the
Arsenal Director Nominees (if such proxy statement (or consent solicitation or similar document) relates to the election of directors
of the class or classes to which Arsenal Director Nominees belong) pursuant to <U>Section&nbsp;2.1(a)(i)</U>&nbsp;and shall provide at
least the same level of support for the election of each person nominated pursuant to <U>Section&nbsp;2.1(a)(i)</U>&nbsp;as it provides
to any other individual standing for election as a director of the Company as part of such Company slate of directors. Unless an Arsenal
Stockholder notifies the Company otherwise prior to the mailing to stockholders of the Director Election Proxy Statement (or, if earlier,
the filing of the definitive Director Election Proxy Statement with the SEC), the Arsenal Director Nominees for such election shall be
presumed to be the same Arsenal Director Nominees currently serving on the Board, and no further action shall be required of the Arsenal
Stockholders for the Board to include such Arsenal Director Nominees on the Board&rsquo;s slate; <U>provided</U>, that, in the event
the Arsenal Stockholders are no longer entitled to nominate the full number of Arsenal Director Nominees then serving on the Board, the
Arsenal Stockholders shall provide advance written notice to the Company of which currently serving Arsenal Director Nominee(s)&nbsp;shall
be excluded from the Board slate, and of any other changes to the list of Arsenal Director Nominees. If the Arsenal Stockholders fail
to provide such notice prior to the mailing to stockholders of the Director Election Proxy Statement relating to such election (or, if
earlier, the filing of the definitive Director Election Proxy Statement with the SEC), a majority of the independent directors then serving
on the Board shall determine which of the Arsenal Director Nominees of the Arsenal Stockholders then serving on the Board will be included
in the Board&rsquo;s slate. The Company agrees to provide written notice of the preparation of a Director Election Proxy Statement to
the Arsenal Stockholders at least 20 business days, but no more than 40 business days, prior to the earlier of the mailing and the filing
date of any Director Election Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>In
the event that an Arsenal Director Nominee shall cease to serve as a director for any reason (other than (i)&nbsp;the failure of the
stockholders of the Company to elect such individual as a director or (ii)&nbsp;for the avoidance of doubt, where an Arsenal Director
Nominee ceases to serve due to the Arsenal Stockholders no longer having a right to designate such an Arsenal Director Nominee pursuant
to <U>Section&nbsp;2.1(a)(i)</U>), the Arsenal Stockholders shall have the right to designate a replacement Arsenal Director Nominee
and the Company agrees to take all reasonable actions necessary to cause the appointment of any such replacement Arsenal Director Nominee
to fill the vacancy resulting therefrom; it being understood that any such designee shall serve the remainder of the term of the director
whom such designee replaces. For the avoidance of doubt, it is understood that the failure of the stockholders of the Company to elect
any Arsenal Director Nominee shall not affect the right of the Arsenal Stockholders to designate such Arsenal Director Nominee pursuant
to <U>Section&nbsp;2.1(a)(i)</U>&nbsp;in connection with any future election of directors of the Company. If an Arsenal Director Nominee
is not appointed or elected to the Board because of such person&rsquo;s death, disability, disqualification, withdrawal as a nominee
or for other reason is unavailable or unable to serve on the Board, the Arsenal Stockholders shall be entitled to designate promptly
another nominee and the director position for which the original Arsenal Director Nominee was nominated shall not be filled pending such
designation. In the event the Arsenal Stockholders may designate a replacement nominee under this <U>Section&nbsp;2.1(a)(iii)</U>, the
Arsenal Stockholders must provide notice of any such replacement as soon as reasonably practicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
Arsenal Stockholder (and any Co-Investor, or any of its Affiliates to which such Co-Investor has transferred Shares in accordance with
this Agreement, as applicable) hereby agrees with the Company that for so long as any Arsenal Stockholder is entitled to designate an
Arsenal Stockholder Nominee pursuant to <U>Section&nbsp;2.1(a)(i)</U>, such Arsenal Stockholder (and any Co-Investor, as applicable)
shall vote all of its Shares in favor of each individual standing for election as a director of the Company as part of the Company&rsquo;s
slate of directors that is included in any Director Election Proxy Statement (or consent solicitation or similar document) of the Company
relating to the election of directors to the Board of Directors and whose election the Board of Directors has recommended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company will pay directly or reimburse, or cause to be paid directly or reimbursed, the actual and reasonable out-of-pocket costs and
expenses incurred by the Arsenal Director Nominees hereunder in connection with such Arsenal Director Nominees&rsquo; board service (including
travel but not private air travel), in the same manner and to the same extent as other directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>At
the Effective Date, the Board shall be comprised of eleven members. The initial Arsenal Director Nominees shall be Steve McLean as a
Class&nbsp;III director and Dave Spaight as a Class&nbsp;I director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>From
and after the Effective Date hereof, (i)&nbsp;for so long as the Arsenal Stockholders have the right to designate two (2)&nbsp;Arsenal
Director Nominees for nomination to serve on the Board of Directors pursuant to <U>Section&nbsp;2.1(a)(i)</U>, the Board (excluding the
Arsenal Directors Nominees) shall appoint one (1)&nbsp;Arsenal Director Nominee to the Nominating and Corporate Governance Committee
and one (1)&nbsp;Arsenal Director Nominee to the Compensation Committee, it being understood that the Board (excluding the Arsenal Director
Nominees) may determine in its sole discretion which Arsenal Director Nominee is appointed to which committee; (ii)&nbsp;at such time
that the Arsenal Stockholders cease to have the right to designate two (2)&nbsp;Arsenal Director Nominees but continue to have the right
to designate one (1)&nbsp;Arsenal Director Nominee for nomination to serve on the Board of Directors, in each case, pursuant to <U>Section&nbsp;2.1(a)(i)</U>,
the Board (excluding any Arsenal Director Nominees) shall (x)&nbsp;appoint one (1)&nbsp;Arsenal Director Nominee (who is specified by
the Arsenal Stockholders) to either the Nominating and Corporate Governance Committee or the Compensation Committee (or allow such Arsenal
Director Nominee to continue to serve on such committee, as applicable), it being understood that the Board (excluding the Arsenal Director
Nominees) shall determine, after good faith consultation with the Arsenal Stockholders, which of the committees such Arsenal Director
Nominee be appointed to and serve, and (y)&nbsp;immediately remove the other Arsenal Director Nominee from any and all committees of
the Board; and (iii)&nbsp;at such time that the Arsenal Stockholders cease to have the right to designate any Arsenal Director Nominees
for nomination to serve on the Board of Directors pursuant to <U>Section&nbsp;2.1(a)(i)</U>, the Board (excluding any Arsenal Director
Nominees) shall immediately remove any and all Arsenal Director Nominees from any and all committees of the Board; <U>provided</U> that,
in the case of the foregoing (i)&nbsp;and (ii), any such Arsenal Director Nominee shall be eligible to serve on the applicable committee
under applicable law or listing standards of the NASDAQ Global Select Market, including any applicable independence requirements (subject
in each case to any applicable exceptions).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Notwithstanding
anything in this Agreement to the contrary, if the Board of Directors (excluding any Arsenal Director Nominees) reasonably determines
that an Arsenal Director Nominee serving on the Board of Directors is a director of another company that (i)&nbsp;engages in the same
or similar business activities or lines of business as the Company or any of its Subsidiaries or (ii)&nbsp;is reasonably and in good
faith deemed to be competing with the Company or any of its Subsidiaries in any material respect (such Arsenal Director Nominee is a
 &ldquo;<U>Competing Arsenal Director Nominee</U>&rdquo;), the Board of Directors (excluding any Arsenal Director Nominee) may determine,
after good faith consultation with the Arsenal Stockholders, and upon good faith review of all of the relevant facts and circumstances,
including all documentation provided by the Arsenal Stockholders in connection with such determination, to immediately remove such Arsenal
Director Nominee, in which case the Arsenal Stockholders shall be entitled to designate promptly another nominee pursuant to and in accordance
with <U>Section&nbsp;2.1(a)(i)</U>&nbsp;(who would not be a Competing Arsenal Director Nominee) and the director position for which the
original Arsenal Director Nominee was nominated shall not be filled pending such designation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Confidentiality</U>.
Each Arsenal Stockholder (and any Co-Investor, or any of its Affiliates to which such Co-Investor has transferred Shares in accordance
with this Agreement, as applicable) shall, and shall cause its Affiliates and its and its Affiliates&rsquo; representatives to, maintain
the confidentiality of any confidential and proprietary information of the Company and its Subsidiaries (&ldquo;<U>Proprietary Information</U>&rdquo;)
using the same standard of care, but in no event less than reasonable care, as it applies to its own confidential information, except
(i)&nbsp;for any Proprietary Information which is publicly available (other than as a result of dissemination by such Arsenal Stockholder
or such Co-Investor, as applicable, its Affiliates or its or its Affiliates&rsquo; representatives in breach of this Agreement) or a
matter of public knowledge generally, (ii)&nbsp;if the release of such Proprietary Information is ordered pursuant to a subpoena or other
order from a court of competent jurisdiction or other applicable law, rule, regulation, legal or judicial process or audit or inquiries
by a regulator, bank examiner or self-regulatory organization (collectively, &ldquo;<U>Law</U>&rdquo;), following delivery of prior written
notice to the Company (to the extent reasonably practicable and permitted under applicable Law), (iii)&nbsp;for Proprietary Information
that was known to such Arsenal Stockholder or such Co-Investor (or its Affiliates) on a non-confidential basis, without, to such Person&rsquo;s
knowledge, breach of any confidentiality obligations to the Company or its Affiliates in respect thereof, prior to its disclosure by
the Company or its Affiliates or (iv)&nbsp;if such Proprietary Information is or has been independently developed or conceived by any
Arsenal Stockholder or any Co-Investor (or its Affiliates) without use of or reference to the Company&rsquo;s Proprietary Information.
The Company recognizes that each Arsenal Director Nominee (A)&nbsp;will from time to time receive non-public information concerning the
Company, and (B)&nbsp;may share such information on a case-by-case basis, with (i)&nbsp;the members of the healthcare investment committee
of the Arsenal Stockholders (or their controlling Affiliates) to enable such members to fulfill their fiduciary obligations to the investors
in the Arsenal Stockholders (or their controlling Affiliates) and (ii)&nbsp;the other employees of the Arsenal Stockholders (or their
controlling Affiliates), subject, in the case of this clause (ii)&nbsp;only, to the prior consent of the Company, which consent may be
withheld in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #010000"><FONT STYLE="text-transform: uppercase">ARTICLE&nbsp;III</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Remedies</U>.
The parties to this Agreement acknowledge and agree that the covenants of the Company and the Arsenal Stockholders set forth in this
Agreement may be enforced in equity by a decree requiring specific performance. In the event of a breach of any material provision of
this Agreement, the aggrieved party will be entitled to institute and prosecute a proceeding to enforce specific performance of such
provision, as well as to obtain damages for breach of this Agreement. Without limiting the foregoing, if any dispute arises concerning
any provisions hereof or the obligations of the parties hereunder, the parties to this Agreement agree that an injunction may be issued
in connection therewith. Such remedies shall be cumulative and non-exclusive and shall be in addition to any other rights and remedies
the parties may have under this Agreement or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Entire
Agreement; Amendment; Waiver</U>. This Agreement, together with the Letter Agreement (with respect to the Company and Arsenal), and the
Purchase Agreement (and any document executed by a Co-Investor pursuant to the Purchase Agreement), sets forth the entire understanding
of the parties, and as of the date hereof supersedes all prior agreements and all other arrangements and communications, whether oral
or written, with respect to the subject matter hereof and thereof. This Agreement may be amended, modified, supplemented, restated, waived
or terminated only upon (i)&nbsp;the written consent of the Company and (ii)&nbsp;the Arsenal Consent. Except as otherwise expressly
provided for hereby, no waiver of or consent to any departure from any provision of this Agreement shall be effective unless signed in
writing by the Company if it is entitled to the benefit thereof or the Arsenal Consent if the Arsenal Stockholders are entitled to the
benefit thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Severability</U>.
It is the desire and intent of the parties that the provisions of this Agreement be enforced to the fullest extent permissible under
the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, the invalidity or unenforceability
of any particular provision of this Agreement shall not affect the other provisions hereof, and this Agreement shall be construed in
all respects as if the invalid or unenforceable provision were omitted. Notwithstanding the foregoing, if such provision could be more
narrowly drawn so as not to be invalid or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so more narrowly
drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision
in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notices</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Unless otherwise specified herein, all notices,
consents, approvals, reports, designations, requests, waivers, elections and other communications authorized or required to be given
pursuant to this Agreement shall be in writing and shall be deemed to have been given (a)&nbsp;when personally delivered, (b)&nbsp;the
day following the day (except if not a business day then the next business day) on which the same has been delivered prepaid to a reputable
national overnight air courier service, (c)&nbsp;when transmitted via email (including via attached pdf document) to the email address
set out below or (d)&nbsp;the third business day following the day on which the same is sent by certified or registered mail, postage
prepaid, in each case, to the respective parties, as applicable, at the address or email address set forth below or on <U>Exhibit&nbsp;A
</U>hereto, as applicable (or such other address or email address as any Stockholder may specify by notice to the Company in accordance
with this <U>Section&nbsp;3.4</U>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>For
notices and communications to the Company, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Certara,&nbsp;Inc.<BR>
100 Overlook Center, Suite&nbsp;101&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Princeton, NJ 08540<BR>
Attention: Richard Traynor&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
[</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">with a copy to (which shall not constitute actual or constructive
notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Simpson Thacher&nbsp;&amp; Bartlett LLP&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">425 Lexington Avenue&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">New York, New York 10017&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Attention: Michael T. Holick&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
[</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Simpson Thacher&nbsp;&amp; Bartlett LLP<BR>
2475 Hanover Street&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Palo Alto, CA 94304&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
William Brentani and Frederick W.P. de Albuquerque<BR>
Email: [</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>for
notices and communications to the Arsenal Stockholders, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in">c/o Arsenal Capital Group LLC&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in">100 Park Avenue, 31st Floor&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in">New York, NY 10017&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in">Attention: Chief Financial Officer,
Frank Scrudato&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
[</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">with a copy to (which shall not constitute actual or constructive
notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in">Kirkland&nbsp;&amp; Ellis LLP&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in">300 North LaSalle&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in">Chicago,&nbsp;Illinois 60654&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in">Attention: Ted M. Frankel, P.C. and
Robert E. Goedert, P.C.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
[</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By notice complying with the foregoing provisions of this <U>Section&nbsp;3.4</U>,
each party shall have the right to change the mailing address or email address for future notices and communications to such party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Binding
Effect; Assignment</U>. This Agreement shall be binding upon and inure to the benefit of the parties hereto and to their respective transferees,
successors and assigns; <U>provided</U>, <U>however</U>, that no right or obligation under this Agreement may be assigned except as expressly
provided herein, it being understood that (i)&nbsp;the Company&rsquo;s right hereunder may be assigned by the Company to any corporation
or other entity which is the surviving entity in a merger, consolidation or like event involving the Company, and (ii)&nbsp;an Arsenal
Stockholder&rsquo;s rights hereunder may be assigned to an Affiliate in connection with a Permitted Transfer to such Affiliate by such
Arsenal Stockholder; <U>provided</U>, that such Permitted Transferee executes and delivers to the Company a Joinder Agreement evidencing
that is has become bound to the provisions hereof. Except as otherwise expressly provided in this <U>Section&nbsp;3.5</U>, nothing herein
contained shall confer or is intended to confer on any third party or entity that is not a party to this Agreement any rights under this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Governing
Law</U>. All matters relating to the interpretation, construction, validity and enforcement of this Agreement, including all claims (whether
in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of
this Agreement, shall be governed by and construed in accordance with the domestic laws of the State of Delaware without giving effect
to any choice or conflict of law provision or rule&nbsp;(whether of the State of Delaware or any other jurisdiction) that would cause
the application of laws of any jurisdiction other than the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Termination</U>.
Without affecting any other provision of this Agreement requiring termination of any rights in favor of any Arsenal Stockholder, the
provisions of <U>ARTICLE&nbsp;II</U> (other than <U>Section&nbsp;2.2</U>, which shall terminate on the date that is two (2)&nbsp;years
after such time) shall automatically terminate at such time as the Arsenal Amount represents less than 6% of the total number of Adjusted
Shares Outstanding; <U>provided</U>, that the obligation of the Arsenal Stockholders to cause any Arsenal Director Nominees to irrevocably
tender their resignation to the Board shall survive until all such Arsenal Director Nominees are no longer on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Recapitalizations,
Exchanges, Etc.</U> The provisions of this Agreement shall apply, to the full extent set forth herein with respect to Shares, to any
and all shares of capital stock of the Company or any successor or assign of the Company (whether by merger, consolidation, sale of assets
or otherwise) which may be issued in respect of, in exchange for, or in substitution of the Shares, by reason of a stock dividend, stock
split, stock issuance, reverse stock split, combination, recapitalization, reclassification, merger, consolidation or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Action
Necessary to Effectuate the Agreement</U>. The parties hereto agree to take or cause to be taken all such corporate and other action
as may be reasonably necessary to effect the intent and purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Other
Business Opportunities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
parties expressly acknowledge and agree that to the fullest extent permitted by applicable law: (i)&nbsp;each of the Arsenal Stockholders
(in each case, including (A)&nbsp;their respective Affiliates, (B)&nbsp;any portfolio company in which they or any of their respective
affiliated investment funds or Affiliates have made a debt or equity investment (and vice versa) and (C)&nbsp;their respective limited
partners, non-managing members or other similar direct or indirect investors) and each Arsenal Director Nominee has the right to, and
shall have no duty (fiduciary, contractual or otherwise) not to, directly or indirectly engage in and possess interests in other business
ventures of every type and description, including those engaged in the same or similar business activities or lines of business as the
Company or any of its Subsidiaries or deemed to be competing with the Company or any of its Subsidiaries, on its own account, or in partnership
with, or as an employee, officer, director or shareholder of any other Person, with no obligation to offer to the Company or any of its
Subsidiaries the right to participate therein; (ii)&nbsp;each of the Arsenal Stockholders (in each case, including (A)&nbsp;their respective
Affiliates, (B)&nbsp;any portfolio company in which they or any of their respective affiliated investment funds or Affiliates have made
a debt or equity investment (and vice versa) and (C)&nbsp;their respective limited partners, non-managing members or other similar direct
or indirect investors) and each Arsenal Director Nominee may invest in, or provide services to, any Person that directly or indirectly
competes with the Company or any of its Subsidiaries; and (iii)&nbsp;in the event that any of the Arsenal Stockholders (in each case,
including (A)&nbsp;their respective Affiliates, (B)&nbsp;any portfolio company in which they or any of their respective affiliated investment
funds or Affiliates have made a debt or equity investment (and vice versa) and (C)&nbsp;their respective limited partners, non-managing
members or other similar direct or indirect investors) or any Arsenal Director Nominee acquires knowledge of a potential transaction
or matter that may be a corporate or other business opportunity for the Company or any of its Subsidiaries, such Person shall have no
duty (fiduciary, contractual or otherwise) to communicate or present such corporate opportunity to the Company or any of its Subsidiaries,
as the case may be, and, notwithstanding any provision of this Agreement to the contrary, shall not be liable to the Company or any of
its Subsidiaries for breach of any duty (fiduciary, contractual or otherwise) by reason of the fact that such Person, directly or indirectly,
pursues or acquires such opportunity for itself, directs such opportunity to another Person or does not present such opportunity to the
Company or any of its Subsidiaries. For the avoidance of doubt, the parties acknowledge that this paragraph is intended to disclaim and
renounce, to the fullest extent permitted by applicable law, any right of the Company or any of its Subsidiaries with respect to the
matters set forth herein, and this paragraph shall be construed to effect such disclaimer and renunciation to the fullest extent permitted
by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company and each of its Subsidiaries hereby, to the fullest extent permitted by applicable law:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;confirms
that no Arsenal Stockholder nor any of its Affiliates has any duty to the Company or any of its Subsidiaries other than the specific
covenants and agreements set forth in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;acknowledges
and agrees that (A)&nbsp;in the event of any conflict of interest between the Company or any of its Subsidiaries, on the one hand, and
any Arsenal Stockholder or any of its Affiliates, on the other hand, such Arsenal Stockholder or any of its Affiliates (and any Arsenal
Director Nominee) may act in its best interest and (B)&nbsp;none of the Arsenal Stockholders nor any of their respective Affiliates (or
any Arsenal Director Nominee), shall be obligated (1)&nbsp;to reveal to the Company or any of its Subsidiaries confidential information
belonging to or relating to the business of such Person or any of its Affiliates or (2)&nbsp;to recommend or take any action in its capacity
as a Stockholder or director, as the case may be, that prefers the interest of the Company or its Subsidiaries over the interest of such
Person; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;waives
any claim or cause of action against any of the Arsenal Stockholders, any Arsenal Director Nominee and any officer, employee, agent or
Affiliate of any such Person that may from time to time arise in respect of a breach by any such person of any duty or obligation disclaimed
under <U>Section&nbsp;3.10(b)(i)</U>&nbsp;or <U>Section&nbsp;3.10(b)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
of the parties hereto agrees that the waivers, limitations, acknowledgments and agreements set forth in this <U>Section&nbsp;3.10</U>
shall not apply to any alleged claim or cause of action against any Arsenal Stockholder based upon the breach or nonperformance by such
Arsenal Stockholder of this Agreement or any other agreement to which such Person is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
provisions of this <U>Section&nbsp;3.10</U>, to the extent that they restrict the duties and liabilities of any of the Arsenal Stockholders
or any Arsenal Director Nominee otherwise existing at law or in equity, are agreed by the parties hereto to replace such other duties
and liabilities of the Arsenal Stockholders or any such Arsenal Director Nominee to the fullest extent permitted by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Waiver</U>. No course of dealing and no delay on the part of any party hereto in exercising any right, power or remedy conferred by this
Agreement shall operate as waiver thereof or otherwise prejudice such party&rsquo;s rights, powers and remedies. No single or partial
exercise of any rights, powers or remedies conferred by this Agreement shall preclude any other or further exercise thereof or the exercise
of any other right, power or remedy. The Arsenal Stockholders shall not be obligated to designate all (or any) of the Arsenal Director
Nominees they are entitled to designate pursuant to this Agreement for any election of directors but the failure to do so shall not constitute
a waiver of their rights hereunder with respect to future elections; <U>provided</U>, <U>however</U>, that in the event the Arsenal Stockholders
fail to designate all (or any) of the Arsenal Director Nominees they are entitled to designate pursuant to this Agreement prior to the
mailing to stockholders of the Director Election Proxy Statement relating to such election (or, if earlier, the filing of the definitive
Director Election Proxy Statement with the SEC), the Nominating and Corporate Governance Committee of the Board shall be entitled to
nominate individuals in lieu of such Arsenal Director Nominees for inclusion in the Board&rsquo;s slate and the applicable Director Election
Proxy Statement with respect to the election for which such failure occurred and the Arsenal Stockholders shall be deemed to have waived
its rights hereunder with respect to such election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Costs
and Expenses</U>. Each party shall pay its own costs and expenses incurred in connection with this Agreement, and any and all other documents
furnished pursuant hereto or in connection herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Counterpart</U>.
This Agreement may be executed in two or more counterparts each of which shall be deemed an original but all of which together shall
constitute one and the same instrument, and all signatures need not appear on any one counterpart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Headings</U>.
All headings and captions in this Agreement are for purposes of reference only and shall not be construed to limit or affect the substance
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Consent
to Jurisdiction</U>. The Company and each of the Arsenal Stockholders, by its, his or her execution hereof, (i)&nbsp;hereby irrevocably
submit to the exclusive jurisdiction of the state and federal courts in the State of Delaware for the purposes of any claim or action
arising out of or based upon this Agreement or relating to the subject matter hereof, (ii)&nbsp;hereby waive, to the extent not prohibited
by applicable law, and agree not to assert by way of motion, as a defense or otherwise, in any such claim or action, any claim that it
or he is not subject personally to the jurisdiction of the above-named courts, that its, his or her property is exempt or immune from
attachment or execution, that any such proceeding brought in the above-named court is improper or that this Agreement or the subject
matter hereof may not be enforced in or by such court and (iii)&nbsp;hereby agree not to commence any claim or action arising out of
or based upon this Agreement or relating to the subject matter hereof other than before the above-named courts nor to make any motion
or take any other action seeking or intending to cause the transfer or removal of any such claim or action to any court other than the
above-named courts whether on the grounds of inconvenient forum or otherwise. The Company and each of the Arsenal Stockholders hereby
consent, to the fullest extent permitted by law, to service of process in any such proceeding, and agree that service of process by registered
or certified mail, return receipt requested, at its address specified pursuant to <U>Section&nbsp;3.4</U> is reasonably calculated to
give actual notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>WAIVER
OF JURY TRIAL</U>. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH PARTY HERETO HEREBY WAIVES AND COVENANTS
THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE
OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE),&nbsp;INQUIRY, PROCEEDING OR INVESTIGATION ARISING OUT OF
OR BASED UPON THIS AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE TRANSACTIONS CONTEMPLATED
HEREBY,&nbsp;IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING. EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE
OTHER PARTIES HERETO THAT THIS <U>SECTION&nbsp;3.16</U> CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH THEY ARE RELYING AND WILL RELY IN
ENTERING INTO THIS AGREEMENT. ANY PARTY HERETO MAY&nbsp;FILE AN ORIGINAL COUNTERPART&nbsp;OR A COPY OF THIS <U>SECTION&nbsp;3.16</U>
WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Representations
and Warranties</U>. The Company hereby represents and warrants to the Arsenal Stockholders that it has full power, capacity, legal right
and authority to execute, deliver and perform this Agreement, and each Arsenal Stockholder hereby represents and warrants to the Company
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Such
Arsenal Stockholder, to the extent applicable, is duly organized or incorporated, validly existing and in good standing under the laws
of the jurisdiction of its organization or incorporation and has all requisite power and authority to conduct its business as it is now
being conducted and is proposed to be conducted. Such Arsenal Stockholder has the full power, authority and legal right to execute, deliver
and perform this Agreement. The execution, delivery and performance of this Agreement have been duly authorized by all necessary action,
corporate or otherwise, of such Arsenal Stockholder. This Agreement has been duly executed and delivered by such Arsenal Stockholder
and constitutes its, his or her legal, valid and binding obligation, enforceable against it, him or her in accordance with its terms,
subject to applicable bankruptcy, insolvency and similar laws affecting creditors&rsquo; rights generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
execution and delivery by such Arsenal Stockholder of this Agreement, the performance by such Arsenal Stockholder of its, his or her
obligations hereunder by such Arsenal Stockholder does not and will not violate (i)&nbsp;in the case of parties who are not individuals,
any provision of its organizational or constituent documents, (ii)&nbsp;any provision of any material agreement to which it, he or she
is a party or by which it, he or she is bound or (iii)&nbsp;any law, rule, regulation, judgment, order or decree to which it, he or she
is subject. No notice, consent, waiver, approval, authorization, exemption, registration, license or declaration is required to be made
or obtained by such Arsenal Stockholder in connection with the execution, delivery or enforceability of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Such
Arsenal Stockholder is not currently in violation of any law, rule, regulation, judgment, order or decree, which violation could reasonably
be expected at any time to have a material adverse effect upon such Arsenal Stockholder&rsquo;s ability to enter into this Agreement
or to perform its, his or her obligations hereunder. There is no pending legal action, suit or proceeding that would materially and adversely
affect the ability of such Arsenal Stockholder to enter into this Agreement or to perform its, his or her obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Consents,
Approvals and Actions</U>. If any consent, approval or action of the Arsenal Stockholders is required at any time pursuant to this Agreement,
such consent, approval or action shall be deemed given if the holders of a majority of the shares of Common Stock held by the Arsenal
Stockholders at such time provide such consent, approval or action in writing at such time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Third Party Liabilities</U>. This Agreement may only be enforced against the named parties hereto (or any of their permitted assigns
pursuant to <U>Section&nbsp;3.5</U> hereto). All claims or causes of action (whether in contract or tort) that may be based upon, arise
out of or relate to any of this Agreement, or the negotiation, execution or performance of this Agreement (including any representation
or warranty made in or in connection with this Agreement or as an inducement to enter into this Agreement), may be made only against
the entities that are expressly identified as parties hereto, as applicable (or any of their permitted assigns pursuant to <U>Section&nbsp;3.5
</U>hereto); and no past, present or future director, officer, employee, incorporator, member, partner, stockholder, Affiliate, portfolio
company in which any such party or any of its investment fund Affiliates have made a debt or equity investment (and vice versa), agent,
attorney or representative of any party hereto (including any Person negotiating or executing this Agreement on behalf of a party hereto),
unless a party to this Agreement (or a permitted assign pursuant to <U>Section&nbsp;3.5</U> hereto), shall have any liability or obligation
with respect to this Agreement or with respect any claim or cause of action (whether in contract or tort) that may arise out of or relate
to this Agreement, or the negotiation, execution or performance of this Agreement (including a representation or warranty made in or
in connection with this Agreement or as an inducement to enter into this Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Mutual
Drafting</U>. The Company and each Arsenal Stockholder confirms that each Arsenal Stockholder has had the opportunity to independently
participate with the Company and its subsidiaries in the negotiation of the transaction contemplated hereby with the advice of its own
counsel and advisors. The parties are sophisticated and have been represented by attorneys throughout the transactions contemplated by
this Agreement who have carefully negotiated the provisions hereof. As a consequence, the parties do not intend that the presumptions
of laws or rules&nbsp;relating to the interpretation of contracts against the drafter of any particular clause should be applied to this
Agreement or any agreement or instrument executed in connection herewith and therefore waive their effects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Enforcement</U>.
Each of the parties hereto covenant and agree that the disinterested members of the Board have the right to enforce, waive or take any
other action with respect to this Agreement on behalf of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Effectiveness</U>.
This Agreement shall only become effective, and the Prior Agreement shall only be terminated, upon the Effective Date. The parties agree
that all rights and obligations under the Prior Agreement, including the right to appoint Arsenal Director Nominees (as that term is
defined in the Prior Agreement) under <U>Section&nbsp;2.1</U> of the Prior Agreement, will terminate upon the Effective Date. Notwithstanding
anything else in this Agreement, including <U>Section&nbsp;3.7</U>, this Agreement shall terminate automatically and have no force or
effect upon the termination of the Purchase Agreement without the Sale Transaction having occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Remainder of page&nbsp;intentionally left
blank</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">IN WITNESS WHEREOF, each of the parties hereto has
duly executed this Agreement (or caused this Agreement to be executed on its behalf by its officer or representative thereunto duly authorized)
as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">THE COMPANY:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">CERTARA,&nbsp;INC.</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-size: 10pt">/s/
    William Feehery&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: William Feehery&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: &nbsp;&nbsp;CEO</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page&nbsp;to Stockholders Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ARSENAL STOCKHOLDERS:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ARSENAL SATURN HOLDINGS LP</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Arsenal Capital Investment VI LP, its general
    partner</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Arsenal Group LLC, its general partner</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/
    Frank Scrudato&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Frank Scrudato&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">CFO</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ARSENAL CAPITAL PARTNERS III LP</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Arsenal Capital Investment III LP, its general
    partner</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Arsenal Group LLC, its general partner</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/
    Frank Scrudato&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Frank Scrudato&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">CFO</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ARSENAL CAPITAL PARTNERS III-B LP</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Arsenal Capital Investment III LP, its general
    partner</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Arsenal Group LLC, its general partner</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/
    Frank Scrudato&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-size: 10pt">Frank Scrudato</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page&nbsp;to Stockholders Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Annex I</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF<BR>
JOINDER AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The undersigned is executing and delivering this
Joinder Agreement pursuant to that certain Stockholders Agreement of Certara,&nbsp;Inc., dated as of [__________], 2022 (as amended,
restated, supplemented or otherwise modified in accordance with the terms thereof, the &ldquo;<U>Stockholders Agreement</U>&rdquo;) by
and among Certara,&nbsp;Inc. (the &ldquo;<U>Company</U>&rdquo;) and the Arsenal Stockholders. Capitalized terms used but not defined
in this Joinder Agreement shall have the respective meanings ascribed to such terms in the Stockholders Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">By executing and delivering this Joinder Agreement
to the Stockholders Agreement, the undersigned hereby adopts and approves the Stockholders Agreement and agrees, effective commencing
on the date hereof and as a condition to the undersigned&rsquo;s becoming the transferee of Shares[, to become a party to, and to be
bound by and comply with the provisions of, the Stockholders Agreement applicable to an Arsenal Stockholder]<SUP>1</SUP>[, to be bound
by and comply with Sections 2.1(b)&nbsp;and 2.2 of the Stockholders Agreement as [a Co-Investor][an Affiliate of a Co-Investor who has
been transferred Shares by such Co-Investor in accordance with the Stockholders Agreement]]<SUP>2</SUP> in the same manner as if the
undersigned were an original signatory to the Stockholders Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The undersigned hereby represents and warrants that,
pursuant to this Joinder Agreement and the Stockholders Agreement, it is [a Permitted Transferee of an Arsenal Stockholder][a Co-Investor][an
Affiliate of a Co-Investor who has been transferred Shares by such Co-Investor in accordance with the Stockholders Agreement] and will
be the lawful record owner of ___________ shares of Common Stock of the Company as of the date hereof. The undersigned hereby covenants
and agrees that it will take all such actions as required of [a Permitted Transferee][a Co-Investor][an Affiliate of such Co-Investor]
as set forth in the Stockholders Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The undersigned acknowledges and agrees that <U>Sections
3.1</U>, <U>3.6</U>, 3.7, <U>3.15</U> and <U>3.16</U> of the Stockholders Agreement are incorporated herein by reference, <I>mutatis
mutandis</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[Remainder of page&nbsp;intentionally left blank]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP> To be used for a transfer of Shares by an Arsenal Stockholder
in connection with a Permitted Transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-indent: -0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><SUP>2</SUP> To be used when this
Joinder Agreement is being signed by a (i) Co-Investor, or (ii) an Affiliate of a Co-Investor who is transferred Shares by such Co-Investor
in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Accordingly, the undersigned has executed and delivered
this Joinder Agreement as of the __ day of __, 20[&#9679;].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Signature</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Print
    Name</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 6%"><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Telephone:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Facsimile:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">AGREED AND ACCEPTED&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">as of the ____ day of ____________,
_____.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">CERTARA,&nbsp;INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: left">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: left">&nbsp;</TD><TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Name:&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Title:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>tm2229794d1_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Execution Version</I></B></P>

<P STYLE="border-bottom: Black medium double; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BY AND AMONG</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTARA,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE PARTIES HERETO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of November&nbsp;3, 2022</P>

<P STYLE="border-bottom: Black medium double; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: right"><B>Page</B></TD>
    </TR>
<TR STYLE="vertical-align: top">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 90%"><FONT STYLE="text-transform: uppercase">Article&nbsp;I DEFINITIONS</FONT></TD>
  <TD STYLE="text-align: right; width: 10%"><FONT STYLE="text-transform: uppercase">1</FONT></TD>
    </TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;1.01.</FONT></TD>
  <TD STYLE="width: 75%">Defined Terms</TD>
    <TD STYLE="text-align: right; width: 8%">1</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;1.02.</FONT></TD>
  <TD>Other Interpretive Provisions</TD>
    <TD STYLE="text-align: right">6</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 90%"><FONT STYLE="text-transform: uppercase">Article&nbsp;II REGISTRATION RIGHTS</FONT></TD>
  <TD STYLE="text-align: right; width: 10%"><FONT STYLE="text-transform: uppercase">7</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.01.</FONT></TD>
  <TD STYLE="width: 75%">Demand Registration</TD>
    <TD STYLE="text-align: right; width: 8%">7</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.02.</FONT></TD>
  <TD>Shelf Registration&#9;</TD>
    <TD STYLE="text-align: right">9</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.03.</FONT></TD>
  <TD>Piggyback Registration</TD>
    <TD STYLE="text-align: right">10</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.04.</FONT></TD>
  <TD>Black-out Periods&#9;</TD>
    <TD STYLE="text-align: right">12</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.05.</FONT></TD>
  <TD>Registration Procedures&#9;</TD>
    <TD STYLE="text-align: right">13</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.06.</FONT></TD>
  <TD>Underwritten Offerings&#9;</TD>
    <TD STYLE="text-align: right">18</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.07.</FONT></TD>
  <TD>No Inconsistent Agreements; Additional Rights&#9;</TD>
    <TD STYLE="text-align: right">19</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.08.</FONT></TD>
  <TD>Registration Expenses&#9;</TD>
    <TD STYLE="text-align: right">19</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.09.</FONT></TD>
  <TD>Indemnification</TD>
    <TD STYLE="text-align: right">20</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.10.</FONT></TD>
  <TD>Rules&nbsp;144 and 144A and Regulation&nbsp;S</TD>
    <TD STYLE="text-align: right">23</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.11.</FONT></TD>
  <TD>Limitation on Registrations and Underwritten Offerings&#9;</TD>
    <TD STYLE="text-align: right">23</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.12.</FONT></TD>
  <TD>Clear Market&#9;</TD>
    <TD STYLE="text-align: right">23</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.13.</FONT></TD>
  <TD>In-Kind Distributions</TD>
    <TD STYLE="text-align: right">24</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 90%"><FONT STYLE="text-transform: uppercase">Article&nbsp;III MISCELLANEOUS</FONT></TD>
  <TD STYLE="text-align: right; width: 10%"><FONT STYLE="text-transform: uppercase">24</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.01.</FONT></TD>
  <TD STYLE="width: 75%">Term&#9;</TD>
    <TD STYLE="text-align: right; width: 8%">24</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.02.</FONT></TD>
  <TD>Injunctive Relief&#9;</TD>
    <TD STYLE="text-align: right">24</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.03.</FONT></TD>
  <TD>Attorneys&rsquo; Fees&#9;</TD>
    <TD STYLE="text-align: right">24</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.04.</FONT></TD>
  <TD>Notices&#9;</TD>
    <TD STYLE="text-align: right">25</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.05.</FONT></TD>
  <TD>Publicity and Confidentiality&#9;</TD>
    <TD STYLE="text-align: right">25</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.06.</FONT></TD>
  <TD>Amendment&#9;</TD>
    <TD STYLE="text-align: right">25</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.07.</FONT></TD>
  <TD>Successors, Assigns and Transferees&#9;</TD>
    <TD STYLE="text-align: right">26</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.08.</FONT></TD>
  <TD>Binding Effect</TD>
    <TD STYLE="text-align: right">26</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.09.</FONT></TD>
  <TD>Third Party Beneficiaries&#9;</TD>
    <TD STYLE="text-align: right">27</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.10.</FONT></TD>
  <TD>Governing Law; Jurisdiction&#9;</TD>
    <TD STYLE="text-align: right">27</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.11.</FONT></TD>
  <TD>Waiver of Jury Trial&#9;</TD>
    <TD STYLE="text-align: right">27</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.12.</FONT></TD>
  <TD>Severability&#9;</TD>
    <TD STYLE="text-align: right">27</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.13.</FONT></TD>
  <TD>Counterparts&#9;</TD>
    <TD STYLE="text-align: right">27</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.14.</FONT></TD>
  <TD>Headings&#9;</TD>
    <TD STYLE="text-align: right">27</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.15.</FONT></TD>
  <TD>Joinder&#9;</TD>
    <TD STYLE="text-align: right">27</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.16.</FONT></TD>
  <TD>Effectiveness</TD>
    <TD STYLE="text-align: right">27</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">i</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">This Registration Rights Agreement (this&nbsp;&ldquo;<U>Agreement</U>&rdquo;)
is made and entered into as of November&nbsp;3, 2022, by and among the Company (as defined herein), the Institutional Investors (as defined
herein) set forth on <U>Schedule&nbsp;A</U> hereto and any other Person (as defined herein) who becomes a party hereto from time to time
in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WITNESSETH:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, the Company and certain other persons entered
into an Amended and Restated Registration Rights Agreement, dated December&nbsp;10, 2020 (as amended, supplemented or otherwise modified
from time to time, the &ldquo;<U>A&amp;R Registration Rights Agreement</U>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">WHEREAS, on November&nbsp;3,
2022, the Company and the Arsenal (as defined below) entered into a letter agreement (&ldquo;<U>Letter Agreement</U>&rdquo;) in connection
with the Sale Transaction (as that term is defined in the Letter Agreement, the &ldquo;<U>Sale Transaction</U>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">WHEREAS, the A&amp;R Registration
Rights Agreement will terminate in accordance with its terms in connection with the consummation of the Sale Transaction, and the Company
and the Arsenal Stockholders wish to enter into this Agreement in connection with the Sale Transaction, with this Agreement taking effect
upon the consummation of the Sale Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">NOW, THEREFORE, in consideration of the foregoing
and the mutual promises, covenants and agreements of the parties hereto, and for other good and valuable consideration the receipt and
sufficiency of which are hereby acknowledged, the parties hereto agree that, subject to Section&nbsp;3.16, in connection with the consummation
of the Sale Transaction, the A&amp;R Registration Rights Agreement shall be terminated and this Agreement shall become effective as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;I</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;1.01.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Defined
Terms</U>. As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>A&amp;R Registration Rights Agreement</U>&rdquo;
has the meaning set forth in the recitals of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Acceptable Holders</U>&rdquo; means, individually
or collectively, the Arsenal Stockholders and their respective Permitted Assignees and Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Adverse Disclosure</U>&rdquo; means public
disclosure of material non-public information that, in the Board of Directors&rsquo; good faith judgment, after consultation with independent
outside counsel to the Company, would be required to be made in any Registration Statement filed with the SEC by the Company so that
such Registration Statement would not contain any untrue statement of material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not materially misleading and would not be required to be made at such time but for
the filing, effectiveness or use of such Registration Statement, but which information the Company has a bona fide, material business
purpose for not disclosing publicly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Affiliate</U>&rdquo; has the meaning specified
in Rule&nbsp;12b-2 under the Exchange Act; <U>provided</U>, that no Holder shall be deemed an Affiliate of the Company or its Subsidiaries
for purposes of this Agreement; <U>provided</U>, <U>further</U>, that neither portfolio companies (as such term is commonly used in the
private equity industry) of Arsenal or any of their Investment Fund Affiliates nor limited partners, non-managing members or other similar
direct or indirect third party investors in Arsenal or any of their Investment Fund Affiliates shall be deemed to be Affiliates of any
Institutional Investor. The term &ldquo;<U>Affiliated</U>&rdquo; has a correlative meaning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Agreement</U>&rdquo; has the meaning set
forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Arsenal</U>&rdquo; means Arsenal Saturn
Holdings LP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Arsenal Stockholders</U>&rdquo; means
Arsenal, Arsenal Capital Partners III LP and Arsenal Capital Partners III-B LP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Board of Directors</U>&rdquo; means the
board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Business Day</U>&rdquo; means any day
other than a Saturday, Sunday or a day on which commercial banks located in New York, New York are required or authorized by law or executive
order to be closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Change of Control</U>&rdquo; means (a)&nbsp;the
sale or disposition, in one or a series of related transactions, of all or substantially all of the assets of the Company and its Subsidiaries
on a consolidated basis as determined under section&nbsp;271 of the Delaware General Corporation Law, to any &ldquo;person&rdquo; or
 &ldquo;group&rdquo; (as defined in section&nbsp;13(d)(3)&nbsp;of the Exchange Act) (excluding the Acceptable Holders) or (b)&nbsp;any
person or group (excluding the Acceptable Holders) is or becomes the&nbsp;&ldquo;beneficial owner&rdquo; (as defined in Rules&nbsp;13d-3
and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the total voting power of the voting stock of the Company
(a&nbsp;&ldquo;<U>Sale of Control</U>&rdquo;) and, following such Sale of Control, the Acceptable Holders cease to have the right to
designate a majority of the members of the Board of the Company; <U>provided</U>, <U>however</U>, notwithstanding anything to the contrary
in this definition or any provision of the Exchange Act, including section&nbsp;13(d)-3 or 13(d)-5 of the Exchange Act and Rules&nbsp;13d-3
and 13d-5 under the Exchange Act, (A)&nbsp;if any such person or group includes one or more Acceptable Holders, the issued and outstanding
Company Shares and Company Share Equivalents that are directly or indirectly owned by the Acceptable Holders that are part of such person
or group shall not be treated as being beneficially owned by such person or group or any other member of such group for purposes of this
definition, (B)&nbsp;such person or group shall not be deemed to beneficially own Company Shares and Company Share Equivalents to be
acquired by such person or group pursuant to a stock or asset purchase agreement, merger agreement, option agreement, warrant agreement
or similar agreement (or voting or option or similar agreement related thereto) until the consummation of the acquisition of Company
Shares and Company Share Equivalents in connection with the transactions contemplated by such agreement and (C)&nbsp;such person or group
will not be deemed to beneficially own Company Shares and Company Share Equivalents of another Person as a result of its ownership of
capital stock or other securities of such other Person or such Person&rsquo;s parent (or related contractual rights) unless it owns 50%
or more of the total voting power of the capital stock or other securities entitled to vote for the election of directors or similar
governing body of such Person or such Person&rsquo;s parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Co-Investor</U>&rdquo; means each Person
who executes a joinder to the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company</U>&rdquo; means Certara,&nbsp;Inc.,
a Delaware corporation, and any successors and assigns thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Public Sale</U>&rdquo; means any
offering of the Company&rsquo;s equity securities for its own account or for the account of any other Person(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Share Equivalent</U>&rdquo; means
securities exercisable, exchangeable or convertible into Company Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Shares</U>&rdquo; means the shares
of voting common stock of the Company, any securities into which such shares of voting common stock shall have been changed, or any securities
resulting from any reclassification, recapitalization or similar transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Demand Company Notice</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;2.01(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Demand Notice</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;2.01(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Demand Registration</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;2.01(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Demand Registration Statement</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;2.01(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Demand Suspension</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;2.01(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Exchange Act</U>&rdquo; means the Securities
Exchange Act of 1934, as amended, and any successor thereto, and any rules&nbsp;and regulations promulgated thereunder, all as the same
shall be in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>FINRA</U>&rdquo; means the U.S. Financial
Industry Regulatory Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Form&nbsp;S-1</U>&rdquo; means a registration
statement on Form&nbsp;S-1 under the Securities Act, or any comparable or successor form or forms thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Form&nbsp;S-3</U>&rdquo; means a registration
statement on Form&nbsp;S-3 under the Securities Act, or any comparable or successor form or forms thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Form&nbsp;S-4</U>&rdquo; means a registration
statement on Form&nbsp;S-4 under the Securities Act, or any comparable or successor form or forms thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Form&nbsp;S-8</U>&rdquo; means a registration
statement on Form&nbsp;S-8 under the Securities Act, or any comparable or successor form or forms thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Holder</U>&rdquo; means (i)&nbsp;any holder
of Registrable Securities that is a party hereto or that succeeds to rights hereunder pursuant to <U>Section&nbsp;3.07</U> and (ii)&nbsp;any
Co-Investor who executes a joinder agreement, in form and substance reasonably acceptable to the Institutional Investors and the Company,
agreeing to be bound by the terms and conditions of this Agreement as if such Person were a party hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Impacted Holder</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;3.06</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Institutional Investors</U>&rdquo; means
the Arsenal Stockholders and any Permitted Assignee thereof that becomes a party hereto as an Institutional Investor, together with each
of their respective successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&ldquo;<U>Investment Fund</U>&rdquo;
means, collectively, (x)&nbsp;a private equity or other investment fund that (A)&nbsp;makes investments in multiple portfolio companies
and was not formed primarily to invest in the Company or its Subsidiaries or (B)&nbsp;is an alternative investment vehicle for a fund
described in clause (A)&nbsp;and (y)&nbsp;any Person directly or indirectly wholly-owned by any private equity or other investment fund
(or group of Affiliated private equity or other investment funds) described in clause (x)&nbsp;and/or any general partner or managing
member who is an Affiliate thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Issuer Free Writing Prospectus</U>&rdquo;
means an issuer free writing prospectus, as defined in Rule&nbsp;433 under the Securities Act, relating to an offer of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Letter Agreement</U>&rdquo; has the meaning
set forth in the recitals of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Long-Form&nbsp;Registration</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;2.01(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Loss</U>&rdquo; or &ldquo;<U>Losses</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;2.09(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Majority Impacted Holders</U>&rdquo; means
the Impacted Holders holding a majority of the Registrable Securities held by all Impacted Holders as of the applicable date of determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Marketed
Underwritten Offering</U>&rdquo; means any Underwritten Offering (including a Marketed Underwritten Shelf Take-Down, but, for the avoidance
of doubt, not including any Shelf Take-Down that is not a Marketed Underwritten Shelf Take-Down) </FONT>that involves a customary &ldquo;road
show&rdquo; (including an&nbsp;&ldquo;electronic road show&rdquo;) or other substantial marketing effort by the Company and the underwriters
over a period of at least 48 hours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Marketed Underwritten Shelf Take-Down</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;2.02(c)(iii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Marketed Underwritten Shelf Take-Down
Notice</U>&rdquo; has the meaning set forth in <U>Section&nbsp;2.02(c)(iii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Participating Holder</U>&rdquo; means,
with respect to any Registration, any Holder of Registrable Securities covered by the applicable Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Permitted Assignee</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;3.07(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Person</U>&rdquo; means any individual,
partnership, corporation, limited liability company, unincorporated organization, trust or joint venture, or a governmental agency or
political subdivision thereof or any other entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Piggyback Registration</U>&rdquo; has
the meaning set forth in <U>Section&nbsp;2.03(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Prospectus</U>&rdquo; means the prospectus
included in any Registration Statement, all amendments and supplements to such prospectus, including pre- and post-effective amendments
to such Registration Statement, and all other material incorporated by reference in such prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Purchase Agreement</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;3.16</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Registrable Securities</U>&rdquo; means
any Company Shares and any securities that may be issued or distributed or be issuable or distributable in respect of, or in substitution
for, any Company Shares by way of conversion, exercise, dividend, stock split or other distribution, merger, consolidation, exchange,
recapitalization or reclassification or similar transaction, in each case whether now owned or hereinafter acquired; <U>provided</U>,
<U>however</U>, that any such Registrable Securities shall cease to be Registrable Securities to the extent (i)&nbsp;a Registration Statement
with respect to the sale of such Registrable Securities has been declared effective under the Securities Act and such Registrable Securities
have been disposed of in accordance with the plan of distribution set forth in such Registration Statement, (ii)&nbsp;such Registrable
Securities have been distributed pursuant to Rule&nbsp;144 or Rule&nbsp;145 of the Securities Act (or any successor rule&nbsp;or other
exemption from the registration requirements of the Securities Act), (iii)&nbsp;a Registration Statement on Form&nbsp;S-8 (or any successor
form) covering the resale of such securities is effective, (iv)&nbsp;such security ceases to be outstanding or (v)&nbsp;when a Holder
(other than the Institutional Investors or any of their respective Affiliates) is able to dispose of such Registrable Securities held
by it pursuant to Rule&nbsp;144 under the Securities Act without any limitation. &ldquo;<U>Registration</U>&rdquo; means a registration
with the SEC of the Company&rsquo;s securities for offer and sale to the public under a Registration Statement. The terms &ldquo;<U>Register</U>&rdquo;
and &ldquo;<U>Registered</U>&rdquo; shall have correlative meanings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Registration Expenses</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;2.08</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Registration Statement</U>&rdquo; means
any registration statement of the Company that covers Registrable Securities pursuant to the provisions of this Agreement filed with,
or to be filed with, the SEC under the rules&nbsp;and regulations promulgated under the Securities Act, including any related Prospectus,
amendments and supplements to such registration statement, including pre- and post-effective amendments, and all exhibits and all material
incorporated by reference in such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Representatives</U>&rdquo; means, with
respect to any Person, any of such Person&rsquo;s officers, directors, employees, agents, attorneys, accountants, actuaries, consultants,
equity financing partners or financial advisors or other Person associated with, or acting on behalf of, such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Rule&nbsp;144</U>&rdquo; means Rule&nbsp;144
(or any successor provisions) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Sale Transaction</U>&rdquo; shall have
the meaning set forth in the recitals of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>SEC</U>&rdquo; means the Securities and
Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Securities Act</U>&rdquo; means the Securities
Act of 1933, as amended, and any successor thereto, and any rules&nbsp;and regulations promulgated thereunder, all as the same shall
be in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Shelf Holder</U>&rdquo; has the meaning
set forth in Section&nbsp;2.02(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Shelf Period</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;2.02(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Shelf Registration</U>&rdquo; means a
Registration effected pursuant to <U>Section&nbsp;2.02</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Shelf Registration Statement</U>&rdquo;
means a Registration Statement of the Company filed with the SEC on either (i)&nbsp;Form&nbsp;S-3 (or any successor or similar short-form
registration statement) or (ii)&nbsp;if the Company is not permitted to file a Registration Statement on Form&nbsp;S-3, a Registration
Statement on Form&nbsp;S-1 (or any successor or similar registration statement), in each case for an offering to be made on a delayed
or continuous basis pursuant to Rule&nbsp;415 under the Securities Act (or any successor provision) covering all or any portion of the
Registrable Securities, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Shelf Take-Down</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;2.02(c)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Short-Form&nbsp;Registration</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;2.01(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Special Registration</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;2.12</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholders
Agreement</U>&rdquo; means </FONT>the Stockholders Agreement of the Company, dated as of the date hereof, by and among the Company and
the Arsenal Stockholders, as amended, supplemented or otherwise modified from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means, with respect to any Person, any entity of which (i)&nbsp;a majority of the total voting power of shares of stock or equivalent
ownership interests entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, trustees
or other members of the applicable governing body thereof is at the time owned or controlled, directly or indirectly, by that Person
or one or more of the Subsidiaries of that Person or a combination thereof, or (ii)&nbsp;if no such governing body exists at such entity,
a majority of the total voting power of shares of stock or equivalent ownership interests of the entity is at the time owned or controlled,
directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person
or Persons shall be deemed to have a majority ownership interest in a limited liability company, company, association or other business
entity if such Person or Persons shall be allocated a majority of limited liability company, company, association or other business entity
gains or losses or is (or controls) the managing member or general partner of such limited liability company, company, association or
other business entity</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Underwritten Offering</U>&rdquo; means
a Registration in which securities of the Company are sold to an underwriter or underwriters on a firm commitment basis for reoffering
to the public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Underwritten Shelf Take-Down Notice</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;2.02(c)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;1.02.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Other
Interpretive Provisions</U>. (a)&nbsp; In this Agreement, except as otherwise provided:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
reference to an Article, Section, Schedule&nbsp;or Exhibit&nbsp;is a reference to an Article&nbsp;or Section&nbsp;of, or Schedule&nbsp;or
Exhibit&nbsp;to, this Agreement, and references to this Agreement include any recital in or Schedule&nbsp;or Exhibit&nbsp;to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Schedules and Exhibits&nbsp;form an integral part of and are hereby incorporated by reference into this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Headings
and the Table of Contents are inserted for convenience only and shall not affect the construction or interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
the context otherwise requires, words importing the singular include the plural and vice versa, words importing the masculine include
the feminine and vice versa, and words importing persons include corporations, associations, partnerships, joint ventures and limited
liability companies and vice versa.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
the context otherwise requires, the words &ldquo;hereof&rdquo; and &ldquo;herein&rdquo;, and words of similar meaning refer to this Agreement
as a whole and not to any particular Article, Section&nbsp;or clause. The words &ldquo;include&rdquo;, &ldquo;includes&rdquo; and &ldquo;including&rdquo;
shall be deemed to be followed by the words &ldquo;without limitation.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
reference to any legislation or to any provision of any legislation shall include any amendment, modification or re-enactment thereof
and any legislative provision substituted therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
determinations to be made by the Institutional Investors hereunder shall be made by the Institutional Investors in their sole discretion,
and the Institutional Investors may determine, in their sole discretion, whether or not to take actions that are permitted, but not required,
by this Agreement to be taken by the Institutional Investors, including the giving of consents required hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
parties hereto have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of
intention or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto, and no presumption
or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;II</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">REGISTRATION
RIGHTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.01.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Demand
Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Demand
by Institutional Investors</U>. At any time, subject to the terms of the Letter Agreement, the Institutional Investors may, subject to
<U>Section&nbsp;2.11</U>, make a written request (a&nbsp;&ldquo;<U>Demand Notice</U>&rdquo;) to the Company for Registration of all or
part of the Registrable Securities held by the Institutional Investors (i)&nbsp;on Form&nbsp;S-1 (a&nbsp;&ldquo;<U>Long-Form&nbsp;Registration</U>&rdquo;)
or (ii)&nbsp;on Form&nbsp;S-3 (a&nbsp;&ldquo;<U>Short-Form&nbsp;Registration</U>&rdquo;) if the Company qualifies to use such short form
(any such requested Long-Form&nbsp;Registration or Short-Form&nbsp;Registration, a&nbsp;&ldquo;<U>Demand Registration</U>&rdquo;). Each
Demand Notice shall specify the aggregate amount of Registrable Securities of the Institutional Investors to be registered and the intended
methods of disposition thereof. Subject to <U>Section&nbsp;2.11</U>, after delivery of such Demand Notice, the Company (x)&nbsp;shall
file promptly (and, in any event, within (i)&nbsp;ninety&nbsp;(90) days in the case of a request for a Long-Form&nbsp;Registration or
(ii)&nbsp;thirty&nbsp;(30) days in the case of a request for a Short-Form&nbsp;Registration, in each case, following delivery of such
Demand Notice) with the SEC a Registration Statement (which the Company shall designate as an automatically effective Registration Statement
if the Company qualifies at such time to file such a Registration Statement) relating to such Demand Registration (a&nbsp;&ldquo;<U>Demand
Registration Statement</U>&rdquo;), and (y)&nbsp;shall use its reasonable best efforts to cause such Demand Registration Statement to
promptly be declared effective under (x)&nbsp;the Securities Act (if such Registration Statement is not automatically effective) and
(y)&nbsp;the&nbsp;&ldquo;Blue Sky&rdquo; laws of such jurisdictions as any Participating Holder or any underwriter, if any, reasonably
requests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Demand
Withdrawal</U>. The Institutional Investors may withdraw their Registrable Securities from a Demand Registration at any time prior to
the effectiveness of the applicable Demand Registration Statement. Upon delivery of a notice by the Institutional Investors to such effect,
the Company shall cease all efforts to secure effectiveness of the applicable Demand Registration Statement. For the avoidance of doubt,
the Institutional Investors shall not have any liability or obligation to any other Holder following their determination to terminate,
withdraw and/or delay any Demand Registration initiated by them under this <U>Section&nbsp;2.01</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Demand
Company Notice</U>. Subject to <U>Section&nbsp;2.11</U>, promptly upon delivery of any Demand Notice (but in no event more than five&nbsp;(5)&nbsp;Business
Days following delivery of such Demand Notice), the Company shall deliver a written notice (a&nbsp;&ldquo;<U>Demand Company Notice</U>&rdquo;)
of any such Registration request to all Holders (other than the Institutional Investors), and the Company shall include in such Demand
Registration all such Registrable Securities of such Holders which the Company has received written requests for inclusion therein within
ten&nbsp;(10)&nbsp;Business Days after the date that such Demand Company Notice has been delivered. All requests made pursuant to this
<U>Section&nbsp;2.01(c)</U>&nbsp;shall specify the aggregate amount of Registrable Securities of such Holder to be registered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delay
in Filing; Suspension of Registration</U>. If the Company shall furnish to the Participating Holders a certificate signed by the Chief
Executive Officer or equivalent senior executive officer of the Company stating that the filing, effectiveness or continued use of a
Demand Registration Statement would require the Company to make an Adverse Disclosure, then the Company may delay the filing (but not
the preparation of) or initial effectiveness of, or suspend use of, the Demand Registration Statement (a&nbsp;&ldquo;<U>Demand Suspension</U>&rdquo;);
<U>provided</U>, <U>however</U>, that the Company, unless otherwise approved in writing by the Institutional Investors, shall not be
permitted to exercise aggregate Demand Suspensions more than twice, or for more than an aggregate of sixty&nbsp;(60) days, in each case,
during any twelve&nbsp;(12) month period; <U>provided</U>, <U>further</U>, that in the event of a Demand Suspension, such Demand Suspension
shall terminate at such earlier time as the Company would no longer be required to make any Adverse Disclosure. Each Participating Holder
shall keep confidential the fact that a Demand Suspension is in effect, the certificate referred to above and its contents unless and
until otherwise notified by the Company, except (A)&nbsp;for disclosure to such Participating Holder&rsquo;s employees, agents and professional
advisers who reasonably need to know such information for purposes of assisting the Participating Holder with respect to its investment
in the Company Shares and agree to keep it confidential, (B)&nbsp;for disclosures to the extent required in order to comply with reporting
obligations to its limited partners or other direct or indirect investors who have agreed to keep such information confidential, (C)&nbsp;if
and to the extent such matters are publicly disclosed by the Company or any of its Subsidiaries or any other Person that, to the actual
knowledge of such Participating Holder, was not subject to an obligation or duty of confidentiality to the Company and its Subsidiaries,
(D)&nbsp;as required by law, rule&nbsp;or regulation, (E)&nbsp;for disclosures to potential limited partners or investors of a Participating
Holder who have agreed to keep such information confidential and (F)&nbsp;for disclosures to potential transferees of a Holder&rsquo;s
Registrable Securities who have agreed to keep such information confidential. In the case of a Demand Suspension, the Participating Holders
agree to suspend use of the applicable Prospectus and any Issuer Free Writing Prospectus in connection with any sale or purchase of,
or offer to sell or purchase, Registrable Securities, upon delivery of the notice referred to above. The Company shall immediately notify
the Participating Holders upon the termination of any Demand Suspension, and (i)&nbsp;in the case of a Demand Registration Statement
that has not been declared effective, shall promptly thereafter file the Demand Registration Statement and use its reasonable best efforts
to have such Demand Registration Statement declared effective under the Securities Act and (ii)&nbsp;in the case of an effective Demand
Registration Statement, shall amend or supplement the Prospectus and any Issuer Free Writing Prospectus, if necessary, so it does not
contain any untrue statement or omission and furnish to the Participating Holders such numbers of copies of the Prospectus and any Issuer
Free Writing Prospectus as so amended or supplemented as the Participating Holders may reasonably request. The Company agrees, if necessary,
to supplement or make amendments to the Demand Registration Statement if required by the registration form used by the Company for the
applicable Registration or by the instructions applicable to such registration form or by the Securities Act, or as may reasonably be
requested by the Institutional Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Underwritten
Offering</U>. If the Institutional Investors so request, an offering of Registrable Securities pursuant to a Demand Registration shall
be in the form of an Underwritten Offering, and the Institutional Investors shall have the right to select the managing underwriter or
underwriters to administer the offering. If the Institutional Investors intend to sell the Registrable Securities covered by their demand
by means of an Underwritten Offering, the Institutional Investors shall so advise the Company as part of its Demand Notice, and the Company
shall include such information in the Demand Company Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Priority
of Securities Registered Pursuant to Demand Registrations</U>. If the managing underwriter or underwriters of a proposed Underwritten
Offering of the Registrable Securities included in a Demand Registration advise the Board of Directors in writing (with a copy provided
to the Institutional Investors requesting participation in such Demand Registration) that, in its or their opinion, the number of securities
requested to be included in such Demand Registration exceeds the number which can be sold in such offering without being likely to have
a significant adverse effect on the price, timing or distribution of the securities offered or the market for the securities offered,
the securities to be included in such Demand Registration (i)&nbsp;<U>first</U>, shall be allocated <U>pro rata</U> among the Holders
that have requested to participate in such Demand Registration based on the relative number of Registrable Securities then held by each
such Holder (<U>provided</U>, that any securities thereby allocated to a Holder that exceed such Holder&rsquo;s request shall be reallocated
among the remaining requesting Holders in like manner), (ii)&nbsp;<U>second</U>, and only if all the securities referred to in clause
(i)&nbsp;have been included in such Registration, the number of securities that the Company proposes to include in such Registration
that, in the opinion of the managing underwriter or underwriters, can be sold without having such adverse effect and (iii)&nbsp;<U>third</U>,
and only if all of the securities referred to in clause (ii)&nbsp;have been included in such Registration, any other securities eligible
for inclusion in such Registration that, in the opinion of the managing underwriter or underwriters, can be sold without having such
adverse effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.02.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Shelf
Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Filing</U>.
If the Company is then eligible to Register on Form&nbsp;S-3, a Demand Registration may be in the form of a Shelf Registration Statement
on Form&nbsp;S-3 covering the Registrable Securities held by the Institutional Investors and the Demand Notice relating to such Demand
Registration shall so state (each such Holder delivering such a notice, a &ldquo;<U>Shelf Holder</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Continued
Effectiveness</U>. The Company shall use its reasonable best efforts to keep any Shelf Registration Statement filed pursuant to <U>Section&nbsp;2.02(a)</U>&nbsp;continuously
effective under the Securities Act in order to permit the Prospectus forming a part thereof to be usable by Shelf Holders until the earliest
of (i)&nbsp;the date as of which all Registrable Securities have been sold pursuant to the Shelf Registration Statement or another Registration
Statement filed under the Securities Act (but in no event prior to the applicable period referred to in section&nbsp;4(a)(3)&nbsp;of
the Securities Act and Rule&nbsp;174 thereunder), (ii)&nbsp;the date as of which each of the Shelf Holders is permitted to sell its Registrable
Securities without Registration pursuant to Rule&nbsp;144 without volume limitation or other restrictions on transfer thereunder and
(iii)&nbsp;such shorter period as the Institutional Investors with respect to such Shelf Registration shall agree in writing (such period
of effectiveness, the&nbsp;&ldquo;<U>Shelf Period</U>&rdquo;). Subject to Section&nbsp;2.01(d), the Company shall not be deemed to have
used its reasonable best efforts to keep the Shelf Registration Statement effective during the Shelf Period if the Company voluntarily
takes any action or omits to take any action that would result in Shelf Holders not being able to offer and sell any Registrable Securities
pursuant to such Shelf Registration Statement during the Shelf Period, unless such action or omission is (x)&nbsp;a Demand Suspension
permitted pursuant to Section&nbsp;2.01(d)&nbsp;or (y)&nbsp;required by applicable law, rule&nbsp;or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Shelf
Take-Downs</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
offering or sale of Registrable Securities pursuant to a Shelf Registration Statement (each, a&nbsp;&ldquo;<U>Shelf Take-Down</U>&rdquo;)
may be initiated only by the Institutional Investors. Except as set forth in <U>Section&nbsp;2.02(c)(iii)</U>&nbsp;with respect to Marketed
Underwritten Shelf Take-Downs, the Company shall not be required to permit the offer and sale of Registrable Securities by other Shelf
Holders in connection with any such Shelf Take-Down initiated by the Institutional Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to <U>Section&nbsp;2.11</U>, if the Institutional Investors elect by written request to the Company, a Shelf Take-Down shall be in the
form of an Underwritten Offering (an&nbsp;&ldquo;<U>Underwritten Shelf Take-Down Notice</U>&rdquo;) and the Company shall amend or supplement
the Shelf Registration Statement for such purpose as soon as practicable. The Institutional Investors shall have the right to select
the managing underwriter or underwriters to administer such offering. The provisions of <U>Section&nbsp;2.01(f)</U>&nbsp;shall apply
to any Underwritten Offering pursuant to this <U>Section&nbsp;2.02(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the plan of distribution set forth in any Underwritten Shelf Take-Down Notice includes a customary &ldquo;road show&rdquo; (including
an&nbsp;&ldquo;electronic road show&rdquo;) or other marketing effort, which may be conducted confidentially, by the Company and the
underwriters over a period expected to exceed forty-eight&nbsp;(48) hours (a&nbsp;&ldquo;<U>Marketed Underwritten Shelf Take-Down</U>&rdquo;),
promptly upon delivery of such Underwritten Shelf Take-Down Notice (but in no event more than three&nbsp;(3)&nbsp;Business Days thereafter),
the Company shall promptly deliver a written notice (a&nbsp;&ldquo;<U>Marketed Underwritten Shelf Take-Down Notice</U>&rdquo;) of such
Marketed Underwritten Shelf Take-Down to all Shelf Holders (other than the Institutional Investors), and the Company shall include in
such Marketed Underwritten Shelf Take-Down all such Registrable Securities of such Shelf Holders that are Registered on such Shelf Registration
Statement for which the Company has received written requests, which requests must specify the aggregate amount of such Registrable Securities
of such Holder to be offered and sold pursuant to such Marketed Underwritten Shelf Take-Down, for inclusion therein within three&nbsp;(3)&nbsp;Business
Days after the date that such Marketed Underwritten Shelf Take-Down Notice has been delivered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.03.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Piggyback
Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Participation</U>.
If the Company at any time proposes to file a Registration Statement with respect to any Company Public Sale (other than (i)&nbsp; a
Registration under <U>Section&nbsp;2.01</U> or <U>Section&nbsp;2.02</U>, it being understood that this clause (i)&nbsp;does not limit
the rights of Holders to make written requests pursuant to <U>Sections&nbsp;2.01</U> or <U>2.02</U> or otherwise limit the applicability
thereof, (ii)&nbsp;a Registration Statement on Form&nbsp;S-4 or Form&nbsp;S-8, (iii)&nbsp;a registration of securities solely relating
to an offering and sale to employees, directors or consultants of the Company or its Subsidiaries pursuant to any employee stock plan
or other employee benefit plan arrangement, (iv)&nbsp;a registration not otherwise covered by clause (ii)&nbsp;above pursuant to which
the Company is offering to exchange its own securities for other securities, (v)&nbsp;a Registration Statement relating solely to dividend
reinvestment or similar plans or (vi)&nbsp;a Shelf Registration Statement pursuant to which only the initial purchasers and subsequent
transferees of debt securities of the Company or any of its Subsidiaries that are convertible or exchangeable for Company Shares and
that are initially issued pursuant to Rule&nbsp;144A and/or Regulation&nbsp;S (or any successor provisions) of the Securities Act may
resell such notes and sell the Company Shares into which such notes may be converted or exchanged), then, (A)&nbsp;as soon as practicable
(but in no event less than thirty&nbsp;(30) days prior to the proposed date of filing of such Registration Statement), the Company shall
give written notice of such proposed filing to the Institutional Investor, and such notice shall offer each Institutional Investor the
opportunity to Register under such Registration Statement such number of Registrable Securities as such Institutional Investor may request
in writing delivered to the Company within ten&nbsp;(10)&nbsp;days of delivery of such written notice by the Company, and (B)&nbsp;subject
to <U>Section&nbsp;2.03(c)</U>, as soon as practicable after the expiration of such ten&nbsp;(10)-&nbsp;day period (but in no event less
than fifteen&nbsp;(15) days prior to the proposed date of filing of such Registration Statement), the Company shall give written notice
of such proposed filing to the Holders (other than the Institutional Investor), and such notice shall offer each such Holder the opportunity
to Register under such Registration Statement such number of Registrable Securities as such Holder may request in writing within ten&nbsp;(10)&nbsp;days
of delivery of such written notice by the Company. Subject to <U>Sections&nbsp;2.03(b)</U>&nbsp;and <U>(c)</U>, the Company shall include
in such Registration Statement all such Registrable Securities that are requested by Holders to be included therein in compliance with
the immediately foregoing sentence (a&nbsp;&ldquo;<U>Piggyback Registration</U>&rdquo;); <U>provided,</U> that, if at any time after
giving written notice of its intention to Register any equity securities and prior to the effective date of the Registration Statement
filed in connection with such Piggyback Registration, the Company shall determine for any reason not to Register or to delay Registration
of the equity securities covered by such Piggyback Registration, the Company shall give written notice of such determination to each
Holder that had requested to Register its, his or her Registrable Securities in such Registration Statement and, thereupon, (1)&nbsp;in
the case of a determination not to Register, shall be relieved of its obligation to Register any Registrable Securities in connection
with such Registration (but not from its obligation to pay the Registration Expenses in connection therewith, to the extent payable),
without prejudice, however, to the rights of the Institutional Investors to request that such Registration be effected as a Demand Registration
under <U>Section&nbsp;2.01</U>, and (2)&nbsp;in the case of a determination to delay Registering, in the absence of a request by the
Institutional Investors to request that such Registration be effected as a Demand Registration under <U>Section&nbsp;2.01</U>, shall
be permitted to delay Registering any Registrable Securities, for the same period as the delay in Registering the other equity securities
covered by such Piggyback Registration. If the offering pursuant to such Registration Statement is to be underwritten, the Company shall
so advise the Holders as a part of the written notice given pursuant this <U>Section&nbsp;2.03(a)</U>, and each Holder making a request
for a Piggyback Registration pursuant to this <U>Section&nbsp;2.03(a)</U>&nbsp;must, and the Company shall make such arrangements with
the managing underwriter or underwriters so that each such Holder may, participate in such Underwritten Offering, subject to the conditions
of <U>Section&nbsp;2.03(b)</U>&nbsp;and <U>(c)</U>. If the offering pursuant to such Registration Statement is to be on any other basis,
the Company shall so advise the Holders as part of the written notice given pursuant to this <U>Section&nbsp;2.03(a)</U>, and each Holder
making a request for a Piggyback Registration pursuant to this <U>Section&nbsp;2.03(a)</U>&nbsp;must, and the Company shall make such
arrangements so that each such Holder may, participate in such offering on such basis, subject to the conditions of <U>Section&nbsp;2.03(b)</U>&nbsp;and
<U>(c)</U>. Each Holder shall be permitted to withdraw all or part of its Registrable Securities from a Piggyback Registration at any
time prior to the effectiveness of such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Priority
of Piggyback Registration</U>. If the managing underwriter or underwriters of any proposed Underwritten Offering of Registrable Securities
included in a Piggyback Registration informs the Company and the Holders that have requested to participate in such Piggyback Registration
in writing that, in its or their opinion, the number of securities which such Holders and any other Persons intend to include in such
offering exceeds the number which can be sold in such offering without being likely to have a significant adverse effect on the price,
timing or distribution of the securities offered or the market for the securities offered, then the securities to be included in such
Registration shall be (i)&nbsp;<U>first</U>, 100% of the securities that the Company or (subject to <U>Section&nbsp;2.07</U>) any Person
(other than a Holder) exercising a contractual right to demand Registration, as the case may be, proposes to sell, (ii)&nbsp;<U>second</U>,
and only if all the securities referred to in clause (i)&nbsp;have been included, the number of Registrable Securities that, in the opinion
of such managing underwriter or underwriters, can be sold without having such adverse effect in such Registration, which such number
shall be allocated <U>pro rata</U> among the Holders that have requested to participate in such Registration based on the relative number
of Registrable Securities then held by each such Holder (<U>provided,</U> that any securities thereby allocated to a Holder that exceed
such Holder&rsquo;s request shall be reallocated among the remaining requesting Holders in like manner), and (iii)&nbsp;<U>third</U>,
and only if all of the Registrable Securities referred to in clause (ii)&nbsp;have been included in such Registration, any other securities
eligible for inclusion in such Registration that, in the opinion of the managing underwriter or underwriters, can be sold without having
such adverse effect in such Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictions
on Non-Institutional Investor Holders</U>. Notwithstanding any provisions contained herein, Holders other than the Institutional Investors
shall not be able to exercise the right to a Piggyback Registration unless at least one Institutional Investor exercises its rights with
respect to such Piggyback Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Effect on Demand Registrations</U>. No Registration of Registrable Securities effected pursuant to a request under this <U>Section&nbsp;2.03
</U>shall be deemed to have been effected pursuant to <U>Section&nbsp;2.01</U> or <U>Section&nbsp;2.02</U> or shall relieve the Company
of its obligations under <U>Section&nbsp;2.01</U> or <U>Section&nbsp;2.02</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.04.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Black-out
Periods</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Black-out
Periods for Holders</U>. In the event of a Company Public Sale of the Company&rsquo;s equity securities in an Underwritten Offering,
each of the Holders agrees, if requested by the managing underwriter or underwriters in such Underwritten Offering, not to (1)&nbsp;offer
for sale, sell, pledge, or otherwise dispose of (or enter into any transaction or device that is designed to, or could be expected to,
result in the disposition by any Person at any time in the future of) any Company Shares (including Company Shares that may be deemed
to be beneficially owned by the undersigned in accordance with the rules&nbsp;and regulations of the SEC and Company Shares that may
be issued upon exercise of any options or warrants) or Company Share Equivalents or any other securities of the Company, (2)&nbsp;enter
into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks
of ownership of Company Shares, Company Share Equivalents or any other securities of the Company, whether any such transaction described
in clause (1)&nbsp;or (2)&nbsp;above is to be settled by delivery of Company Shares or other securities, in cash or otherwise, (3)&nbsp;make
any demand for or exercise any right or cause to be filed a Registration Statement, including any amendments thereto, with respect to
the registration of any Company Shares or Company Share Equivalents or any other securities of the Company or (4)&nbsp;publicly disclose
the intention to do any of the foregoing without the prior written consent of the Company, in each case, during the period commencing
on the date of such offering and continuing for not more than sixty&nbsp;(60) days after the date of the underwriting agreement entered
into in connection with such Company Public Sale, to the extent timely notified in writing by the Company or the managing underwriter
or underwriters; <U>provided,</U> that no Holder shall be subject to any such black-out period of longer duration than that applicable
to any Institutional Investor and such restrictions shall be subject to customary exceptions typically included in underwriter lock-up
agreements, to the extent acceptable to the managing underwriter or underwriters. If requested by the managing underwriter or underwriters
of any such Company Public Sale, the Holders shall execute a separate agreement to the foregoing effect. The Company may impose stop-transfer
instructions with respect to the Company Shares or Company Share Equivalents (or other securities) subject to the foregoing restriction
until the end of the period referenced above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Black-out
Period for the Company and Others</U>. In the case of an offering of Registrable Securities pursuant to <U>Section&nbsp;2.01</U> or <U>2.02
</U>that is a Marketed Underwritten Offering, the Company and each of the Holders agree, if requested by the managing underwriter or
underwriters with respect to such Marketed Underwritten Offering and only to the extent the Institutional Investors also agree, not to
(1)&nbsp;offer for sale, sell, pledge, or otherwise dispose of (or enter into any transaction or device that is designed to, or could
be expected to, result in the disposition by any Person at any time in the future of) any Company Shares (including Company Shares that
may be deemed to be beneficially owned by the undersigned in accordance with the rules&nbsp;and regulations of the SEC and Company Shares
that may be issued upon exercise of any options or warrants) or Company Share Equivalents or any other securities of the Company, (2)&nbsp;enter
into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks
of ownership of Company Shares, whether any such transaction described in clause (1)&nbsp;or (2)&nbsp;above is to be settled by delivery
of Company Shares or other securities, in cash or otherwise, (3)&nbsp;make any demand for or exercise any right or cause to be filed
a Registration Statement, including any amendments thereto, with respect to the registration of any Company Shares or Company Share Equivalents
or any other securities of the Company or (4)&nbsp;publicly disclose the intention to do any of the foregoing without the prior written
consent of the Company, in each case, during the period commencing on the date of such offering and continuing for not more than sixty&nbsp;(60)
days (or such lesser period as may be agreed by the managing underwriter or underwriters) after the date of the underwriting agreement
entered into in connection with such Marketed Underwritten Offering, to the extent timely notified in writing by an Institutional Investor
or the managing underwriter or underwriters, as the case may be; <U>provided</U>, that no Holder shall be subject to any such black-out
period of longer duration than that applicable to any Institutional Investor and such restrictions shall be subject to customary exceptions
typically included in underwriter lock-up agreements, to the extent acceptable to the managing underwriter or underwriters. Notwithstanding
the foregoing, the Company may effect a public sale or distribution of securities of the type described above and during the periods
described above if such sale or distribution is made pursuant to Registrations on Form&nbsp;S-4 or Form&nbsp;S-8 or as part of any Registration
of securities for offering and sale to employees, directors or consultants of the Company and its Subsidiaries pursuant to any employee
stock plan or other employee benefit plan arrangement. Without limiting the foregoing (but subject to <U>Section&nbsp;2.07</U>), if after
the date hereof the Company or any of its Subsidiaries grants any Person (other than a Holder) any rights to demand or participate in
a Registration, the Company shall, and shall cause its Subsidiaries to, provide that the agreement with respect thereto shall include
such Person&rsquo;s agreement to comply with any black-out period required by this <U>Section&nbsp;2.04(b)</U>&nbsp;as if it were a Holder
hereunder. If requested by the managing underwriter or underwriters of any such Marketed Underwritten Offering (and if and only if the
Institutional Investors agree to such request and enters into such separate agreement), the Holders shall execute a separate agreement
to the foregoing effect. Subject to the provisions of this Agreement, the Company shall be responsible for negotiating all lock-up agreements
with the managing underwriters and the Holders agree to execute the form so negotiated in accordance with the terms of this Agreement.
The Company may impose stop-transfer instructions with respect to the Company Shares (or other securities) subject to the foregoing restriction
until the end of the period referenced above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.05.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Registration
Procedures</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the Company&rsquo;s Registration obligations under <U>Sections&nbsp;2.01</U>, <U>2.02</U>, and <U>2.03</U> and subject
to the applicable terms and conditions set forth therein, the Company shall use its reasonable best efforts to effect such Registration
to permit the sale of such Registrable Securities in accordance with the intended method or methods of distribution thereof as expeditiously
as reasonably practicable, and in connection therewith the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prepare
the required Registration Statement including all exhibits and financial statements required under the Securities Act to be filed therewith,
and before filing a Registration Statement, Prospectus or any Issuer Free Writing Prospectus, or any amendments or supplements thereto,
(x)&nbsp;furnish to the underwriters, if any, and the Institutional Investors, if applicable, copies of all documents prepared to be
filed, which documents shall be subject to the review of such underwriters and the Institutional Investors and their respective counsel
and (y)&nbsp;except in the case of a Registration under <U>Section&nbsp;2.03</U>, not file any Registration Statement or Prospectus or
amendments or supplements thereto to which the Institutional Investors or the underwriters, if any, shall reasonably object;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as
promptly as practicable and in accordance with the other provisions of this Agreement, file with the SEC a Registration Statement relating
to the Registrable Securities including all exhibits and financial statements required by the SEC to be filed therewith, and use its
reasonable best efforts to cause such Registration Statement to become effective under the Securities Act as soon as practicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prepare
and file with the SEC such pre- and post-effective amendments to such Registration Statement, supplements to the Prospectus and such
amendments or supplements to any Issuer Free Writing Prospectus as may be (x)&nbsp;reasonably requested by the Institutional Investors,
(y)&nbsp;reasonably requested by any other Participating Holder (to the extent such request relates to information relating to such Participating
Holder), or (z)&nbsp;necessary to keep such Registration effective for the period of time required by this Agreement, and comply with
provisions of the applicable securities laws with respect to the sale or other disposition of all securities covered by such Registration
Statement during such period in accordance with the intended method or methods of disposition by the sellers thereof set forth in such
Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;promptly
notify the Participating Holders and the managing underwriter or underwriters, if any, and (if requested) confirm such advice in writing
and provide copies of the relevant documents, as soon as reasonably practicable after notice thereof is received by the Company (A)&nbsp;when
the applicable Registration Statement or any amendment thereto has been filed or becomes effective, and when the applicable Prospectus
or Issuer Free Writing Prospectus or any amendment or supplement thereto has been filed, (B)&nbsp;of any written comments by the SEC
or any request by the SEC or any other federal or state governmental authority for amendments or supplements to such Registration Statement,
Prospectus or Issuer Free Writing Prospectus or for additional information, (C)&nbsp;of the issuance by the SEC of any stop order suspending
the effectiveness of such Registration Statement or any order by the SEC or any other regulatory authority preventing or suspending the
use of any preliminary or final Prospectus or any Issuer Free Writing Prospectus or the initiation or threatening of any proceedings
for such purposes, (D)&nbsp;if, at any time, the representations and warranties of the Company in any applicable underwriting agreement
cease to be true and correct in all material respects, (E)&nbsp;of the receipt by the Company of any notification with respect to the
suspension of the qualification of the Registrable Securities for offering or sale in any jurisdiction and (F)&nbsp;of the receipt by
the Company of any notification with respect to the initiation or threatening of any proceeding for the suspension of the qualification
of the Registrable Securities for offering or sale in any jurisdiction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;promptly
notify the Participating Holders and the managing underwriter or underwriters, if any, when the Company becomes aware of the happening
of any event as a result of which the applicable Registration Statement, the Prospectus included in such Registration Statement (as then
in effect) or any Issuer Free Writing Prospectus contains any untrue statement of a material fact or omits to state a material fact necessary
to make the statements therein (in the case of such Prospectus, any preliminary Prospectus or any Issuer Free Writing Prospectus, in
light of the circumstances under which they were made) not misleading, when any Issuer Free Writing Prospectus includes information that
may conflict with the information contained in the Registration Statement, or, if for any other reason it shall be necessary during such
time period to amend or supplement such Registration Statement, Prospectus or Issuer Free Writing Prospectus in order to comply with
the Securities Act and, in either case as promptly as reasonably practicable thereafter, prepare and file with the SEC, and furnish without
charge to the Participating Holders and the managing underwriter or underwriters, if any, an amendment or supplement to such Registration
Statement, Prospectus or Issuer Free Writing Prospectus which shall correct such misstatement or omission or effect such compliance;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;use
its reasonable best efforts to prevent, or obtain the withdrawal of, any stop order or other order suspending the use of any preliminary
or final Prospectus or any Issuer Free Writing Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;promptly
incorporate in a Prospectus supplement,&nbsp;Issuer Free Writing Prospectus or post-effective amendment to the applicable Registration
Statement such information as the managing underwriter or underwriters and the Institutional Investors (to the extent the Institutional
Investors are participating in such Registration) agree should be included therein relating to the plan of distribution with respect
to such Registrable Securities, and make all required filings of such Prospectus supplement,&nbsp;Issuer Free Writing Prospectus or post-effective
amendment as soon as reasonably practicable after being notified of the matters to be incorporated in such Prospectus supplement,&nbsp;Issuer
Free Writing Prospectus or post-effective amendment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;furnish
to each Participating Holder and each underwriter, if any, without charge, as many conformed copies as such Participating Holder or underwriter
may reasonably request of the applicable Registration Statement and any amendment or post-effective amendment thereto, including financial
statements and schedules, all documents incorporated therein by reference and all exhibits (including those incorporated by reference);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;deliver
to each Participating Holder and each underwriter, if any, without charge, as many copies of the applicable Prospectus (including each
preliminary Prospectus), any Issuer Free Writing Prospectus and any amendment or supplement thereto as such Participating Holder or underwriter
may reasonably request (it being understood that the Company consents to the use of such Prospectus, any Issuer Free Writing Prospectus
and any amendment or supplement thereto by such Participating Holder and the underwriters, if any, in connection with the offering and
sale of the Registrable Securities thereby) and such other documents as such Participating Holder or underwriter may reasonably request
in order to facilitate the disposition of the Registrable Securities by such Participating Holder or underwriter;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;on
or prior to the date on which the applicable Registration Statement is declared effective, use its reasonable best efforts to register
or qualify, and cooperate with the Participating Holders, the managing underwriter or underwriters, if any, and their respective counsel,
in connection with the registration or qualification of such Registrable Securities for offer and sale under the securities or &ldquo;Blue
Sky&rdquo; laws of each state and other jurisdiction of the United States as any Participating Holder or managing underwriter or underwriters,
if any, or their respective counsel reasonably request in writing and do any and all other acts or things reasonably necessary or advisable
to keep such registration or qualification in effect for such period as required by <U>Section&nbsp;2.02(b)</U>, <U>provided,</U> that
the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified or to take
any action which would subject it to taxation or general service of process in any such jurisdiction where it is not then so subject;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cooperate
with the Participating Holders and the managing underwriter or underwriters, if any, to facilitate the timely preparation and delivery
of certificates representing Registrable Securities to be sold and not bearing any restrictive legends, and enable such Registrable Securities
to be in such denominations and registered in such names as the managing underwriters may request at least two&nbsp;(2)&nbsp;Business
Days prior to any sale of Registrable Securities to the underwriters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;use
its reasonable best efforts to cause the Registrable Securities covered by the applicable Registration Statement to be registered with
or approved by such other governmental agencies or authorities as may be necessary to enable the seller or sellers thereof or the underwriter
or underwriters, if any, to consummate the disposition of such Registrable Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;not
later than the effective date of the applicable Registration Statement, provide a CUSIP number for all Registrable Securities and provide
the applicable transfer agent with printed certificates for the Registrable Securities which are in a form eligible for deposit with
The Depository Trust Company or any other required depository;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make
such representations and warranties to the Participating Holders and the underwriters or agents, if any, in form, substance and scope
as are customarily made by issuers in secondary underwritten public offerings;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enter
into such customary agreements (including underwriting and indemnification agreements) and take all such other actions as the Institutional
Investors or the managing underwriter or underwriters, if any, reasonably request in order to expedite or facilitate the registration
and disposition of such Registrable Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;obtain
for delivery to the Participating Holders and to the underwriter or underwriters, if any, an opinion or opinions from counsel for the
Company dated the effective date of the Registration Statement or, in the event of an Underwritten Offering, the date of the closing
under the underwriting agreement, in customary form, scope and substance, which opinions shall be reasonably satisfactory to such Participating
Holders or underwriters, as the case may be, and their respective counsel;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xvii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in
the case of an Underwritten Offering, obtain for delivery to the Company and the managing underwriter or underwriters, with copies to
the Participating Holders, a cold comfort letter from the Company&rsquo;s independent certified public accountants in customary form
and covering such matters of the type customarily covered by cold comfort letters as the managing underwriter or underwriters reasonably
request, dated the date of execution of the underwriting agreement and brought down to the closing under the underwriting agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xviii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cooperate
with each Participating Holder and each underwriter, if any, participating in the disposition of such Registrable Securities and their
respective counsel in connection with any filings required to be made with the FINRA;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;use
its reasonable best efforts to comply with all applicable securities laws and make available to its security holders, as soon as reasonably
practicable, an earnings statement satisfying the provisions of section&nbsp;11(a)&nbsp;of the Securities Act and the rules&nbsp;and
regulations promulgated thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xx)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provide
and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by the applicable Registration Statement
from and after a date not later than the effective date of such Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xxi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;use
its reasonable best efforts to cause all Registrable Securities covered by the applicable Registration Statement to be listed on each
securities exchange on which any of the Company Shares are then listed or quoted and on each inter-dealer quotation system on which any
of the Company Shares are then quoted;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xxii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make
available upon reasonable notice at reasonable times and for reasonable periods for inspection by the Institutional Investors, by any
underwriter participating in any disposition to be effected pursuant to such Registration Statement and by any attorney, accountant or
other agent retained by such Institutional Investors or any such underwriter, all pertinent financial and other records, pertinent corporate
documents and properties of the Company, and cause all of the Company&rsquo;s officers, directors and employees and the independent public
accountants who have certified its financial statements to make themselves available to discuss the business of the Company and to supply
all information reasonably requested by any such Person in connection with such Registration Statement as shall be necessary to enable
them to exercise their due diligence responsibility; <U>provided,</U> that any such Person gaining access to information regarding the
Company pursuant to this <U>Section&nbsp;2.05(a)(xii)</U>&nbsp;shall agree to hold in strict confidence and shall not make any disclosure
or use any information regarding the Company that the Company determines in good faith to be confidential, and of which determination
such Person is notified, unless (w)&nbsp;the release of such information is requested or required by law or by deposition, interrogatory,
requests for information or documents by a governmental entity, subpoena or similar process, (x)&nbsp;such information is or becomes
publicly known other than through a breach of this or any other agreement of which such Person has actual knowledge, (y)&nbsp;such information
is or becomes available to such Person on a non-confidential basis from a source other than the Company or (z)&nbsp;such information
is independently developed by such Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xxiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in
the case of an Underwritten Offering, cause the senior executive officers of the Company to participate in the customary &ldquo;road
show&rdquo; presentations that may be reasonably requested by the managing underwriter or underwriters in any such Underwritten Offering
and otherwise to facilitate, cooperate with, and participate in each proposed offering contemplated herein and customary selling efforts
related thereto; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(xxiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;otherwise
comply in all material respects with all applicable rules&nbsp;and regulations of the SEC in connection with any Registration Statement
and the disposition of all Registrable Securities covered by such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company may require each Participating Holder to furnish to the Company such information regarding the distribution of such securities
and such other information relating to such Participating Holder and its ownership of Registrable Securities as the Company may from
time to time reasonably request in writing. Each Participating Holder agrees to furnish such information to the Company and to cooperate
with the Company as reasonably necessary to enable the Company to comply with the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Participating Holder agrees that, upon delivery of any notice by the Company of the happening of any event of the kind described in <U>Section&nbsp;2.05(a)(iv)(C)</U>,
<U>(D)</U>, or <U>(E)</U>&nbsp;or <U>Section&nbsp;2.05(a)(v)</U>, such Participating Holder will forthwith discontinue disposition of
Registrable Securities pursuant to such Registration Statement until (i)&nbsp;such Participating Holder&rsquo;s receipt of the copies
of the supplemented or amended Prospectus or Issuer Free Writing Prospectus contemplated by <U>Section&nbsp;2.05(a)(v)</U>, (ii)&nbsp;such
Participating Holder is advised in writing by the Company that the use of the Prospectus or Issuer Free Writing Prospectus, as the case
may be, may be resumed, (iii)&nbsp;such Participating Holder is advised in writing by the Company of the termination, expiration or cessation
of such order or suspension referenced in <U>Section&nbsp;2.05(a)(iv)(C)</U>&nbsp;or <U>(E)</U>&nbsp;or <U>(iv)</U>&nbsp;such Participating
Holder is advised in writing by the Company that the representations and warranties of the Company in such applicable underwriting agreement
are true and correct in all material respects. If so directed by the Company, such Participating Holder shall deliver to the Company
(at the Company&rsquo;s expense) all copies, other than permanent file copies then in such Participating Holder&rsquo;s possession, of
the Prospectus or any Issuer Free Writing Prospectus covering such Registrable Securities current at the time of delivery of such notice.
In the event the Company shall give any such notice, the period during which the applicable Registration Statement is required to be
maintained effective shall be extended by the number of days during the period from and including the date of the giving of such notice
to and including the date when each seller of Registrable Securities covered by such Registration Statement either receives the copies
of the supplemented or amended Prospectus or Issuer Free Writing Prospectus contemplated by <U>Section&nbsp;2.05(a)(v)</U>&nbsp;or is
advised in writing by the Company that the use of the Prospectus or Issuer Free Writing Prospectus may be resumed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.06.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Underwritten
Offerings</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Demand
and Shelf Registrations</U>. If requested by the underwriters for any Underwritten Offering requested by the Institutional Investors
pursuant to a Registration under <U>Section&nbsp;2.01</U> or <U>Section&nbsp;2.02</U>, as applicable, the Company shall enter into an
underwriting agreement with such underwriters for such offering, such agreement to be reasonably satisfactory in substance and form to
the Company, the Institutional Investors and the underwriters, and to contain such representations and warranties by the Company and
such other terms as are generally prevailing in agreements of that type, including indemnities no less favorable to the recipient thereof
than those provided in <U>Section&nbsp;2.09</U>. The Institutional Investors shall cooperate with the Company in the negotiation of such
underwriting agreement and shall give consideration to the reasonable suggestions of the Company regarding the form thereof. The Participating
Holders shall be parties to such underwriting agreement, which underwriting agreement shall (i)&nbsp;contain such representations and
warranties by, and the other agreements on the part of, the Company to and for the benefit of such Participating Holders as are customarily
made by issuers to selling stockholders in secondary underwritten public offerings and (ii)&nbsp;provide that any or all of the conditions
precedent to the obligations of such underwriters under such underwriting agreement also shall be conditions precedent to the obligations
of such Participating Holders. Any such Participating Holder shall not be required to make any representations or warranties to or agreements
with the Company or the underwriters in connection with such underwriting agreement other than representations, warranties or agreements
regarding such Participating Holder, such Participating Holder&rsquo;s title to the Registrable Securities, such Participating Holder&rsquo;s
authority to sell the Registrable Securities, such Participating Holder&rsquo;s intended method of distribution, absence of liens with
respect to the Registrable Securities, enforceability of the applicable underwriting agreement as against such Participating Holder,
receipt of all consents and approvals with respect to the entry into such underwriting agreement and the sale of such Registrable Securities
and any other representations required to be made by such Participating Holder under applicable law, rule&nbsp;or regulation, and the
aggregate amount of the liability of such Participating Holder in connection with such underwriting agreement shall not exceed such Participating
Holder&rsquo;s net proceeds from such Underwritten Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Piggyback
Registrations</U>. If the Company proposes to register any of its securities under the Securities Act as contemplated by <U>Section&nbsp;2.03
</U>and such securities are to be distributed in an Underwritten Offering through one or more underwriters, the Company shall, if requested
by any Holder pursuant to <U>Section&nbsp;2.03</U> and subject to the provisions of <U>Section&nbsp;2.03(b)</U>&nbsp;and (c), use its
reasonable best efforts to arrange for such underwriters to include on the same terms and conditions that apply to the other sellers
in such Registration all the Registrable Securities to be offered and sold by such Holder among the securities of the Company to be distributed
by such underwriters in such Registration. The Participating Holders shall be parties to the underwriting agreement between the Company
and such underwriters, which underwriting agreement shall (i)&nbsp;contain such representations and warranties by, and the other agreements
on the part of, the Company to and for the benefit of such Participating Holders as are customarily made by issuers to selling stockholders
in secondary underwritten public offerings and (ii)&nbsp;provide that any or all of the conditions precedent to the obligations of such
underwriters under such underwriting agreement also shall be conditions precedent to the obligations of such Participating Holders. Any
such Participating Holder shall not be required to make any representations or warranties to, or agreements with the Company or the underwriters
in connection with such underwriting agreement other than representations, warranties or agreements regarding such Participating Holder,
such Participating Holder&rsquo;s title to the Registrable Securities, such Participating Holder&rsquo;s authority to sell the Registrable
Securities, such Holder&rsquo;s intended method of distribution, absence of liens with respect to the Registrable Securities, enforceability
of the applicable underwriting agreement as against such Participating Holder, receipt of all consents and approvals with respect to
the entry into such underwriting agreement and the sale of such Registrable Securities or any other representations required to be made
by such Participating Holder under applicable law, rule&nbsp;or regulation, and the aggregate amount of the liability of such Participating
Holder in connection with such underwriting agreement shall not exceed such Participating Holder&rsquo;s net proceeds from such Underwritten
Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Participation
in Underwritten Registrations</U>. Subject to the provisions of <U>Sections&nbsp;2.06(a)</U>&nbsp;and <U>2.06(b)</U>&nbsp;above, no Person
may participate in any Underwritten Offering hereunder unless such Person (i)&nbsp;agrees to sell such Person&rsquo;s securities on the
basis provided in any underwriting arrangements approved by the Persons entitled to approve such arrangements and (ii)&nbsp;completes
and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents required under the terms
of such underwriting arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Price
and Underwriting Discounts</U>. In the case of an Underwritten Offering under <U>Section&nbsp;2.01</U> or <U>Section&nbsp;2.02</U>, the
price, underwriting discount and other financial terms for the Registrable Securities shall be determined by the Institutional Investors
so long as all Registrable Securities are subject to the same financial terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.07.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No
Inconsistent Agreements; Additional Rights</U>. The Company is not currently a party to, and shall not hereafter enter into without the
prior written consent of the Institutional Investors, any agreement with respect to its securities that is inconsistent with the rights
granted to the Holders by this Agreement, including allowing any other holder or prospective holder of any securities of the Company
(a)&nbsp;registration rights in the nature or substantially in the nature of those set forth in <U>Section&nbsp;2.01</U>, <U>Section&nbsp;2.02
</U>or <U>Section&nbsp;2.03</U> that would have priority over the Registrable Securities with respect to the inclusion of such securities
in any Registration (except to the extent such registration rights are solely related to registrations of the type contemplated by <U>Section&nbsp;2.03(a)(iii)</U>&nbsp;and
<U>(iv)</U>) or (b)&nbsp;demand registration rights in the nature or substantially in the nature of those set forth in <U>Section&nbsp;2.01
</U>or <U>Section&nbsp;2.02</U> that are exercisable prior to such time as the Institutional Investors and the Holders can first exercise
their rights under <U>Section&nbsp;2.01</U> or <U>Section&nbsp;2.02</U>, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.08.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Registration
Expenses</U>. The following expenses incident to the Company&rsquo;s performance of or compliance with this Agreement shall be borne
equally by the Company and the Institutional Investors: (i)&nbsp;all registration and filing fees, and any other fees and expenses associated
with filings required to be made with the SEC, FINRA and if applicable, the fees and expenses of any &ldquo;qualified independent underwriter,&rdquo;
as such term is defined in FINRA Rule&nbsp;5121 (or any successor provision), and of its counsel, (ii)&nbsp;all fees and expenses in
connection with compliance with any securities or &ldquo;Blue Sky&rdquo; laws (including fees and disbursements of counsel for the underwriters
in connection with &ldquo;Blue Sky&rdquo; qualifications of the Registrable Securities), (iii)&nbsp;all printing, duplicating, word processing,
messenger, telephone, facsimile and delivery expenses (including expenses of printing certificates for the Registrable Securities in
a form eligible for deposit with The Depository Trust Company or any other required depositories and of printing Prospectuses and Issuer
Free Writing Prospectuses), (iv)&nbsp;all fees and disbursements of counsel for the Company and of all independent certified public accountants
of the Company (including the expenses of any special audit and cold comfort letters required by or incident to such performance), (v)&nbsp;all
fees and expenses incurred in connection with the listing of Registrable Securities on any securities exchange or quotation of the Registrable
Securities on any inter-dealer quotation system, (vi)&nbsp;all applicable rating agency fees with respect to the Registrable Securities,
(vii)&nbsp;all reasonable fees and expenses of the Institutional Investors&rsquo; counsel, (viii)&nbsp;the reasonable fees and expenses
of one counsel to the other Holders (not including the Institutional Investors), which counsel shall be designated by other Holders holding
a majority of the Registrable Securities included in such Registration and may (but is not required to) be the same counsel for the Institutional
Investors, (ix)&nbsp;any reasonable fees and disbursements of underwriters customarily paid by issuers or sellers of securities, (x)&nbsp;all
fees and expenses of any special experts or other Persons retained by the Company in connection with any Registration, and (xi)&nbsp;all
expenses related to the&nbsp;&ldquo;road-show&rdquo; for any Underwritten Offering, including all travel, meals and lodging. All such
expenses are referred to herein as &ldquo;<U>Registration Expenses</U>.&rdquo; All other expenses incident to the Company&rsquo;s performance
of or compliance with this Agreement shall be paid by the Company, including all of the Company&rsquo;s internal expenses (including
all salaries and expenses of its officers and employees performing legal or accounting duties). The Company shall not be required to
pay any underwriting discounts and commissions and transfer taxes, if any, attributable to the sale of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.09.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification
by the Company</U>. The Company agrees to indemnify and hold harmless, to the full extent permitted by law, each of the Holders, each
of their respective direct or indirect partners, members, managers or shareholders and each of such partner&rsquo;s, member&rsquo;s or
shareholder&rsquo;s partners, members, managers or shareholders and, with respect to all of the foregoing Persons, each of their respective
Affiliates, employees, directors, officers, trustees or agents and each Person who controls (within the meaning of the Securities Act
or the Exchange Act) such Persons and each of their respective Representatives from and against any and all losses, penalties, judgments,
suits, costs, claims, damages, liabilities and expenses, joint or several (including reasonable costs of preparation and investigation
and legal expenses) (each, a&nbsp;&ldquo;<U>Loss</U>&rdquo; and collectively,&nbsp;&ldquo;<U>Losses</U>&rdquo;) arising out of or based
upon (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement under which
such Registrable Securities were Registered under the Securities Act (including any final, preliminary or summary Prospectus contained
therein or any amendment or supplement thereto or any documents incorporated by reference therein), any Issuer Free Writing Prospectus
or amendment or supplement thereto, or any other disclosure document produced by or on behalf of the Company or any of its Subsidiaries
including reports and other documents filed under the Exchange Act, (ii)&nbsp;any omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus, preliminary Prospectus or
Issuer Free Writing Prospectus, in light of the circumstances under which they were made) not misleading, (iii)&nbsp;any violation or
alleged violation by the Company of any federal, state or common law rule&nbsp;or regulation applicable to the Company or any of its
Subsidiaries in connection with any such registration, qualification, compliance or sale of Registrable Securities, (iv)&nbsp;any failure
to register or qualify Registrable Securities in any state where the Company or its agents have affirmatively undertaken or agreed in
writing that the Company (the undertaking of any underwriter being attributed to the Company) will undertake such registration or qualification
on behalf of the Holders of such Registrable Securities (<U>provided</U>, that, in such instance, the Company shall not be so liable
if it has undertaken its reasonable best efforts to so register or qualify such Registrable Securities) or (v)&nbsp;any actions or inactions
or proceedings in respect of the foregoing whether or not such indemnified party is a party thereto, and the Company will reimburse,
as incurred, each such Holder and each of their respective direct or indirect partners, members or shareholders and each of such partner&rsquo;s,
member&rsquo;s or shareholder&rsquo;s partners members or shareholders and, with respect to all of the foregoing Persons, each of their
respective Affiliates, employees, directors, officers, trustees or agents and controlling Persons and each of their respective Representatives,
for any legal and any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage,
liability or action; <U>provided</U>, that the Company shall not be liable to any particular indemnified party to the extent that any
such Loss arises out of or is based upon (A)&nbsp;an untrue statement or alleged untrue statement or omission or alleged omission made
in any such Registration Statement or other document in reliance upon and in conformity with written information furnished to the Company
by such indemnified party expressly for use in the preparation thereof or (B)&nbsp;an untrue statement or omission in a preliminary Prospectus
relating to Registrable Securities, if a Prospectus (as then amended or supplemented) that would have cured the defect was furnished
to the indemnified party from whom the Person asserting the claim giving rise to such Loss purchased Registrable Securities at least
five&nbsp;(5)&nbsp;days prior to the written confirmation of the sale of the Registrable Securities to such Person and a copy of such
Prospectus (as amended and supplemented) was not sent or given by or on behalf of such indemnified party to such Person at or prior to
the written confirmation of the sale of the Registrable Securities to such Person. This indemnity shall be in addition to any liability
the Company may otherwise have. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf
of such Holder or any indemnified party and shall survive the transfer of such securities by such Holder. The Company shall also indemnify
underwriters, selling brokers, dealer managers and similar securities industry professionals participating in the distribution, their
officers and directors and each Person who controls such Persons (within the meaning of the Securities Act and the Exchange Act) to the
same extent as provided above with respect to the indemnification of the indemnified parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification
by the Participating Holders</U>. Each Participating Holder agrees (severally and not jointly) to indemnify and hold harmless, to the
fullest extent permitted by law, the Company, its directors and officers and each Person who controls the Company (within the meaning
of the Securities Act or the Exchange Act), and each other Holder, each of such other Holder&rsquo;s respective direct or indirect partners,
members, managers or shareholders and each of such partner&rsquo;s, member&rsquo;s or shareholder&rsquo;s partners, members, managers
or shareholders and, with respect to all of the foregoing Persons, each of their respective Affiliates, employees, directors, officers,
trustees or agents and each Person who controls (within the meaning of the Securities Act or the Exchange Act) such Persons and each
of their respective Representatives from and against any Losses resulting from (i)&nbsp;any untrue statement or alleged untrue statement
of a material fact in any Registration Statement under which such Registrable Securities were Registered under the Securities Act (including
any final, preliminary or summary Prospectus contained therein or any amendment or supplement thereto or any documents incorporated by
reference therein) or any Issuer Free Writing Prospectus or amendment or supplement thereto, or (ii)&nbsp;any omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus,
preliminary Prospectus or Issuer Free Writing Prospectus, in light of the circumstances under which they were made) not misleading, in
each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission)
is contained in any information furnished in writing by such Holder to the Company specifically for inclusion in such Registration Statement
and has not been corrected in a subsequent writing prior to or concurrently with the sale of the Registrable Securities to the Person
asserting the claim, in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or
omission (or alleged omission) was made in such Registration Statement, Prospectus, offering circular,&nbsp;Issuer Free Writing Prospectus
or other document, in reliance upon and in conformity with written information furnished to the Company by such Holder expressly for
use therein. In no event shall the liability of such Holder hereunder be greater in amount than the dollar amount of the net proceeds
received by such Holder under the sale of Registrable Securities giving rise to such indemnification obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conduct
of Indemnification Proceedings</U>. Any Person entitled to indemnification under this <U>Section&nbsp;2.09</U> shall (i)&nbsp;give prompt
written notice to the indemnifying party of any claim with respect to which it seeks indemnification (<U>provided</U>, that any delay
or failure to so notify the indemnifying party shall relieve the indemnifying party of its obligations hereunder only to the extent,
if at all, that it is actually and materially prejudiced by reason of such delay or failure) and (ii)&nbsp;permit such indemnifying party
to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party; <U>provided</U>, that any Person entitled
to indemnification hereunder shall have the right to select and employ separate counsel and to participate in the defense of such claim,
but the fees and expenses of such counsel shall be at the expense of such Person unless (A)&nbsp;the indemnifying party has agreed in
writing to pay such fees or expenses, (B)&nbsp;the indemnifying party shall have failed to assume the defense of such claim within a
reasonable time after delivery of notice of such claim from the Person entitled to indemnification hereunder and employ counsel reasonably
satisfactory to such Person, (C)&nbsp;the indemnified party has reasonably concluded (based upon advice of its counsel) that there may
be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying
party, or (D)&nbsp;in the reasonable judgment of any such Person (based upon advice of its counsel) a conflict of interest may exist
between such Person and the indemnifying party with respect to such claims (in which case, if the Person notifies the indemnifying party
in writing that such Person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall
not have the right to assume the defense of such claim on behalf of such Person). If the indemnifying party assumes the defense, the
indemnifying party shall not have the right to settle such action, consent to entry of any judgment or enter into any settlement, in
each case without the prior written consent of the indemnified party, unless the entry of such judgment or settlement (i)&nbsp;includes
as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of an unconditional release from all
liability in respect to such claim or litigation and (ii)&nbsp;does not include a statement as to or an admission of fault, culpability
or a failure to act by or on behalf of such indemnified party, and <U>provided</U>, that any sums payable in connection with such settlement
are paid in full by the indemnifying party. If such defense is not assumed by the indemnifying party, the indemnifying party will not
be subject to any liability for any settlement made without its prior written consent, but such consent may not be unreasonably withheld.
It is understood that the indemnifying party or parties shall not, except as specifically set forth in this <U>Section&nbsp;2.09(c)</U>,
in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements or
other charges of more than one separate firm admitted to practice in such jurisdiction at any one time unless (x)&nbsp;the employment
of more than one counsel has been authorized in writing by the indemnifying party or parties, (y)&nbsp;an indemnified party has reasonably
concluded (based on the advice of counsel) that there may be legal defenses available to it that are different from or in addition to
those available to the other indemnified parties, or (z)&nbsp;a conflict or potential conflict exists or may exist (based upon advice
of counsel to an indemnified party) between such indemnified party and the other indemnified parties, in each of which cases the indemnifying
party shall be obligated to pay the reasonable fees and expenses of such additional counsel or counsels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Contribution</U>.
If for any reason the indemnification provided for in paragraphs (a)&nbsp;and (b)&nbsp;of this <U>Section&nbsp;2.09</U> is unavailable
to an indemnified party or insufficient in respect of any Losses referred to therein, then the indemnifying party shall contribute to
the amount paid or payable by the indemnified party as a result of such Loss in such proportion as is appropriate to reflect the relative
fault of the indemnifying party on the one hand and the indemnified party or parties on the other hand in connection with the acts, statements
or omissions that resulted in such losses, as well as any other relevant equitable considerations. In connection with any Registration
Statement filed with the SEC by the Company, the relative fault of the indemnifying party on the one hand and the indemnified party on
the other hand shall be determined by reference to, among other things, whether any untrue or alleged untrue statement of a material
fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the
indemnified party and the parties&rsquo; relative intent, knowledge, access to information and opportunity to correct or prevent such
statement or omission. The parties hereto agree that it would not be just or equitable if contribution pursuant to this <U>Section&nbsp;2.09(d)</U>&nbsp;were
determined by <U>pro rata</U> allocation or by any other method of allocation that does not take account of the equitable considerations
referred to in this <U>Section&nbsp;2.09(d)</U>. No Person guilty of fraudulent misrepresentation (within the meaning of section&nbsp;11(f)&nbsp;of
the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. The amount
paid or payable by an indemnified party as a result of the Losses referred to in <U>Sections&nbsp;2.09(a)</U>&nbsp;and <U>2.09(b)</U>&nbsp;shall
be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this <U>Section&nbsp;2.09(d)</U>,
in connection with any Registration Statement filed by the Company, a Participating Holder shall not be required to contribute any amount
in excess of the dollar amount of the net proceeds received by such Holder under the sale of Registrable Securities giving rise to such
contribution obligation less any amount paid by such Holders pursuant to <U>Section&nbsp;2.09(b)</U>. If indemnification is available
under this <U>Section&nbsp;2.09</U>, the indemnifying parties shall indemnify each indemnified party to the full extent provided in <U>Sections&nbsp;2.09(a)</U>&nbsp;and
<U>2.09(b)</U>&nbsp;hereof without regard to the provisions of this <U>Section&nbsp;2.09(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Exclusivity</U>. The remedies provided for in this <U>Section&nbsp;2.09</U> are not exclusive and shall not limit any rights or remedies
which may be available to any indemnified party at law or in equity or pursuant to any other agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conflicts</U>.
Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement
entered into in connection with the underwritten public offering are in conflict with the foregoing provisions in this <U>Section&nbsp;2.09</U>,
the provisions in the underwriting agreement shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Survival</U>.
The indemnities provided in this <U>Section&nbsp;2.09</U> shall survive the transfer of any Registrable Securities by such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.10.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Rules&nbsp;144
and 144A and Regulation&nbsp;S</U>. The Company covenants that it will file the reports required to be filed by it under the Securities
Act and the Exchange Act and the rules&nbsp;and regulations adopted by the SEC thereunder (or, if the Company is not required to file
such reports, it will, upon the reasonable request of the Institutional Investors, make publicly available such necessary information
for so long as necessary to permit sales pursuant to Rules&nbsp;144, 144A or Regulation&nbsp;S under the Securities Act), and it will
take such further action as the Institutional Investors may reasonably request, all to the extent required from time to time to enable
the Holders to sell Registrable Securities without Registration under the Securities Act within the limitation of the exemptions provided
by (i)&nbsp;Rules&nbsp;144, 144A or Regulation&nbsp;S under the Securities Act, as such Rules&nbsp;may be amended from time to time,
or (ii)&nbsp;any similar rule&nbsp;or regulation hereafter adopted by the SEC. Upon the reasonable request of a Holder, the Company will
deliver to such Holder a written statement as to whether it has complied with such requirements and, if not, the specifics thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.11.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Limitation
on Registrations and Underwritten Offerings</U>. Notwithstanding the rights and obligations set forth in <U>Sections&nbsp;2.01</U> and
<U>2.02</U>, in no event shall the Company be obligated to take any action to (i)&nbsp;effect more than four (4)&nbsp;Demand Registrations,
(ii)&nbsp;effect more than one (1)&nbsp;Underwritten Offering in any consecutive 90-day period, (iii)&nbsp;effect more than two (2)&nbsp;Underwritten
Offerings in any consecutive 360-day period, or (iii)&nbsp;effect any Underwritten Offering unless the Institutional Investors initiating
such Underwritten Offering propose to sell Registrable Securities in such Underwritten Offering having a reasonably anticipated gross
aggregate price (before deduction of underwriter commissions and offering expenses) of at least $50,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.12.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Clear
Market</U>. With respect to any Underwritten Offerings of Registrable Securities by the Institutional Investors pursuant to this Agreement,
the Company agrees not to effect (other than pursuant to the Registration applicable to such Underwritten Offering or pursuant to a Special
Registration) any public sale or distribution, or to file any Registration Statement (other than pursuant to the Registration applicable
to such Underwritten Offering or pursuant to a Special Registration) covering any of its equity securities or any securities convertible
into or exchangeable or exercisable for such securities, during the period not to exceed ten&nbsp;(10)&nbsp;days prior and sixty&nbsp;(60)
days following the effective date of such offering or such longer period up to sixty&nbsp;(60) days as may be requested by the managing
underwriter for such Underwritten Offering. &ldquo;<U>Special Registration</U>&rdquo; means the registration of (A)&nbsp;equity securities
and/or options or other rights in respect thereof solely registered on Form&nbsp;S-4 or Form&nbsp;S-8 or (B)&nbsp;shares of equity securities
and/or options or other rights in respect thereof to be offered to directors, employees, consultants, customers, lenders or vendors of
the Company or its Subsidiaries or in connection with dividend reinvestment plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.13.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>In-Kind
Distributions</U>. If any Institutional Investor, as an Investment Fund or an Affiliate of an Investment Fund, seeks to effectuate an
in-kind distribution of all or part of its Company Shares to its direct or indirect equityholders, the Company will reasonably cooperate
with and assist such Institutional Investor, such equityholders and the Company&rsquo;s transfer agent to facilitate such in-kind distribution
in the manner reasonably requested by such Institutional Investor (including the delivery of instruction letters by the Company or its
counsel to the Company&rsquo;s transfer agent, the delivery of customary legal opinions by counsel to the Company and the delivery of
Company Shares without restrictive legends, to the extent no longer applicable) and any such equityholder shall, with its consent and
with the consent of such Institutional Investor, be treated as an Institutional Investor and/or Holder (as determined by such Institutional
Investor) for all purposes of this Agreement, with the same rights, benefits and obligations hereunder as an Institutional Investor and/or
Holder, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;III</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.01.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Term</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement shall terminate with respect to any Holder (i)&nbsp;with the prior written consent of the Institutional Investors in connection
with the consummation of a Change of Control, (ii)&nbsp;for those Holders (other than the Institutional Investors) that beneficially
own less than five percent&nbsp;(5%) of the Company&rsquo;s outstanding Company Shares, if all of the Registrable Securities then owned
by such Holder could be sold in any ninety&nbsp;(90)-day period pursuant to Rule&nbsp;144 or (iii)&nbsp;as to any Holder, if all of the
Registrable Securities held by such Holder have been sold or otherwise transferred in a Registration pursuant to the Securities Act or
pursuant to an exemption therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the foregoing, the provisions of <U>Sections&nbsp;2.09</U>, <U>2.10</U> and <U>2.13</U> and all of this <U>Article&nbsp;III</U> shall
survive any such termination. Upon the written request of the Company, each Holder agrees to promptly deliver a certificate to the Company
setting forth the number of Registrable Securities then beneficially owned by such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.02.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Injunctive
Relief</U>. It is hereby agreed and acknowledged that it will be impossible to measure in money the damage that would be suffered if
the parties fail to comply with any of the obligations herein imposed on them and that in the event of any such failure, an aggrieved
Person will be irreparably damaged and will not have an adequate remedy at law. Any such Person shall, therefore, be entitled (in addition
to any other remedy to which it may be entitled in law or in equity) to injunctive relief, including specific performance, to enforce
such obligations, and if any action should be brought in equity to enforce any of the provisions of this Agreement, none of the parties
hereto shall raise the defense that there is an adequate remedy at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.03.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Attorneys&rsquo;
Fees</U>. In any action or proceeding brought to enforce any provision of this Agreement or where any provision hereof is validly asserted
as a defense, the successful party shall, to the extent permitted by applicable law, be entitled to recover reasonable attorneys&rsquo;
fees in addition to any other available remedy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.04.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notices</U>.
Unless otherwise specified herein, all notices, consents, approvals, reports, designations, requests, waivers, elections and other communications
authorized or required to be given pursuant to this Agreement shall be in writing and shall be deemed to have been given (a)&nbsp;when
personally delivered, (b)&nbsp;the day following the day (except if not a Business Day then the next Business Day) on which the same
has been delivered prepaid to a reputable national air courier service, (c)&nbsp;when transmitted via email (including via attached pdf
document) to the email address set out below or on <U>Schedule&nbsp;A</U>, as applicable, on the same day such email is transmitted or
(d)&nbsp;the third Business Day following the day on which the same is sent by certified or registered mail, postage prepaid, in each
case, to the respective parties, as applicable, at the address or email address set forth below or on <U>Schedule&nbsp;A</U> hereto,
as applicable (or such other address or email address as any Holder may specify by notice to the Company in accordance with this <U>Section&nbsp;3.04</U>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
notices and communications to the Company, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Certara,&nbsp;Inc.<BR>
100 Overlook Center, Suite&nbsp;101&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Princeton, NJ 08540<BR>
Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Richard Traynor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">with a copy to (which shall not constitute actual or constructive
notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Simpson Thacher&nbsp;&amp; Bartlett LLP&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">425 Lexington Avenue&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">New York, New York 10017&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Attention: Michael T. Holick&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
[</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Simpson Thacher&nbsp;&amp; Bartlett LLP<BR>
2475 Hanover Street&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Palo
Alto, CA 94304<BR>
Attention: William Brentani and Frederick W.P. de Albuquerque<BR>
Email:&nbsp;[</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
notices and communications to the Institutional Investors, at the address or email address set forth on <U>Schedule&nbsp;A</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.05.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Publicity
and Confidentiality</U>. Each of the parties hereto shall keep confidential this Agreement and the transactions contemplated hereby,
and any nonpublic information received pursuant hereto, and shall not disclose, issue any press release or otherwise make any public
statement relating hereto or thereto without the prior written consent of the Company and the Institutional Investors unless so required
by applicable law or any governmental authority; <U>provided</U>, that no such written consent shall be required (and each party shall
be free to release such information) for disclosures (a)&nbsp;to each party&rsquo;s partners, members, advisors, employees, agents, accountants,
trustee, attorneys, Affiliates and investment vehicles managed or advised by such party or the partners, members, advisors, employees,
agents, accountants, trustee or attorneys of such Affiliates or managed or advised investment vehicles, in each case so long as such
Persons agree to keep such information confidential, (b)&nbsp;to the extent required by law, rule&nbsp;or regulation or (c)&nbsp;expressly
permitted by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.06.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Amendment</U>.
The terms and provisions of this Agreement may only be amended, modified or waived at any time and from time to time by a writing executed
by the Company and the Institutional Investors; <U>provided</U>, <U>however</U>, that any modification, amendment or waiver of this Agreement
that would subject any Holder (other than the Institutional Investors) to materially adverse disproportionate treatment relative to the
other Holders (other than the Institutional) taking into account and considering the rights of such Holder prior to such amendment, modification
or waiver (each such Holder, an&nbsp;&ldquo;<U>Impacted Holder</U>&rdquo;) shall require the agreement of the Majority Impacted Holders;
<U>provided</U>, <U>further</U>, that any modification, amendment or waiver of <U>Section&nbsp;2.02(c)</U>, <U>Section&nbsp;2.03</U>,
<U>Section&nbsp;2.04</U> or <U>Section&nbsp;3.06</U> of this Agreement (or to any defined term used in any such Section&nbsp;of this
Agreement) that would materially and adversely affect the rights of any Holder (other than the Institutional Investors) or any other
modification, amendment or waiver of this Agreement that would impose upon any Holder (other than the Institutional Investors) any additional
material obligation or would materially and adversely affect the rights of any Holder (other than the Institutional Investors) under
<U>Section&nbsp;2.09</U> of this Agreement shall require the agreement of the adversely affected Holders (other than the Institutional
Investors) holding a majority of the Registrable Securities held by all such adversely affected Holders (other than the Institutional
Investors) as of the applicable date of determination; <U>provided</U>, <U>further</U>, that notwithstanding the foregoing proviso, the
Institutional Investors may waive <U>Section&nbsp;2.04(a)</U>&nbsp;or <U>Section&nbsp;2.04(b)</U>&nbsp;without the consent of any other
Holder, <U>provided</U>, <U>further</U>, that, in the event the Institutional Investors no longer hold any Company Shares, this Agreement
may be amended, modified, supplemented, restated, waived or terminated with the written consent of (a)&nbsp;the Company and (b)&nbsp;the
Holders holding a majority of the Company Shares held by the Holders. No waiver by any party of any of the provisions hereof will be
effective unless explicitly set forth in writing and executed by the party so waiving. Except as provided in the preceding sentence,
no action taken pursuant to this Agreement, including without limitation, any investigation by or on behalf of any party, will be deemed
to constitute a waiver by the party taking such action of compliance with any covenants or agreements contained herein. The waiver by
any party hereto of a breach of any provision of this Agreement will not operate or be construed as a waiver of any subsequent breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.07.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Successors,
Assigns and Transferees</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
rights and obligations of each party hereto may not be assigned, in whole or in part, without the written consent of (i)&nbsp;the Company
and (ii)&nbsp;the Institutional Investors; <U>provided</U>, <U>however</U>, that notwithstanding the foregoing, the rights and obligations
set forth herein may be assigned, in whole or in part, without such consent by any Institutional Investor to (A)&nbsp;an Affiliate of
such Institutional Investor that holds Company Shares or (B)&nbsp;any Person who receives Company Shares upon a distribution in kind
by Arsenal and who is not permitted under Rule&nbsp;144 under the Securities Act to dispose of such Company Shares without limitation
(each Person to whom the rights and obligations are assigned in compliance with this <U>Section&nbsp;3.07</U> is a&nbsp;&ldquo;<U>Permitted
Assignee</U>&rdquo; and all such Persons, collectively, are &ldquo;<U>Permitted Assignees</U>&rdquo;); <U>provided</U>, <U>further</U>,
that such transferee shall only be admitted as a party hereunder upon its, his or her execution and delivery of a joinder agreement,
in form and substance reasonably acceptable to the Institutional Investors and the Company, agreeing to be bound by the terms and conditions
of this Agreement as if such Person were a party hereto (together with any other documents the Institutional Investors and the Company
reasonably determine are necessary to make such Person a party hereto), whereupon such Person will be treated as an Institutional Investor
and/or Holder, as applicable, for all purposes of this Agreement, with the same rights, benefits and obligations hereunder as an Institutional
Investor and/or Holder, as applicable, with respect to the transferred Registrable Securities (except that if the transferee was a Holder
prior to such transfer, such transferee shall have the same rights, benefits and obligations with respect to such transferred Registrable
Securities as were applicable to Registrable Securities held by such transferee prior to such transfer).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing
herein shall operate to permit a transfer of Registrable Securities otherwise restricted by the Stockholders Agreement, the Letter Agreement,
or any other agreement to which any Holder may be a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.08.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Binding
Effect</U>. Except as otherwise provided in this Agreement, the terms and provisions of this Agreement shall be binding on and inure
to the benefit of each of the parties hereto and their respective successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.09.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Third
Party Beneficiaries</U>. Nothing in this Agreement, express or implied, is intended or shall be construed to confer upon any Person not
a party hereto (other than those Persons entitled to indemnity or contribution under <U>Section&nbsp;2.09</U>, each of whom shall be
a third party beneficiary thereof) any right, remedy or claim under or by virtue of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.10.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Governing
Law; Jurisdiction</U>. THIS AGREEMENT SHALL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE, WITHOUT REGARD
TO THE CONFLICTS OF LAW PRINCIPLES THEREOF. ANY ACTION OR PROCEEDING AGAINST THE PARTIES RELATING IN ANY WAY TO THIS AGREEMENT MAY&nbsp;BE
BROUGHT AND ENFORCED EXCLUSIVELY IN THE COURTS OF THE STATE OF DELAWARE OR (TO THE EXTENT SUBJECT MATTER JURISDICTION EXISTS THEREFOR)
THE U.S. DISTRICT COURT FOR THE DISTRICT OF DELAWARE, AND THE PARTIES IRREVOCABLY SUBMIT TO THE JURISDICTION OF BOTH SUCH COURTS IN RESPECT
OF ANY SUCH ACTION OR PROCEEDING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.11.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Waiver
of Jury Trial</U>. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY&nbsp;HAVE
TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR
ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY. EACH OF THE PARTIES HEREBY (A)&nbsp;CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY
OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT,&nbsp;IN THE EVENT OF LITIGATION, SEEK TO
ENFORCE THE FOREGOING WAIVER AND (B)&nbsp;ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED
BY THIS AGREEMENT, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <FONT STYLE="text-transform: uppercase"><U>Section&nbsp;3.11</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.12.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Severability</U>.
If any provision of this Agreement shall be held to be invalid, illegal or unenforceable, the validity, legality and enforceability of
the remaining provisions shall not in any way be affected or impaired thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.13.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Counterparts</U>.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which shall constitute
one and the same agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.14.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Headings</U>.
The heading references herein and in the table of contents hereto are for convenience purposes only, do not constitute a part of this
Agreement and shall not be deemed to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.15.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Joinder</U>.
Any Person that holds Company Shares may, with the prior written consent of the (i)&nbsp;the Company and (ii)&nbsp;the Institutional
Investors, be admitted as a party to this Agreement upon its execution and delivery of a joinder agreement, in form and substance reasonably
acceptable to the (i)&nbsp;Company and (ii)&nbsp;Institutional Investors, agreeing to be bound by the terms and conditions of this Agreement
as if such Person were a party hereto (together with any other documents the Institutional Investors determine are necessary to make
such Person a party hereto), whereupon such Person will be treated as a Holder for all purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.16.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Effectiveness</U>.
This Agreement shall only become effective, and the A&amp;R Registration Rights Agreement will only be terminated, subject to, and on
and from, the consummation of the Sale Transaction occurring under the Purchase Agreement (as that term is defined in the Letter Agreement,
being the &ldquo;<U>Purchase Agreement</U>&rdquo;). Notwithstanding anything else in this Agreement, this Agreement shall terminate automatically
and have no force or effect upon termination of the Purchase Agreement without the Sale Transaction having occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Remainder of Page&nbsp;Intentionally Blank</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">IN WITNESS WHEREOF, the parties hereto have executed
this Agreement as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 50%"><B>CERTARA,&nbsp;INC.</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 3%; text-align: left">By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ William Feehery</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 53%"></TD><TD STYLE="width: 5%; text-align: left">Name:</TD><TD STYLE="text-align: justify; width: 42%">William Feehery</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD STYLE="text-align: left">Title:</TD><TD STYLE="text-align: justify">CEO</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="background-color: White"><I>[Signature
Page&nbsp;to Registration Rights Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><B>INSTITUTIONAL INVESTORS:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>ARSENAL SATURN HOLDINGS LP</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 5%">By:</TD><TD STYLE="width: 45%">Arsenal Capital Investment VI LP, its general partner</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 5%">By:</TD><TD STYLE="width: 45%">Arsenal Group LLC, its general partner</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 3%; text-align: left">By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ Frank Scrudato</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 5%; text-align: left">Name:</TD><TD STYLE="text-align: justify; width: 45%">Frank Scrudato</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD STYLE="text-align: left">Title:</TD><TD STYLE="text-align: justify">CFO</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">ARSENAL CAPITAL PARTNERS III LP</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 5%">By:</TD><TD STYLE="width: 45%">Arsenal Capital Investment III LP, its general partner</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 5%">By:</TD><TD STYLE="width: 45%">Arsenal Group LLC, its general partner</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 3%; text-align: left">By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ Frank Scrudato</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 5%; text-align: left">Name:</TD><TD STYLE="text-align: justify; width: 45%">Frank Scrudato</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD STYLE="text-align: left">Title:</TD><TD STYLE="text-align: justify">CFO</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 50%">ARSENAL CAPITAL PARTNERS III-B LP</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 5%">By:</TD><TD STYLE="width: 45%">Arsenal Capital Investment III LP, its general partner</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 5%">By:</TD><TD STYLE="width: 45%">Arsenal Group LLC, its general partner</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 3%; text-align: left">By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ Frank Scrudato</TD>
</TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 5%; text-align: left">Name:</TD><TD STYLE="text-align: justify; width: 45%">Frank Scrudato</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: White"><I>[Signature
Page&nbsp;to Registration Rights Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Schedule&nbsp;A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: White">
    <TD STYLE="padding: 1pt 5.4pt; width: 53%; border: Black 1pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INSTITUTIONAL INVESTORS</B></FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; width: 47%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR PURPOSES OF SECTION&nbsp;3.04,<BR>
 WITH A COPY (WHICH SHALL NOT<BR>
 CONSTITUTE NOTICE) TO:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; padding-top: 2pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Arsenal Saturn Holdings LP</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Arsenal Capital Management LP</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 Park Avenue, 31st Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10017</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Chief Financial Officer, Frank Scrudato</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ]</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-top: 2pt; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Kirkland&nbsp;&amp; Ellis LLP</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">300 North LaSalle</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chicago,&nbsp;Illinois 60654</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Ted M. Frankel, P.C. and Robert E. Goedert, P.C.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    </FONT>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ]</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; padding-top: 2pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Arsenal Capital Partners III LP</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Arsenal Capital Management LP</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 Park Avenue, 31st Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10017</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Chief Financial Officer, Frank Scrudato</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: [ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-top: 2pt; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Kirkland&nbsp;&amp; Ellis LLP</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">300 North LaSalle</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chicago,&nbsp;Illinois 60654</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Ted M. Frankel, P.C. and Robert E. Goedert, P.C.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    </FONT>[ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; padding-top: 2pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Arsenal Capital Partners III-B LP</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Arsenal Capital Management LP</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 Park Avenue, 31st Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10017</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Chief Financial Officer, Frank Scrudato</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ]</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P></TD>
    <TD STYLE="border-right: Black 1pt solid; padding-top: 2pt; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Kirkland&nbsp;&amp; Ellis LLP</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">300 North LaSalle</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chicago,&nbsp;Illinois 60654</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Ted M. Frankel, P.C. and Robert E. Goedert, P.C.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    </FONT>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ]</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>tm2229794d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Arsenal Capital Partners Increases Investment
in Global Biosimulation Leader Certara with $449M Stock Purchase</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>Arsenal will acquire approximately 30M shares
at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PRINCETON,
N.J.&mdash; November&nbsp;7, 2022 -- </B></FONT>Certara,&nbsp;Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (&ldquo;Arsenal&rdquo;),
a private equity firm specializing in investing in and building transformational healthcare companies, has committed to make a new $449M
investment in Certara. Arsenal currently owns approximately 4% of common shares outstanding and will acquire approximately 30M additional
shares from funds controlled by EQT Private Equity (&ldquo;EQT&rdquo;), at a price of $15 per share. Upon closing of the transaction,
which is subject to HSR regulatory approval, Arsenal will own approximately 22% of diluted shares outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Arsenal is deeply familiar with Certara&rsquo;s value proposition for
all stakeholders. The firm previously held a majority stake in the company before selling a controlling interest to EQT in 2017. Arsenal
continued to maintain a minority equity interest both before and after Certara&rsquo;s initial public offering in 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In a separate agreement with the company, Arsenal has agreed to a two-year
lock-up prohibiting any sale of the newly purchased shares without company approval, reflecting Arsenal&rsquo;s commitment to being a
long-term shareholder. Arsenal will also have the right, subject to maintaining certain ownership percentages, to nominate up to two board
members, including current board member Stephen McLean. Following the closing of the transaction, Arsenal Operating Partner David Spaight
is expected to join the board, and current board members Eric Liu and Ethan Waxman of EQT will step down from the board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;We are pleased to further enhance our long-term-oriented shareholder
base via a significant new investment from Arsenal,&rdquo; said William F. Feehery, Chief Executive Officer of Certara. &ldquo;Arsenal
has been invested in Certara for almost a decade, is confident in the critical role of biosimulation within drug discovery and development,
and shares in our strategic vision for the business. I also want to thank EQT for its leadership and strategic partnership since 2017,
highlighted by the company&rsquo;s IPO in 2020.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stephen McLean, a Senior Partner of Arsenal, said, &ldquo;This transaction
reflects our long-term advocacy for, and conviction in, the strategic importance of biosimulation in drug development. It also reflects
our belief in the long-term prospects of Certara, our admiration for William Feehery&rsquo;s leadership, and our trust in the entire Certara
management team. We look forward to our continued partnership with Certara and to further supporting its efforts to enable more efficacious
development of therapies and cures for human disease.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Eric Liu, Partner, Head of North American Private Equity, and Co-Head
of the Global Healthcare Sector Team at EQT, added, &ldquo;EQT is proud to have been part of Certara&rsquo;s remarkable journey during
the last five years. We would like to thank the management team for their trusted partnership. EQT is confident that Arsenal will continue
to be a great shareholder as Certara builds on its strong momentum, and we look forward to the company&rsquo;s continued success.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>About
Certara</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B></B></FONT>Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional
drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions, and regulatory
agencies across 62 countries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Arsenal Capital Partners</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Arsenal Capital Partners is a leading private equity firm that specializes
in investments in industrial growth and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment
funds totaling over $10 billion, completed more than 250 platform and add-on acquisitions, and achieved more than 30 realizations. The
firm works with management teams to build strategically important companies with leading market positions, high growth, and high value-add.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Investor
Relations Contact:<BR>
</B></FONT>David Deuchler<BR>
Gilmartin Group<FONT STYLE="color: #707070"><BR>
</FONT><U>ir@certara.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media Contact:</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Daniel Yunger&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Kekst CNC&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>daniel.yunger@kekstcnc.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jackie Schofield&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prosek Partners&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Pro-Arsenal@prosek.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cert-20221103.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWauFibOdzZR+CYkxtmBwbdkqXywhzeAb/ShHvS5mkYYJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:CERT="http://certara.com/20221103" elementFormDefault="qualified" targetNamespace="http://certara.com/20221103">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://certara.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="cert-20221103_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="cert-20221103_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>cert-20221103_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>cert-20221103_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://certara.com/role/Cover" xlink:href="cert-20221103.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://certara.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140519587594624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 03, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  03,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Certara,
Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001827090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-2180925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 Overlook Center<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">716-7900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CERT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>tm2229794d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cert-20221103.xsd" xlink:type="simple"/>
    <context id="From2022-11-03to2022-11-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001827090</identifier>
        </entity>
        <period>
            <startDate>2022-11-03</startDate>
            <endDate>2022-11-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-11-03to2022-11-03">0001827090</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-11-03to2022-11-03">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-11-03to2022-11-03">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-11-03to2022-11-03">2022-11-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-11-03to2022-11-03">Certara, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-11-03to2022-11-03">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-11-03to2022-11-03">001-39799</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-11-03to2022-11-03">82-2180925</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-11-03to2022-11-03">100 Overlook Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-11-03to2022-11-03">Suite 101</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-11-03to2022-11-03">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-11-03to2022-11-03">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-11-03to2022-11-03">08540</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-11-03to2022-11-03">609</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-11-03to2022-11-03">716-7900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-11-03to2022-11-03">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-11-03to2022-11-03">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-11-03to2022-11-03">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-11-03to2022-11-03">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-11-03to2022-11-03">Common stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-11-03to2022-11-03">CERT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-11-03to2022-11-03">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-11-03to2022-11-03">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U
M.EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*
M$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87
M_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( !I 9U4'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ &D!G5:E=.OGO    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ &D!G59E<G",0!@  G"<  !,
M         ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  :
M0&=5C4&OYEL$   7$0  &               @($."   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ &D!G59^@&_"Q @  X@P   T
M         ( !GPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  :0&=5EXJ[
M',     3 @  "P              @ %[#P  7W)E;',O+G)E;'-02P$"% ,4
M    "  :0&=5JL0B%C,!   B @  #P              @ %D$   >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ &D!G520>FZ*M    ^ $  !H
M     ( !Q!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ &D!G5660>9(9 0  SP,  !,              ( !J1(  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  \Q,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2229794d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://certara.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2229794d1_8k.htm">tm2229794d1_8k.htm</File>
    <File>cert-20221103.xsd</File>
    <File>cert-20221103_lab.xml</File>
    <File>cert-20221103_pre.xml</File>
    <File>tm2229794d1_ex10-1.htm</File>
    <File>tm2229794d1_ex10-2.htm</File>
    <File>tm2229794d1_ex10-3.htm</File>
    <File>tm2229794d1_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2229794d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2229794d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cert-20221103_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cert-20221103_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cert-20221103.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "CERT",
   "nsuri": "http://certara.com/20221103",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2229794d1_8k.htm",
      "contextRef": "From2022-11-03to2022-11-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://certara.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2229794d1_8k.htm",
      "contextRef": "From2022-11-03to2022-11-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://certara.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001104659-22-115148-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-22-115148-xbrl.zip
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MQMVAQ5'^Y^'00+:71LO*--7R-U!+ P04    "  :0&=5Y'U0^?\*  !LAP
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M+1> S388FB@@,NS. #0J,2K42,B]P7'+DS7FNT42]70;IM M'I#1-A^Z*B!
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M%O/%$AGAB>K!O'+#!)Y;<K=T983U'5$E(E(RDJEZ\84]TL99U3.W5T#5V(!
MTB:>T7G[]-J98D3?O*<7U7^[JU_]L=W>Z^T\OUQP>N,317MVSS,)ITSM&BSO
M!>4Z_49.3+L+ 6*'F6">R3EU[IF[B"LTNX7S1OR3Z$*;K.<NZ#VW+!U].$:Z
M$Z*)A"6TN@?ER$15XE0RT> $6  <0 347U_K._:C.T!?<(091LJ)SGJ&)4\*
MR.Q/<=OW>:92/_*X585LX-QW#T0&R&]LB#,&(SQC@!62TJ$L=W/E!%B)A[@"
MJ.A=AATC</-O-^DN?E8JN[AFT65UC/X EJRIR$^FJ/]#24JY >V#/A&0ZQ)P
MLBS?>,5^8V>GW>N_;!PS![%%0Y@WM\YS97)6E$%*>U&YFUIXW%220KR^%I=B
M8V8W8  B*E0>B*AEB_C$XTRT@D'5G@/>P66(F$7>%(+K) 8S)SCZHP%C(\-9
M,$MXX[ '@T,_$'QJ:08UU]>H)NZGPM9X YI.'9W+[08]+3JJ;- @.HH&BOG%
M^-KGA%4?EHI>.;#RHYRQ^PQ^ULT1$4\\T5./W"SQTS?J?O)ZX%P.H.\W#],@
M,(2<F'"Y9FF<&O!$5Z]43M ".R(W%9N/3_89!>%'3(OERF!2_CTM,U@[C-[G
MN@R$'08:B:E&@>XD $7LHYA&Z!E=GMB040YY0>:8NA]DFD>"GJ)ERV5#4L*(
MI8E'I7#_U2:4^#L1I(%>C2&*E [[#A,9L/P\\#_=Q,0/5H*!8-B_F-\V+)!S
M8$BP(9ZEYQ3)(!C&D]276)H?/TR=!56_OH8W61JNAZH:R"%"NH%M8F(/5+9_
MB)7@&5:R@1K\W__:*Y>+!\I0BT^E@TU">[AE3='Z""O2_..:'!X1P<+":42R
M6X3Z-!;[W\PTY4-XVA=6#L8L5[/5[:WL=KE$U!UPRG9$ABSM'G"1IUP@0$6'
MT4<9VW>PO8\WT, %=AB!<R'R"?];VLX7B^MK86^%MS\];'3H<(;$JM.1X<+O
M*^JX%G,X$,CN2^]:T$#<36B(K7L\6QLAD6$],.X*.O1@K6")%8X*M(]>?GT-
M(QO-M+DH!Y"$$&:<2NL:71/5+%@3\(FYU[W#, AF@0UEB8'J"@;^D0+CBY76
M/* C,-@D& Q</5WX"CQ6VR(=BI'A4!\(K+"X=RI2I0!PA8N@O(PP4?P)2)7K
M:*!D<FV\!=8FA^@%.C Z:0W1CQ#<$8DC=G>R&'W0H7!A5N?;+RD_/U=Z6[@9
M;UG*HQ+,!=2$Q0@Y(1N5D;C<Q6M# A%<86W(:Q(N=21QEK]VQER8>JC,(818
M[?T0;Y9)KE/6'YQV"#8$58*USQ)=*"(JM.NT98AIE6F"AJI3\*&O#&4,@ SF
M#BC QR#!E.KJT<[AC1^ AV6AON&H9I2F4-HF&\!Y-$PS&]5;OA9E8XV-E#[J
M,AQO8'0-G$0/ E&I%'O,<20*+&(\HHI?8 =6SQ4#$:I]\PS0\D:B@/G8Y3%N
M@<&QF7A,N3 $/FIAN57D1@6T \Q0<CE-1#$Z!'6@2WL]'!7\#V]D6[%1WR7+
M/B&>8A&D@\%_"6E<2)-ILX2H)@-(%M@\B=[C)#)OD=[K:Y'QHZ))!O1!9A5$
MS@I$T7-EO@$>A>6*602J[J-D_@!'-G5T5 =$!YG37!NP#-6$"2TY&OU]LF%L
M*J%&(^<[)+IROZ9=H%E-0Z**1LBAW<N*7 >WB6FC$>3!K#"E95@>+#B@:3]:
M(K3VQU%*1+4%O]!SM %(/T_3&#&+O&$8Z!F[ROE)1"^N!],F&<,>>"5$O\LL
M"&$P.6-.$'V.'JW)*)"R5 [FX=KHJ,I29>'"ZG?@<@%7R6M3R:7GBG0.HK 1
M3_;"4U!XIN:9@@V[DWG,LBF:P[PC*_C4W"(+V .R_, *@D/TU!*2958P_US6
M7U]+YGVL%_=Y/VTV<Q9TYS<YJ(E';<"08>D!/'IBC=?75K'(H3[9!+)8$Y&:
M!(OOP9@ZXT;?\GOZ$]F@L5;K:S#9L"5&GU-1#VGXI+E ZC$61#)#C _ 6*)B
MH! RF6;.!94,$:1E0',F[Q)(#,[.J47[TN:>74&X@K8_$HMQ]#6T@0@QK&A<
M-I)!':#ICZ*>8,@#3>T1WO(K@AR_);R0$F_)BQ\B%$*O(T#-@<6$:+MK3M #
M, WV@-S(H\7DL/3?H)_R)#!4=H#W$,F0?Y2WT)6<U<,PU@,NU,+L<9"7%<-C
M8Y_^*E:;7J%H_E8S*2:0Q8QF(TF0'(YD4KPGV7L#?#09)PK(:<O*,>S6!.W4
MM5/<-E$PN.8P(7?_T"BO)],10#KD[JQ4?.(XB;":J?04["$2!%9D-5"F Q7)
MA,J#Q8LK,7P2R.3\08!7/3=N+>?!0E67!BMT*4 Y@V+5J+]5D=8#2&0C%Z(I
M 0G%M)6@$8[996(W(N1/A^7$3@@R.7PT'(<]V!K*&QY$1&,,/"SJY0CN&\(H
M**U.1#0"TR4HF0TJ2L(60SJ!@<5^" 0&(&)BN^1.[K\H];FD4*0) XDDA43B
M:Y;:&%K- 1W;ETE7[-+*^>D<AKPH=*,D=%2#S=JHP"2MK^V\CM<1,4A9T3R)
M!.MKB@8;0-]D*8E.$NU,-B8XPO)(_D3XHFD:G7$,U\XF,ARX)G,Y+NHFI/,;
M^6%V"P@RC]]XX)2$<(7P4<Z%2<K.%58N&0G0K6,/TA(457^W6J'WGQ6>;*+W
MD">?I\+A; 09'SY:.D=L46*%GXD7H9*AB(]XGF"H)7+[@.)\5$4@WG&A.SG7
MSACF>]'2SF(L)M) K=<942&%T89!LW^H_7I#&VN+;%?]O7;(WA&?'"<&/NMK
M Z5PEO5,1"2E BZE2Z6_'%7TV60=F:3'HCI2.BC@F=L&>KMSG!I?A5\H1(0"
M!K6G;@QCY,2&@!8+*40&:(AG[)AH,@^J"&G]S#ZSN)QAT!^4=:J17H'/1V(N
MG\#EN3[?CRS24X9LB47:4(YDF*<-;0Y:;\*,H#QNJ95<7[.=.0M%-M!ZX![,
M?!]"1%Z*X#$:B5Z:#T[NB8U&$.YAL:+R@(SAD.DR?%Q?<]C05DLEP]'TE4%O
M5U3YH1>%_K@_#(_%=\]A-L$S(8?,=U,789$%?=ED3GK"3_8Y*4)'HL@8)<^<
M"2Q*R7^F@Q!-?BM*BXUE)K>5T^FJ&(";0F,AWXFC]*)O<'?UR+''^"UQ>-&\
MO!#?E,*K&"6("6$EP@1TD'\%%TXPJ_2]!9N/@*5P4P=/]2LE(.(!E5<)$W-R
M;QUD EU0$V%R;R1NZ^\IK1 =7!Q%B0R LFP$4+F(%L2Q_NDL4A L(=0 8BPK
ME"<M>*++G?LPSA8;?SQ,<OJK /-]L%VQ_]6C#[8S56NQOK8<R5-2FM!3?&&:
M*9-9"ZJ#?ZB0M"2ORR]U$(2'>"3PD6:4=ZAXDW*$/5O>$"%3CF"$E'$#D)A+
M%3EW:IB>PZ96/D@V\*AZ1?N(; =\@>P;8<VIU*3*A.K2B/E+;$G6P"B8/OC>
M5X(?(3.R5BIK;&9#@OBA8 J#X==B0# AV3/5 J)D1\5")D+H/1-*/,C7,B+W
M!3BQF,:XW)RP97I JC#E@PQ5:C1(&2R$!8#JB8%%92_W3*&]'J@&GL;D'RH-
MUZD6/K+TZ5OH)+ER)II3  'S]_$7V8!MP,J+?%:I*'9@BUE1FRT,_A#U7KQF
MSN<L*7BX58 G&[ (/E(AX$\D2+W)%)BF050LO$R!-RI<;+%2Q?AF"@/\VY7$
M.K51)[QL?< [DX&TFH&Y9%NB=& NG+0* D0LVG%];;JGB&5 M'BT1D;(G-+7
M@3:,5/HX$D@DEC# K4@\CJU2GSYU@D+#];7XF:0\N1G@C=GN%,8S4Y5>CE(I
MV30/1A0HV)[C4T]GL.2Z(E-P*D,6*ZVO"5.(4:E [U'=KB,RPVH/#'$7.VKJ
MOL1J,:?3B5\^&6ZI8[">"(0G0:GL1,%DT6C+/1*<H#@.C75,$<*;!@0K$NTI
M/_)INH7>J[_7&#.FLIA6#;2^QL88(\NH*-P6#?UU930C=)0!+LQ]:!F]2<2Q
M1>YR(U.@7<.4ZRX]><R<4TP2)]Y5),Z6S7+R[/Q6;FP.946KF%>;"1]:!P%:
M7)YG+1%9D2'"S8J_L25:6OEB6KAOBQ(6QC7'D&6(HEH]J;@O.V^/S5^'^=R&
MPA(6 ,BR0U""J(,<YDYPH8.OU Y2A%@7(29'7@RQ+##XR)!R*\4+,06O%7F7
MXI%-493)85GRI2S^+ O \$=%QN&@2>N>X^"(Z@OM8)C@ICS!O:(>T_^F!7_Z
MT"\\RQ&=_OODP1_:1"G_VD1YF4V41=?_Y;]YZZG;C^)'Q7!;':QBRI5(Q=^2
M3I[ZAZ.V\\6R]*WEA4!)]PLH^ &&58%@M]9@:$A4]J 1YM0<:7Q <"_%S<\.
M/R#-2 8L:'H ]C<>,L]V#!+JMH-VW\'SH_*02$+S?# 5_-[R55\W]&:M5(KG
M$:L@;>(![C/#$TJV*7) -W0\Q-UN6$#A$*);)DH*1!4-)E&F2F$BYTABGL\Y
MYT#[]34?O (L;SN5T(;B*%0TDR_K/L/ZV*@?->URS,OT!TZZ&(W'ZR\;%-S2
M8+L^5HV9.)? #NI1WI;S(U/3B]/F9QBBUU!$3]R4HZYBF[J=)*I[IDZY3EU3
MHN;716L5:J7=/'Y_QQ-W%X7::.E!P,O!TB*4EN,&Z"..RP^+G4^_+&AU5[LG
M"?>K:)#X.=!=_QQH-%HS\#HY79R)9+@C E$99IBQ(!O84?.E)5XEC5ZA*F6G
MKNQ)_(Y8V.JZH%UDX*(\1%*MYDM8!<7$ 4M=[2Z$3E_4Q2,R/GG9%.@K+8"L
M2I+W8R#W1;=4$KQC"#(B[K$?P?K.,$H)V0A.9R815Q3ORA))E:SH>8YE<%@.
M/U^!Y)?;<5C-WD75QS L]-NC=Z_:KJ_ACL+(@V7BX9YF]%:'+ !Q_-V]*+3T
MU56I"W7G=>J-PNI:&=SZAEA#1L]9=2P,.0N,%S(>WJ3-Q%84F T81^WT:_$!
M18)!CKARMIIVROX>.ELIYFJ@F)?7R-W:L7^3".GXFX8RL^,'CGD2^J+OXTLU
M-O3-"/8R7>#[%<P/AX,H64@E>C1O[)+(%3/84M?G*>KY5_A=V/GYS%5)^>+4
M1IB<6?B>OQ1)0&<KA]0#YK7L1X="JP^4#!R\^,@=ELOEZFYU2R_=LG&IF"OE
M!^XPH"A>7I8#]!PPC_L^"^!7UN5!<.CT%6\_"'4VQ3,OY?]DAM!WI3L4/%^+
M? )G6V27SZX"U%^-JN4%J5I>BJH+07W.2<QG9%]=::)?G[25!4E;68JT"T']
M@0VK=T/A:G4QX44W;7$*+PKU2KC?;>E^^Q2==OI?BB*EXM;4;.I8+"E2F+!0
MH*NHW#UI4)<2\2VV&](95NO>LL G8^3/H_;99O[%_8#HSQ?^:IWI)&[E5Q+W
M)9*X(?'EORMVZJ>_WO=%(H?(-XMU6B<7A]>?V\T.>=OW48'>F2K,=9BX6R-(
MU4Z%=+$[X]7EGO) 4!#;22BQ*PYU#^([47"ERSC8D9M(XAP@P8PE'@:2U8E=
M!E%HSZ\1$'&E:H!6P<.K<00XZKD#VX% 984IO'?EE"L@V\4G[ON.ML.[C _;
MAV!]+^K3>OHI%.;D-^???1S]$K;-UPL2W\O:@4T%I3UKZN>L906Z'4WV%[K?
MO3MMBQ2,K5T 4N %<.= I!V=G$,<[-")93NOQAB)#_%NZ/T?Q^IY@XMKU/=A
MK<7E 5_P@CGTS S=WVP_819X0R:IPVPY,]]3SF,1_V;K@%S*0HE]<H9%\F_&
MW7E!WV/EE)X"6.C:^D1L;4(@8-;B*]!A0![)\V-]?$!:#?'';7'OZ%;< 2S+
M[\1L13_V^_CX3B^>/MX=G@^^5ON[XZ.=,]W^,G#LW4_73O/T^O?F0[WH=:QC
MIVTZA4]\6'%/=EJM=KVC[6YIK3_^,D8[-Z-[UMPZ>WSXZZ_JU4W9N/S,FE]/
MV-Y9?W+<=8[/6WSOYE3[6BY5W<+NX=WA::/_>7C2'%<\JW?A?3K^:S0YZ=QO
M-^^.6Z=L=,(O>&OG],$:-:O#QV_NQ:Y]TNT\_'7>_<*+)^Y_JNU"^3_WPYNA
MR?[4FT?EP?#Q=.]+H[PW\#[?'7WA.W2K-S[6/K6_GOQ.+XZ^_/[I='A3\"Z\
M:_.JT1E_ZS9/;W:JQX7VN/#5*-ZW)3G^'U!+ P04    "  :0&=5Y^=X9M0C
M   'Q0  %@   '1M,C(R.3<Y-&0Q7V5X,3 M,2YH=&WM/6MSVT:2WUG%_S"G
MNTM)5; >?B1925$514$6LA3))2EK75?W 02'%"(08/"0K/OUUX\98 "">MBR
M8SG<K8I%$ICI[NGIZ?<<GHW..T?-QN&9W3J!?P7^[W#DC#KVT>$._PN_[JB?
M#X][)Q_%</2Q8_^V,8W"=%_L[2Y2,?+G,A%=>2L&T=P-+?["$D,9^],->!%>
M[3_UO0,Q=^.9'^X+?'3W0*3R4_K*#?P9?.7),)7QQM%/X3A9'!SN]+_&)+$_
MNTHWC@Z/C^Q/5_[83V' [;W#G>.CKSZAQNL;3'7H 'K2RU(_"L4'&2?P[^&.
M\_5!^"9KJ"<Y/.UU1^;(KZ;NW _N]A\:FYY-_/^3# J1K"WCU(U=J]EP0F^;
M283CPV\#0&)O=U?T;F0<1-&U:!, ,%SFIQ*&V.-G^K$?>C*-8+[N[V+WUW=O
M=U\RF14[=:,;.1_+6+RQQ.O=UZ^_[FS/C-'&4<>=^/#X3^Y\<2#> ]T".9?A
M_C/.\.P@/Q]?VZYWU6Q$4Z&Y6R!S6\(5)S)P;]U8"B^*%U'LDJ383*.93*]@
MK6_]]$KX:2*2S/-DDD1Q(MQP(A8RGOMI*B?"31)8-SFQ!+P@?@HF?V;1 >ZC
M:+YPPSO<0#_%]*6(8O-WAL3X?0OV'([=BA,9NH$8NFD6A^(L"B9^.$M$IP^
ME>;03_;=.+TKC02DO)8BEE,92]B+(HWVQ::_!3"Z*>P:F-H/Q3"-O.LK&!X$
MHVC-8HD<D8I--P% X,\)8C6/)O[4!T0!^B1;+(AM$/%I',U%"G2'P?E?&-+U
M@(X3%Z?,20<[=)Y4R5,_MXF#B*;-!KZD*&D)VNPPLQ_"C&X"#]"@$Q>$#RR6
MC*:6&-_1^KCS*)P));E*@^"'$MVL_&/;7?BI^CI$N!S'0:K#@,W&?0^].H;'
M#H# 50KWL]B[<A-98&@1N)-Z\)'T0#)8O#LQEB)? _4' Q++),4AK/)RP/)$
MR+*W/DR7+]K2(E7781G",A^5Z&G0#J0\$H]^M/\U$JT;%]@9J8(LU-GN;XO-
M8A9XHK(1*MP@@T#&Y9EOKWSO2BSBZ,:?P&:?1C%B//Y#>BDA P,DL%V3J>OA
MIJ7MC5\2NQ%<7A1.?/P-MJ],<03DR)">JEL9'C*0N#)Z!9,KP(C6RHOF0 21
M(.-:8@'(WKA!)L5_[6[O[J% X&>M'!#%<B8=ACCZD(8LL3HO$[S#A-#XE?@4
MF -P CET)=+8#1-&>VE?X0RCXG=SF@.6+\"F53X=R)F?I$KZ#? $J@@$\>SR
M@/=V ?B]()0YX\ERX $!</_F5A+@7BE! F!;G"K&=F\BGY$&T"91-@;F0O2C
M+!6!#P>'KX "EI2S"#X!4OJ(>A98Q*87 2<!"]S( ) NZ'R:P?OP6(G_@'.#
M0(11BF)G@C0'00/$12$4ZI=+1--;&4:3L;'O:"W\1 023L=8N#D3(=@//V;!
MHGI!-M$$0F$7^\3)<"@!9Q#KPZF&S#64_(/8H]'?YHM?H.,"@]XA0VJTMS7-
M0#N8*&"RA)AI!>"T45!#P/$F<NJ'2!R>XLJ]D03G7+HAPCP#>H=J^\ZUK*D_
MZ[;%"'X#.9*B7D;S\5P*+;%GY7^^)@3UI[>:?,W&,ID!T(J4]((H0=C4-JE*
M"&,)EX5B6>.X.&KS6(<[%\9^I&.)"3*6(":ED-,I\Y[(%A$30;VY_3TKG$Z(
M9T8"YXV20XIDBUC.X5CE4T5]%TOX%C9$2D_"D*!% E%Q,4&@>& LA/")7\F7
MQSR(D%G]D#>^J!P9>K.4#P#F$1?/PB"(;I.OJ+R/6L<=6[3M3J??.CEQNN]_
MV]C=H,_#?JNM/U\Z)Z.SWS; )OSOC<^%X%4:+0B*_(MQE*;1G+X#&V TT".#
MU9GZGAMH2PE>1/_+X>A$/W'K3]*K?3(==D8G1S6_;+_SP^<S+)3EQC(IB@%F
M.!!E[,$6VCC:V]:&LX*%'!(7<- 5(DT CXV41$MP4Z%4W@9[6F]@BUDNI'_P
MA+7T1A*1YV5QC'_=MX'W>?:=T0#_@ZM:X9A'K +C_3A_V _%1XI;5O'2ZV=F
M)CBRHWA?_.<N$&(7F'C3W:JRT JAD+!V98H0/$HL8(W4#_C<O8W$YNLM<2=!
M<W7#$(1SG+CQG18]*/BR^;PD]Y:."CP-F@U#F^C R?;J8B'Z@%(T*:MIR[ 6
MY[)F>H%?1 A0#LA0:=RW<,ZB&@?VT&:N%%@H/,LZ%BE-2LG*@>9!K*H:5%8Y
M-?#+"OD6GIT($^"5(#W(&0 D#5'\%L8_@)<?T<T&JQ_;HH42''Z?+_"9'%4
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M6$*/H%NVN!(PE@(W-I/98 TGE#Y&N37:WBFE1NA-A;J#!W8Z)<^ TAP%-R1
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MD,=%=/W4F#N 3/(("#.CJD2$T3.!S1J(I8E,^> *;8ZWT.1W!4D?)"8&(F3
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M!\NJ#L(.QB(3C-^!HJON-*_M_WO/+:JQZGY^1V94,=I8IK=2]5&JNZ/ROFL
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M/V[ K^:3,PBS<]P[^8@1BIVST7GGZ/\!4$L#!!0    ( !I 9U6RQL /_T\
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M;1_H-$A("4(W<C#08'XE5@Q=V.IVMNI86XDI*VXD@")V?[5K0O(&N\>R9OI
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M6#3/TCF:T\,II[PI,7".-*4]J#L[N31CS)_#D?@;> JFX<.[F/'2AVY8RH]
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M=B%V4LH*Q:#7C>AP9<AE8-!E9-N2_EG0,F<HEO8OPR 9%?11*KM"M9-HW\G
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MPB1UFM.:6L 4W?5#1)C<WK*KME26%HVF$K "7\4=!B V;K<Z2 &,AR*;A,>
M5JD[+G9J&01I/]$,BI^[ H.A1Y+'9/YZ[.HE#):"S*M]&VXYYFGE]9\\VYD=
M"REMF&Y4@3^1%])2^KP30(;BBIOBF*HP9(&=U0VYO>6D <]$6_ *2RR/0WYN
M.G9T*G+1JPB6GF;('7OJB7ZL32&5]+.QL#4DC4TK'O: XLP0$H;<XSDY%DX
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M-XMM26X?>JB0N)9/";U?H%N#AO$XBQ^O.+31?(D//__ B0_/-XD/]Q"!6GQ
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MP]8U[:#[#HMYA(E6>$)*QX9$NNH'<8A;WL0&VHGO26@JZN^]?GL&+P%9JTZ
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M$8_2H:=.]YI[#$9Y%O=TDJG6GOHU1@TKXR\W_&N=[9]';]Y:3S%W"BT@(N2
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M&V;R4JQ/$\+U."W "?""B368P.)V+*"B9[UIDM#BJ+E<!.X5^F6:F<&_N)L
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M5XEPF7E]2C.W3+J<^<9RGAJ&#R/,3L9Y.$G/*"K^9@/7Y(581&],)(:A:+;
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M(^R-8=I&O'[R=H7O4E5-&]8[4^DPHNOH@32#$T@?!SK9(/S HF.N+'6:9A?
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MDAR^4B?<V.NE.O;3;'4TE/M3%YZ\/3GZXPW^Y7WWP_&;_P]02P,$%     @
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M3!6W;F!:8O&2Z4)H!\'9N*4#DBVP=A3I 4M*U:(ODFT<T#!NK'3)$Q0@=M*
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M6^4>K#@9:+KNANKX#*+8FI0]"]=!_F(#&62Y&%Z$7ONY<7<R+8R+!$F+14;
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M,< =D[&_)-W_W4;I_M<% L<H_591>S2+KJY^C Y<$^T3["1:N5RA3?TQF[F
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M+"FP/C6<^L0T@ ]M,S*@EK+Q\.0#5A:+\MI _P5T%_SBLKC&)L.-EA0\2K9
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MPY8:,*C  R/SO$J'3E:[0Q+#XD(WJ]C$P;2A/-,LD\P==Z1Y?VCK4XQ1XWJ
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M?0_(?TT+-#B@:Y_5[#Y=<'N[!1W1_ZY)V>5?&@F_1<*_;/)O4$L! A0#%
M  @ &D!G53<+CY,[ P  \@L  !$              ( !     &-E<G0M,C R
M,C$Q,#,N>'-D4$L! A0#%     @ &D!G5>1]4/G_"@  ;(<  !4
M     ( !:@,  &-E<G0M,C R,C$Q,#-?;&%B+GAM;%!+ 0(4 Q0    ( !I
M9U77NYI+4@<  +]8   5              "  9P.  !C97)T+3(P,C(Q,3 S
M7W!R92YX;6Q02P$"% ,4    "  :0&=5@/G?1J,=  "II@  $@
M    @ $A%@  =&TR,C(Y-SDT9#%?.&LN:'1M4$L! A0#%     @ &D!G5>?G
M>&;4(P  !\4  !8              ( !]#,  '1M,C(R.3<Y-&0Q7V5X,3 M
M,2YH=&U02P$"% ,4    "  :0&=5LL; #_]/  "J)P( %@
M@ '\5P  =&TR,C(Y-SDT9#%?97@Q,"TR+FAT;5!+ 0(4 Q0    ( !I 9U7%
M\A"FDG\  +LM P 6              "  2^H  !T;3(R,CDW.31D,5]E>#$P
M+3,N:'1M4$L! A0#%     @ &D!G56-TGTG7"0  <R(  !8
M ( !]2<! '1M,C(R.3<Y-&0Q7V5X.3DM,2YH=&U02P4&      @ "  5 @
& #(!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
